##### Table of Contents



SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20459

FORM 10-K

[X] ANNUAL REPORT PURSUANT TO SECTION 13
OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934

|                                          |  |                             
|----------------------------------------- |  | ----------------------------
|For the Fiscal Year
Ended August 31, 2002 |  | Commission
File Number 0-288
|                                          |  |                             

ROBBINS & MYERS, INC.

---

(Exact name of
Registrant as specified in its charter)


|                                   |  |                                        
|---------------------------------- |  | ---------------------------------------
|OHIO                               |  | 31-0424220                             
|                                   |  |                                        
|(State of incorporation)           |  | (I.R.S. employer
identification number)
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|                                  
|1400 Kettering Tower, Dayton, Ohio |  | 45423                                  
|                                   |  |                                        

Registrants telephone number, including area code:

(937) 222-2610

Securities registered pursuant to Section 12(b) of the Act:

|                                                         |  |                         
|-------------------------------------------------------- |  | ------------------------
|                                                         |  | Name of each exchange on
|Title of each class                                      |  | which registered        
|                                                         |  |                         
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|(1)      Common Shares, without par value                |  | New York                
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|(2)      6 1/2% Convertible Subordinated Notes, Due 2003 |  | New York                

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirement for at least the past 90 days.
Yes [x] No [ ].

Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to
the best of registrants knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [x]

1



---

TABLE OF CONTENTS



|                                                                                                        |  |  |  |  |  |  |  | 
|------------------------------------------------------------------------------------------------------- |  |  |  |  |  |  |  | 
|ITEM 1. BUSINESS                                                                                       
|ITEM 2. PROPERTIES                                                                                     
|ITEM 3. LEGAL PROCEEDINGS                                                                              
|ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS                                            
|PART II                                                                                                
|ITEM 5. MARKET FOR THE REGISTRANTS COMMON EQUITY AND RELATED STOCKHOLDER MATTERS                      
|ITEM 6. SELECTED FINANCIAL DATA                                                                        
|ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS          
|ITEM 7A. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK                                    
|ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA                                                    
|NOTES TO CONSOLIDATED FINANCIAL STATEMENTS                                                             
|ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE           
|ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT                                            
|ITEM 11. EXECUTIVE COMPENSATION                                                                        
|ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS                                                
|PART IV                                                                                                
|ITEM 14. CONTROLS AND PROCEDURES                                                                       
|ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K                              
|SIGNATURES                                                                                             
|CERTIFICATIONS                                                                                         
|REPORT OF INDEPENDENT AUDITORS                                                                         
|SCHEDULE II  VALUATION AND QUALIFYING ACCOUNTS                                                        
|INDEX TO EXHIBITS                                                                                      
|EX-21.1 Subsidiaries of Robbins & Myers, Inc.                                                          
|EX-23.1 Consent of Ernst & Young LLP                                                                   
|EX-24.1 Powers of Attorney                                                                             
|EX-99.1 Section 906 CEO Certification                                                                  
|EX-99.2 Section 906 CFO Certification                                                                  



---



##### Table of Contents



At the close of business on October 18, 2002

|                                                                                                  |  |   |             | 
|------------------------------------------------------------------------------------------------- |  | - | ----------- | 
|Number
of Common Shares, without
par value, outstanding                                           |  |   | 14,344,896  | 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|                                                                                                 
|Aggregate
market value of Common
Shares, without par value, held
by non-affiliates of the Company |  | $ | 209,082,481 | 

DOCUMENT INCORPORATED BY REFERENCE

Robbins & Myers, Inc., Proxy Statement, dated November 7, 2002, for its
Annual Meeting of Shareholders on December 11, 2002, definitive copies of the
foregoing have been filed with the Commission. Only such portions of the Proxy
Statement as are specifically incorporated by reference under Part III of this
Report shall be deemed filed as part of this Report.

2



---



##### Table of Contents






ITEM 1. BUSINESS

OVERVIEW

Robbins & Myers, Inc. is an Ohio corporation. As used in this report, the
terms Company, we, our, or us mean Robbins & Myers, Inc. and its
subsidiaries (unless the context indicates another meaning). We are a leading
designer, manufacturer and marketer of highly engineered, application-critical
equipment and systems for the pharmaceutical, energy and industrial markets
worldwide. Our principal brand names  Pfaudler®, Moyno®, Chemineer®, Laetus®,
FrymaKoruma®, Siebler®, Hapa® and Hercules®  hold the number one or two market
share position in the niche markets they serve. We attribute our success to our
close and continuing interaction with customers, our manufacturing, sourcing
and application engineering expertise and our ability to serve customers
globally. Our fiscal 2002 sales were approximately $526 million, and no one
customer accounted for more than 5% of these sales.

During the past five years, our strategy has been to increase our focus on
higher-growth markets, such as pharmaceutical and energy, and to broaden our
international presence. In furtherance to this strategy, on August 31, 2001, we
acquired Romaco, a European-based manufacturer of processing, dosing, filling,
printing and security equipment for the pharmaceutical and healthcare
industries. Our acquisition of Romaco, which had sales of approximately $142
million in our fiscal 2001, expands the breadth of our pharmaceutical
capabilities and positions us as a leading supplier of primary and secondary
processing equipment to the growing pharmaceutical market. The addition of
Romaco also increased our international sales from 45% of our fiscal 2001 sales
to 60% of our fiscal 2002 sales.

Our business consists of three market-focused segments: pharmaceutical,
energy and industrial.

Pharmaceutical.Our pharmaceutical business segment includes our Reactor
Systems and Romaco businesses and is focused primarily on the pharmaceutical
and healthcare industries. Our Reactor Systems business designs, manufacturers
and markets primary processing equipment and has the leading worldwide position
in glass-lined reactors and storage vessels. Our Romaco business designs,
manufacturers and markets secondary processing, dosing, filling, printing and
security equipment. Several of our Romaco brands hold the number one or two
worldwide position in the niche markets they serve. Major customers of our
pharmaceutical segment include Bayer, GlaxoSmithKline, Merck, Novartis and
Pharmacia.

Energy.Our energy business segment designs, manufactures and markets
equipment and systems used in oil and gas exploration and recovery. Our
equipment and systems include hydraulic drilling power sections, down-hole
pumps and a broad line of ancillary equipment, such as rod guides, rod and
tubing rotators, wellhead systems, pipeline closure products and valves. These
products and systems are used at the wellhead and in subsurface drilling and
production. Several of our energy products, including hydraulic drilling power
sections and down-hole pumps, hold the number one

3



---



##### Table of Contents



or two worldwide position in
their respective markets. Major customers of our energy segment include
Schlumberger, Chevron Texaco and National Oilwell.

Industrial.Our industrial business segment is comprised of our Moyno,
Chemineer and Edlon businesses, which design, manufacture and market products
that are used in specialty chemical, wastewater treatment and a variety of
other industrial applications. Our Moyno business manufactures pumps that
utilize progressing cavity technology to provide fluids-handling solutions for
a wide range of applications involving the flow of viscous, abrasive and
solid-laden slurries and sludges. Our Chemineer business manufactures
high-quality standard and customized fluid-agitation equipment and systems. Our
Edlon business manufactures customized fluoropolymer-lined pipe, fittings,
vessels and accessories. Our industrial segment has a highly diversified
customer base and sells its products to over 3,400 customers worldwide.

Information concerning our sales, income before interest and income taxes,
identifiable assets by segment, and sales and identifiable assets by geographic
area for the years ended August 31, 2002, 2001 and 2000 is set forth in Note 13
to the Consolidated Financial Statements included at Item 8 and is incorporated
herein by reference.

Pharmaceutical Business Segment

Our pharmaceutical business segment, which includes our Reactor Systems
and Romaco businesses, primarily serves the pharmaceutical, healthcare,
nutraceutical and fine chemicals markets. We believe that our pharmaceutical
business segment will benefit from the continued trend of high levels of
capital expenditures within these industries. We expect the need for new and
enhanced processing equipment will be driven by numerous factors, including the
accelerating pace of the drug discovery process, the cost advantages of
pharmaceuticals over alternative forms of treatment, the aging of the
population, the increasing availability of generic drugs due to the expiration
of patents, the impact of increasing direct-to-consumer advertising by
pharmaceutical manufacturers, the growing demand for nutraceutical products and
escalating healthcare expenditures in emerging markets.

Reactor Systems

Our Reactor Systems business, which includes our Pfaudler and
TyconTechnoglass brands, designs, manufactures and markets glass-lined reactor
and storage vessels, engineered systems, mixing systems and accessories,
including instrumentation and piping. This equipment is principally used in the
primary processing of pharmaceuticals and fine chemicals. A reactor system
performs critical functions in batch processing by providing a pressure- and
temperature-controlled agitation environment for the often complex chemical
reactions necessary to process pharmaceuticals and fine chemicals.

To produce a reactor system, we fabricate a specialized steel vessel,
which may include an outer jacket for a heating and cooling system, and line
the vessel with glass by bonding the glass to the inside steel surface.
Application-specific glasses are bonded with the inner steel surface of the
vessel to provide an inert and corrosion-resistant

4



---



##### Table of Contents



surface. In response to
market demand, we introduced Pfaudler Pharmaglass PPG in fiscal 2001. We
believe this new glass is smoother, cleaner and less likely to contaminate the
chemicals being processed than any other glass available.

Our Reactor Systems business sells reactor vessels with capacities up to
15,000 gallons, which are generally both custom ordered and designed, and are
often equipped with accessories, such as drives, glass-lined agitators and
baffles. We also sell these vessels as part of an engineered system. Using our
application engineering expertise and our understanding of our customers
requirements, we are able to engineer and produce a complete processing system,
which may be installed at the customers facility or delivered to the customer
as a skid-mounted system. A complete engineered system may include a process
guarantee and range in price from approximately $500,000 to $5 million.
Additionally, we manufacture and sell glass-lined storage vessels with
capacities up to 25,000 gallons, primarily to the same customers that use
glass-lined reactor systems.

Sales, Marketing and Distribution.We primarily market and sell Pfaudler
and TyconTechnoglass equipment and systems through our direct sales force,
which includes approximately 10 direct sales employees in the U.S. and 20
outside the U.S., who are supported by numerous other personnel including our
application engineers. We also use approximately 30 manufacturers
representatives in the marketing of reactor systems equipment. We are focused
on continuing to develop preferred supplier relationships with major
pharmaceutical companies as they continue to expand their production operations
in emerging markets and seek to limit the number of suppliers that service
their needs worldwide.

Aftermarket Sales.Aftermarket products and services, which include field
service, replacement parts, accessories and reconditioning of glass-lined
vessels, are an important part of our Reactor Systems business. Glass-lined
vessels require regular maintenance and care because they are subjected to
harsh operating conditions, and there is often a need to maintain a high-purity
processing environment. We have expanded our aftermarket capabilities to take
advantage of our large installed base of Pfaudler glass-lined vessels and to
better meet the needs of our customers, who are increasingly inclined to
outsource various maintenance and service functions.

We service our own and competitors equipment from our various facilities
and have two units dedicated to serving the aftermarket 
Glasteel Parts and
Service (GPS) and Chemical Reactor Services (CRS). GPS and CRS are the leading
providers of aftermarket services for glass-lined equipment in the U.S. and in
Europe, respectively. Through our joint venture, Universal Glasteel Equipment,
we refurbish and sell used, glass-lined vessels.

Markets and Competition.We believe we have the number one worldwide
market position in glass-lined reactors and storage vessels, representing a
global market share in excess of 50%. Our Pfaudler brand has the leading market
share in glass-lined reactors and vessels, as well as the largest installed
base in most of the countries in which Pfaudler operates, including Germany,
Mexico, Brazil, India, Scotland and the U.S. Our TyconTechnoglass brand has the
leading market share in Italy and a significant project business globally. Our
Pfaudler and TyconTechnoglass brands

5



---



##### Table of Contents



compete principally with DeDeitrich, a
French company, in all world markets except Japan, China and India.

Romaco

Our acquisition of Romaco on August 31, 2001 represented a key step in our
strategy to expand our equipment and systems offerings to our pharmaceutical
customers and to grow internationally. Romaco designs, manufactures and markets
secondary processing, dosing, filling, printing and security equipment used by
the pharmaceutical, healthcare, nutraceutical and cosmetics industries. The
principal brand names in our Romaco business, which hold the number one and two
market share position in the niche markets they serve, are Laetus, FrymaKoruma,
Hapa and Siebler.

Romaco equipment and systems are used in:



| |  | secondary processing of pharmaceuticals, such as homogenizers,
granulators and dryers;                                                                   
|- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------
| 
| |  | dosing, filling and sealing of vials, capsules, tubes, tablet pressing
and other containers; and                                                         
| 
| |  | printing, security and packaging functions, such as strip and blister
packaging equipment, and in-line printing, labeling, security and
control equipment

Romacos expertise extends from secondary processing through the final
packaging of pharmaceuticals, nutraceuticals and cosmetics. For example, Romaco
provides modular processing, dosing and filling systems, which can include
equipment for the in-line labeling of drugs and the printing of dispensing
packages. Romaco employs more than 150 application engineers who work closely
with customers to design specific equipment and systems to meet their
requirements.

Sales, Marketing and Distribution.We distribute Romaco products through
our distribution network, which currently includes 17 sales and service
centers. In the geographic areas served by these centers, we sell directly to
end users through our own sales force. We use manfacturers representatives to
cover territories that are not effectively covered by our direct sales network.

Aftermarket Sales.Aftermarket sales of our Romaco business were
approximately $35 million in fiscal 2002, or 20% of Romacos total sales.
Included in these aftermarket sales are certain proprietary consumables, such
as inks and labels.

Markets and Competition.Romaco has a large installed base of equipment in
Europe, where it has its greatest market share, and a smaller presence in the
U.S. and Asia. We believe there are opportunities, through our Reactor Systems
customer base and our exiting facilities in the U.S. and Asia, to effectively
introduce Romaco products to customers in these markets. We believe Romaco is
one of the top four worldwide manufacturers of the type of pharmaceutical
equipment it provides; however, the market is fragmented with many competitors,
none of which is dominant. Given the fragmented

6



---



##### Table of Contents



nature of the industry, we
believe there are strategic opportunities to expand our market share through
acquisitions of companies and particular product lines.

Energy Business Segment

Our energy business designs, manufactures and markets a variety of
specialized equipment and systems used in oil and gas exploration and recovery.
Our equipment and systems are used at the wellhead and in subsurface drilling
and production and include:



| |  | hydraulic drilling power sections and down-hole progressing cavity
pumps, which we market under our Moyno brand name;
|- |  | ---------------------------------------------------------------------------------------------------------------------
| 
| |  | tubing wear prevention equipment, such as rod guides and rod and
tubing rotators;                                    
| 
| |  | a broad line of ancillary equipment used at the wellhead; and                                                        
| 
| |  | pipeline closure products and valves, which we market under our Yale
and Hercules brand names,                       

Hydraulic drilling power sections are used to drive the drill bit in
horizontal and
directional drilling applications, often drilling multiple wells from a single
location. Down-hole pumps are used primarily to lift crude oil to the surface
where there is insufficient natural pressure and for dewatering gas wells. The
largest oil and natural gas recovery markets that benefit from using down-hole
pumps are in Canada, the U.S., Venezuela, Indonesia and the Commonwealth of
Independent States (CIS). Rod guides are placed on down-hole rods used to pump
oil to protect the rods and the production tubing from damage during operation
and to enhance the flow of fluid to the surface. Tubing rotator products are an
effective way of evenly distributing down-hole tubing wear. Wellhead products
are used at the wellhead to control the flow of oil, gas and other material
from the well. Pipeline closure products are used in oil and gas pipelines to
allow access to a pipeline at selected intervals for inspection and cleaning.
Principal brands of our energy segment include Moyno, Yale and Hercules.

Sales, Marketing and Distribution.We sell our hydraulic drilling power
sections directly to oilfield service companies through our sales office near
Houston, Texas. We sell our tubing wear prevention products and certain
wellhead equipment in the U.S. and Canada through major national distributors
and our service centers in key oilfield locations. We currently operate seven
service centers in the U.S. and eight service centers in Alberta, Canada. We sell
down-hole pumps in the U.S. through three distributors; in Canada and Venezuela
through our service centers; and in the CIS and Asia through several
distributors. We sell wellhead and closure products through distributor
networks in the U.S. and Canada.

Aftermarket Sales.Aftermarket sales in our energy business consist
principally of the relining of stators and the refurbishment of rotors.
However, replacement items, such as power sections and down-hole pump rotors
and rod guides, which wear out

7



---



##### Table of Contents



after regular usage, are complete products and
are not identifiable by us as aftermarket sales.

Markets and Competition.Our energy business is the leading independent
manufacturer of hydraulic drilling power sections worldwide. We are also the
leading manufacturer of rod guides, wellhead components and pipeline closure
products and the second leading manufacturer of down-hole progressing cavity
pumps. While the oil and gas exploration and recovery equipment marketplace is
highly fragmented, we believe that, with our leading products, we are
effectively positioned as a full-line supplier with the capability to provide
customers with complete system sourcing.

Oil and gas service companies use the most advanced technologies available
in the exploration and recovery of oil and gas. Accordingly, new product
innovation is critical to our business. We continually develop new elastomer
compounds, as well as new stator manufacturing technologies, for use in power
sections and down-hole pumps that allow drilling and recovery operations to be
conducted in deeper formations and under more adverse conditions. We are also
focused on innovations that reduce downtime in drilling and production
activities for end-users of our equipment who incur high costs for any
downtime. In addition, we regularly introduce new wellhead equipment and rod
guide designs and materials to improve the efficiency of well production.

Industrial Business Segment

Our industrial business segment is comprised of our Moyno, Chemineer and
Edlon businesses, which design, manufacture and market products that are used
in specialty chemical, wastewater treatment and a variety of other industrial
applications.
Our industrial businesses have strong brand names and market share and maintain
strict operating discipline.

Moyno

Our Moyno business designs, manufactures and markets progressing cavity
pumps and related products for use in the wastewater treatment, specialty
chemical, mining, oil, food and beverage, pulp and paper and general industrial
markets. Prices range from several hundred dollars for small pumps to $200,000
for large pumps, such as those used in wastewater treatment applications.

Progressing cavity technology utilizes a motor-driven, high-strength,
single or multi-helix rotor within an elastomer-lined stator. The spaces
between the helixes create continual cavities, which enable the fluid to move
from the suction end to the discharge end. The continuous seal creates positive
displacement and an even flow regardless of the speed of the application.
Progressing cavity pumps are versatile as they can be positioned at any angle
and can deliver flow in either direction without modification or accessories.
Since progressing cavity pumps have no valves, they are able to efficiently
handle fluids ranging from high-pressure water and shear-sensitive materials to
heavy, viscous, abrasive and solid-laden slurries and sludges. In fiscal 2001,
we introduced the Moyno HS2000 system, which was selected by Flow Control
magazine for its annual product innovation award. The Moyno HS2000 system is a
cost-effective alternative to

8



---



##### Table of Contents



expensive, high-maintenance piston pumps or
conveyors for dewatered sludge transfer in municipal wastewater treatment.

Sales, Marketing and Distribution.We sell our pumps through approximately
35 U.S. and 30 non-U.S. distributors and approximately 25 U.S. and 15 non-U.S.
manufacturers representatives. These networks are managed by five regional
sales offices in the U.S. and offices in the U.K., Mexico, China and Singapore.

Markets and Competition.Moyno has a large installed base and a dominant
market share in progressing cavity pumps in the U.S. and a smaller presence in
Europe and Asia. While we believe Moyno is the U.S. leader in the manufacture
of progressing cavity pumps, the worldwide market is highly competitive and
includes several competitors, none of which is dominant. In addition, there are
several other types of positive displacement pumps, including gear, lobe and
air-operated diaphragm pumps that compete with progressing cavity pumps in
certain applications.

Chemineer

Chemineer manufactures industrial mixers that range in price from hundreds
of dollars for small portable mixers to over $1 million for large, customized
mixers. These products include top-entry, side-entry, gear-driven, belt-driven,
high-shear and static mixers, which are marketed under the Chemineer, Greerco,
Kenics and Prochem brand names for various industrial applications, ranging
from simple storage tank agitation to critical applications in polymerization
and fermentation processes.

Chemineers high-quality gear-driven agitators are available in various
sizes, a wide selection of mounting methods and drives of up to 1,000
horsepower. Chemineer introduced two new agitation drive systems to compete
more effectively in the small-mixer market. These are the DT small mixers, a
line of fixed mounted, small mixers with drive ranges from one-half to five
horsepower for less demanding applications, and the Chemineer XPress portable
mixers, a line of portable gear-driven and direct-drive mixers, which can be
clamp mounted to handle small-batch mixing needs.

Our belt-driven, side-entry mixers are used primarily in the pulp and
paper and mineral processing industries. Our static mixers are continuous
mixing and processing devices with no moving parts, and are used in specialized
mixing and heat transfer applications. Our high-shear mixers are used primarily
for paint, cosmetics, plastics and adhesive applications.

Sales, Marketing and Distribution.Chemineer sells industrial mixers
through regional sales offices and through a network of approximately 30 U.S.
and 30 non-U.S. manufacturers representatives. Our Chemineer business
maintains regional sales offices in Mexico, Canada, the U.K., Singapore,
Taiwan, China and Korea.

Markets and Competition.The mixer equipment industry is highly
competitive. We believe that Lightnin, a unit of SPX Corporation, holds more
than 50% of the world market share, and that we hold the number two market
position worldwide. In addition, there are numerous smaller manufacturers with
which we compete in this market. We believe that Chemineers application
engineering expertise, diverse products, product

9



---



##### Table of Contents



quality and customer support
capabilities allow us to compete effectively in the marketplace.

Edlon

Edlon manufactures and markets fluoropolymer-lined pipe and fittings,
fluoropolymer coated and lined vessels for process equipment, fluoropolymer
roll covers for paper machines and glass-lined reactor systems accessories.
Edlons products are used principally in the specialty chemical, pharmaceutical
and semiconductor markets to provide corrosion protection and high-purity fluid
assurance and in the paper industry for release applications. Edlon has
introduced newly designed storage tanks for de-ionized water and ultra-pure
chemicals and expanded the range of products it sells to chip producers and
wafer manufacturers in the higher-growth semiconductor industry.

Sales, Marketing and Distribution.We sell our Edlon products in the U.S.
through a distributor network for higher-volume items, such as lined pipe and
fittings, as well as through our direct sales force and sales representatives
for lower-volume products. Outside the U.S., we sell our Edlon products through
sales representatives, except in the U.K. where we sell our products through
our direct sales force.

Markets and Competition.Edlon primarily competes by offering highly
engineered products and products made for special needs, which are not readily
supplied by competitors. Edlon is able to compete effectively based on its
extensive knowledge and application expertise with fluoropolymers.

BACKLOG

Our order backlog was $125.7 million at August 31, 2002 compared with
$143.5 million at August 31, 2001. We expect to ship substantially all of our
backlog during the next 12 months.

CUSTOMERS

Sales are not concentrated with any customer, as no customer represented
more than 5% of sales in fiscal 2002, 2001 or 2000.

RAW MATERIALS

Raw materials are purchased from various vendors that generally are
located in the same country as our facility using the raw materials. The supply
of raw materials and components has been adequate and available without
significant delivery delays. No events are known or anticipated that would
change the sources and availability of raw materials. No supplier provides more
than 5% of our raw materials.

GENERAL

We own a number of
patents relating to the design and manufacture of our products. While we consider these patents important to our operations, we
believe that the successful manufacture and sale of our products depend more
upon technological

10



---



##### Table of Contents



know-how and manufacturing skills. We are committed to
maintaining high quality manufacturing standards and have completed ISO
certification at several facilities.

During fiscal 2002, we spent approximately $6.2 million on research and
development activities compared with $2.2 million in fiscal 2001 and $1.8
million in fiscal 2000. The increase in research and development costs was due
to the acquisition of Romaco.

Compliance with federal, state and local laws regulating the discharge of
materials into the environment is not anticipated to have any material effect
upon our capital expenditures, earnings or competitive position.

At August 31, 2002, we had 3,921 employees, which included approximately
600 at majority-owned joint ventures. Approximately 750 of these employees were
covered by collective bargaining agreements at various locations. In fiscal
year 2003, the company has no labor contracts expiring. A labor agreement was
reached with the employees of Chemineers principal manufacturing facility in
October 2000 and extends to March of 2004. A labor agreement was reached with
the employees of Moynos principal manufacturing facility in August 2001 and
extends to February 2005. A labor agreement was reached with the employees of
Pfaudlers facility in Rochester, New York in September 2001 and extends to
September 2004. The Company considers labor relations at each of its locations
to be good.

11



---



##### Table of Contents






ITEM 2. PROPERTIES

Facilities

Our executive offices are located in Dayton, Ohio. The executive offices
are leased and occupy approximately 10,000 square feet. Set forth below is
certain information relating to our principal operating facilities.

|                             |  |             |  |        |                          |                                                        
|---------------------------- |  | ----------- |  | ------ | ------------------------ | -------------------------------------------------------
|                             |  | Square      |  |        | Products Manufactured or
|Location                     |  | Footage     |  |        | Other Use of Facility   
|                             |  |             |  |        |                         
|North and South America:     |  |             |  |        |                          |                                                        
|                            
|                            
|                            
|                            
|Rochester, New York          |  | 500,000     |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Springfield, Ohio            |  | 275,000     |  |        |                          | Industrial Pump Products                               
|                            
|                            
|                            
|                            
|Dayton, Ohio                 |  | 160,000     |  |        |                          | Industrial Mixers                                      
|                            
|                            
|                            
|                            
|Borger, Texas                |  | 115,000     |  |        |                          | Wellhead products for Energy Systems                   
|                            
|                            
|                            
|                            
|Willis, Texas                |  | 110,000     |  |        |                          | Down-hole pumps and power sections for Energy Systems  
|                            
|                            
|                            
|                            
|Mexico City, Mexico          |  | 110,000     |  |        |                          | Reactor Systems, Industrial Pumps and Industrial Mixers
|                            
|                            
|                            
|                            
|Taubate, Brazil              |  | 100,000     |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Charleston, West Virginia    |  | 100,000     |  |        |                          | Corrosion-Resistant Products                           
|                            
|                            
|                            
|                            
|Tomball, Texas               |  | 75,000      |  |        |                          | Valves and closures for Energy Systems                 
|                            
|                            
|                            
|                            
|Avondale, Pennsylvania       |  | 50,000      |  |        |                          | Corrosion-Resistant Products                           
|                            
|                            
|                            
|                            
|West Chester, Pennsylvania   |  | 30,000      |  |        |                          | Corrosion-Resistant Products                           
|                            
|                            
|                            
|                            
|North Andover, Massachusetts |  | 30,000      |  | (1)    |                          | Industrial Mixers                                      
|                            
|                            
|                            
|                            
|Sao Jose Dos Campos, Brazil  |  | 30,000      |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Edmonton, Alberta, Canada    |  | 25,000 to   |  | (2)    |                          | Energy Systems, including two service centers          
|                            
|                            
|                            
|                            
|2 plants                     |  | 30,000 each |  | (1)    |                          |                                                        
|                            
|                            
|                            
|                            
|Rochester, New York          |  | 10,000      |  | (1)    |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Pequannock, New Jersey       |  | 62,000      |  | (1)    |                          | Index equipment                                        
|                            
|                            
|                            
|                            
|                             |  |             |  |        |                          |                                                        
|                            
|                            
|                            
|                            
|Europe:                      |  |             |  |        |                          |                                                        
|                            
|                            
|                            
|                            
|Schwetzingen, Germany        |  | 400,000     |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Leven, Scotland              |  | 240,000     |  |        |                          | Reactor Systems and Corrosion-Resistant Products       
|                            
|                            
|                            
|                            
|Quarto DAltino, Italy       |  | 120,000     |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|San Donà di Piave, Italy     |  | 90,000      |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Bilston, England             |  | 50,000      |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Derby, England               |  | 20,000      |  | (1)    |                          | Industrial Mixers                                      
|                            
|                            
|                            
|                            
|Petit-Rechain, Belgium       |  | 15,000      |  |        |                          | Power sections for Energy Systems                      
|                            
|                            
|                            
|                            
|Bolton, England              |  | 24,000      |  |        |                          | Reactor Systems                                        
|                            
|                            
|                            
|                            
|Southampton, England         |  | 10,000      |  | (1)    |                          | Industrial Pump Products                               
|                            
|                            
|                            
|                            
|Campbridgeshire, England     |  | 8,500       |  |        |                          | Distribution Center-Romaco Products                    
|                            
|                            
|                            
|                            
|DAgen, France               |  | 15,000      |  | (1)(5) |                          | Manufacture of Pharma Modules                          
|                            
|                            
|                            
|                            
|Alsbach  Hahnlein, Germany  |  | 21,000      |  |        |                          | Laetus equipment                                       
|                            
|                            
|                            
|                            
|Remschingen, Germany         |  | 61,000      |  | (1)    |                          | Siebler equipment                                      
|                            
|                            
|                            
|                            
|Karlsruhe, Germany           |  | 47,000      |  |        |                          | Horn & Noack equipment                                 
|                            
|                            
|                            
|                            
|Neuenburg, Germany           |  | 70,000      |  |        |                          | Frymakoruma equipment                                  
|                            
|                            
|                            
|                            
|Bologna, Italy               |  | 44,000      |  | (1)    |                          | Macofar equipment                                      
|                            
|                            
|                            
|                            
|Bologna, Italy               |  | 11,000      |  | (1)    |                          | Promatic equipment                                     
|                            
|                            
|                            
|                            
|Milanese, Italy              |  | 15,000      |  |        |                          | Unipac equipment                                       

12



---



##### Table of Contents



|                         |  |         |  |        |  |                         
|------------------------ |  | ------- |  | ------ |  | ------------------------
|                        
|                        
|                        
|                        
|Milano, Italy            |  | 52,000  |  |        |  | Zanchetta equipment     
|                        
|                        
|                        
|                        
|Volketswil, Switzerland  |  | 50,000  |  | (1)    |  | HAPA equipment          
|                        
|                        
|                        
|                        
|Rheinfenden, Switzerland |  | 115,000 |  |        |  | Frymakoruma equipment   
|                        
|                        
|                        
|                        
|                         |  |         |  |        |  |                         
|                        
|                        
|                        
|                        
|Australia                |  |         |  |        |  |                         
|Tingalpa, Brisbane       |  | 24,000  |  | (1)(3) |  | Bosspak equipment       
|                        
|                        
|                        
|                        
|                         |  |         |  |        |  |                         
|                        
|                        
|                        
|                        
|Asia:                    |  |         |  |        |  |                         
|                        
|                        
|                        
|                        
|Gujurat, India           |  | 350,000 |  | (3)    |  | Reactor Systems         
|                        
|                        
|                        
|                        
|Suzhou, China            |  | 150,000 |  | (4)    |  | Reactor Systems         
|                        
|                        
|                        
|                        
|Singapore                |  | 5,000   |  | (1)    |  | Industrial Pump Products



|(1) |  | Leased facility.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|   
|   
|   
|(2) |  | R&M Energy Systems also operates an additional 13 (7 U.S., 6 Canada)
Service Centers, primarily in leased facilities between 5,000 and 10,000
square feet each. These locations are in the oil producing regions of the
U.S. and Canada and manufacture rod guides and distribute other of the
Companys Energy Systems products. Locations are: Bakersfield,
California, Oklahoma City, Oklahoma, Odessa, Texas, Casper, Wyoming, Mt.
Pleasant, Michigan, Williston, North Dakota, Wooster, Ohio and in Alberta,
Canada  Brooks, Elk Point, Provost, Maidstone, Sedgewick and Taber.
|   
|   
|   
|   
|(3) |  | Facility of a 51%-owned subsidiary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|   
|   
|   
|   
|(4) |  | Facility of a 76%-owned subsidiary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|   
|   
|   
|   
|(5) |  | Facility of a 50% owned subsidiary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

13



---



##### Table of Contents






ITEM 3. LEGAL PROCEEDINGS

There are claims,
suits and complaints arising in the ordinary course of business
filed or pending against us. Although we cannot predict the outcome
of such claims, suits and complaints with certainty, we do not
believe that the disposition of these matters will have a material
adverse effect on our financial position, results of operations or
cash flows.




ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

14



---



##### Table of Contents



Executive Officers of the Registrant

Maynard H. Murch IV, Age 58, has been our Chairman of the Board since July
1979 and a director since 1977. He is also President and Chief Executive
Officer of Maynard H. Murch Co., Inc. (investments), which is managing general
partner of M.H.M. & Co., Ltd. (investments). Mr. Murch is also Vice President
of Parker/Hunter Incorporated (dealer in securities), a successor firm to Murch
and Co., Inc., a securities firm that Mr. Murch had been associated with since
1968. Mr. Murch is a director of Lumitex, Inc. and Shiloh Industries, Inc.

Gerald L. Connelly, age 61, has been our President and Chief Executive
Officer since January 1999. From April 1996 to January 1999, he was our
Executive Vice President and Chief Operating Office and, from June 1994 to
April 1996, he was our Vice President and President of our Process Industries
Group. Previously, he served as President of Pulsafeeder, Inc. (metering pumps)
for 10 years.

Kevin J. Brown, age 44, has been our Vice President and Chief Financial
Officer since January 2000. Previously, he was our Controller and Chief
Accounting Officer since December 1995. Prior to joining us, he was employed by
the accounting firm of Ernst & Young LLP for 15 years.

Milton M. Hernandez, age 46, has been our Group Vice President and
President, Robbins & Myers Europe since September 2001. Previously, he was our
Vice President-Business Development since joining us in April 2000. Prior to
that he was Managing Director-Argentina and Bolivia, Mobil Oil Corporation and
Vice President, Business Development Latin America, Spain and Portugal and he
also held a variety of positions in Corporate Planning and Marketing for Mobil
Chemical as well as Mobil Oil.

Karl H. Bergmann, age 58, has been our Vice President and Vice President
Operations of Robbins & Myers Europe since September 2001. Prior to that he was
Senior Vice President, Reactor Systems Europe since 1998 and President of
Pfaudler Werke GmbH since joining us in 1994.

Hugh E. Becker, age 64, has been our Vice President, Investor Relations
and Human Resources since December 1998. From 1996 to 1998, he was our Senior
Director, Investor Relations and Human Resources. Previously he held various
investor relations and human resource positions for us since 1980.

Albert L. Raiteri, age 61, has been our Treasurer since December 1998. He
has held various positions in finance and accounting for us since 1972.

Thomas J. Schockman, age 38, has been our Corporate Controller and Chief
Accounting Officer since March 2000. Prior to joining us, he was employed as
Controller at Spinnaker Coating, Inc. for three years and, prior to that, the
accounting firm of Ernst & Young LLP for ten years.

Joseph M. Rigot, age 59, has been our Secretary and General Counsel since
1990. He has been a partner with the law firm of Thompson Hine LLP, Dayton,
Ohio for over 10 years.

15



---



##### Table of Contents



The term of office of our executive officers is until the next Annual
Meeting of Directors (December 11, 2002) or until their respective successors
are elected.

16



---



##### Table of Contents






PART II




ITEM 5. MARKET FOR THE REGISTRANTS COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS

(A)  Our common shares trade on the New York Stock Exchange under the
symbol RBN. The prices presented in the following table are the high and low
closing prices for the common shares for the periods presented.

|            |  |      |       |     |  |      |       |  |  |           |      | 
|----------- |  | ---- | ----- | --- |  | ---- | ----- |  |  | --------- | ---- | 
|            |  |      |       |     |  |      |       |  |  | Dividends
|Fiscal 2002 |  | High |       | Low |  | Paid
|            |  |      |       |     |  |     
|1st Quarter |  | $    | 28.70 |     |  | $    | 22.82 |  |  | $         | .055 | 
|2nd Quarter |  |      | 25.70 |     |  |      | 21.97 |  |  |           | .055 | 
|3rd Quarter |  |      | 29.28 |     |  |      | 23.40 |  |  |           | .055 | 
|4th Quarter |  |      | 26.25 |     |  |      | 18.91 |  |  |           | .055 | 
|            |  |      |       |     |  |      |       |  |  |           |      | 
|Fiscal 2001 |  |      |       |     |  |      |       |  |  |           |      | 
|            |  |      |       |     |  |      |       |  |  |           |      | 
|1st Quarter |  | $    | 25.63 |     |  | $    | 22.00 |  |  | $         | .055 | 
|2nd Quarter |  |      | 28.25 |     |  |      | 21.56 |  |  |           | .055 | 
|3rd Quarter |  |      | 29.25 |     |  |      | 24.50 |  |  |           | .055 | 
|4th Quarter |  |      | 28.60 |     |  |      | 24.40 |  |  |           | .055 | 

(B)  As of October 18, 2002, we had approximately 503 shareholders of
record. Based on requests from brokers and other nominees, we estimate there
are approximately an additional 2,306 shareholders.

(C) Dividends paid on common shares are presented in the table in Item
5(A). Our credit agreements include certain covenants which restrict our
payment of dividends. The amount of cash dividends plus stock repurchases we
may incur in each fiscal year is restricted to the greater of $3,500,000 or 50%
of our net income for the immediately preceding fiscal year, plus a portion of
any unused amounts from the preceding fiscal year. For purposes of this test,
stock repurchases related to stock option exercises or in connection with
withholding taxes due under any stock plan in which employees or directors
participate are not included. Under this formula, such cash dividends and
treasury stock purchases in fiscal 2003 are limited to $12,159,000.

17



---



##### Table of Contents



(D)  The following table shows certain information as of August 31, 2002 with
respect to compensation plans under which common shares of the Company are
authorized for issuance:

Equity Compensation Plan Information

|                                                           |  |  |                     |  |                   |   |                     |  |                 |  |                  |  | 
|---------------------------------------------------------- |  |  | ------------------- |  | ----------------- | - | ------------------- |  | --------------- |  | ---------------- |  | 
|                                                           |  |  |                     |  |                   |   |                     |  |                 |  | (c)             
|                                                           |  |  |                     |  |                   |   |                     |  |                 |  | Number of Common
|                                                           |  |  |                     |  |                   |   |                     |  |                 |  | Shares remaining
|                                                           |  |  |                     |  |                   |   |                     |  |                 |  | available for   
|                                                           |  |  | (a)                 |  |                   |   |                     |  | future issuance
|                                                           |  |  | Number of Common    |  | (b)               |   | under equity       
|                                                           |  |  | Shares to be issued |  | Weighted-average  |   | compensation plans 
|                                                           |  |  | upon exercise of    |  | exercise price of |   | (excluding         
|                                                           |  |  | outstanding         |  | outstanding       |   | securities         
|                                                           |  |  | options, warrants   |  | options, warrants |   | reflected in column
|                                                           |  |  | and rights          |  | and rights        |   | (a))               
|                                                           |  |  |                     |  |                   |   |                    
|Equity
compensation
plans approved
by security
holders     |  |  | 1,074,801           |  |                   | $ | 24.78               |  |                 |  | 537,700          | 
|Equity
compensation
plans not
approved by
security holders |  |  | 0                   |  |                   |   | 0                   |  |                 |  | 0                | 
|                                                           |  |  |                     |  |                   |   |                     |  |                 |  |                  |  | 
|Total                                                      |  |  | 1,074,801           |  |                   | $ | 24.78               |  |                 |  | 537,700          | 
|                                                           |  |  |                     |  |                   |   |                     |  |                 |  |                  |  | 

18



---



##### Table of Contents






ITEM 6. SELECTED FINANCIAL DATA

Selected Financial Data (1)
Robbins & Myers, Inc. and Subsidiaries
(In thousands, except percents, per share, shareholder and employee data)

|                                 |                                     |  |              |        |                |        |      |         |      |       |      |         |      |       |      |         |      |       |   |         |   |       |   |         |   |       |   |         |   |       |  
|-------------------------------- | ----------------------------------- |  | ------------ | ------ | -------------- | ------ | ---- | ------- | ---- | ----- | ---- | ------- | ---- | ----- | ---- | ------- | ---- | ----- | - | ------- | - | ----- | - | ------- | - | ----- | - | ------- | - | ----- | -
|                                 |                                     |  |              |        | 5 Year         |        |      |         |      |       |      |         |      |       |      |         |      |       |   |         |   |       |   |         |   |       |   |         |  
|                                 |                                     |  |              |        | Average Growth |        | 2002 |         | 2001 |       | 2000 |         | 1999 |       | 1998 |         | 1997
|                                 |                                     |  |              |        |                |        |      |         |      |       |      |         |      |       |      |         |     
|Operating
Results               
|                                 | Orders                              |  |              | 6.3    | %              |        | $    | 508,943 |      |       | $    | 427,275 |      |       | $    | 412,948 |      |       | $ | 373,135 |   |       | $ | 416,989 |   |       | $ | 375,042 |  
|                                 | Ending backlog                      |  |              |        |                |        |      | 125,665 |      |       |      | 143,522 |      |       |      | 80,484  |      |       |   | 74,330  |   |       |   | 96,022  |   |       |   | 110,078 |  
|                                 | Sales                               |  |              | 6.4    |                |        |      | 526,373 |      |       |      | 425,902 |      |       |      | 406,714 |      |       |   | 400,142 |   |       |   | 436,474 |   |       |   | 385,663 |  
|                                 | Gross profit (2)                    |  |              | 4.6    |                |        |      | 173,764 |      |       |      | 140,734 |      |       |      | 140,234 |      |       |   | 136,166 |   |       |   | 158,713 |   |       |   | 138,781 |  
|                                 | EBITDA (2, 4)                       |  |              | (0.8   | )              |        |      | 62,990  |      |       |      | 67,584  |      |       |      | 67,942  |      |       |   | 57,809  |   |       |   | 83,658  |   |       |   | 65,484  |  
|                                 | EBIT (2, 3)                         |  |              | (3.7   | )              |        |      | 40,947  |      |       |      | 43,236  |      |       |      | 43,572  |      |       |   | 33,288  |   |       |   | 60,142  |   |       |   | 49,521  |  
|                                 | Net income (2, 3)                   |  |              | (12.9  | )              |        |      | 14,503  |      |       |      | 19,631  |      |       |      | 18,056  |      |       |   | 11,849  |   |       |   | 31,230  |   |       |   | 28,866  |  
|                                
|                                 | Amortization (3)                    |  |              |        |                |        |      | 2,015   |      |       |      | 8,187   |      |       |      | 8,077   |      |       |   | 7,660   |   |       |   | 7,670   |   |       |   | 5,170   |  
|                                 | Depreciation                        |  |              |        |                |        |      | 20,028  |      |       |      | 16,161  |      |       |      | 16,293  |      |       |   | 16,861  |   |       |   | 15,846  |   |       |   | 10,793  |  
|                                 | Capital expenditures, net           |  |              |        |                |        |      | 15,112  |      |       |      | 20,200  |      |       |      | 19,842  |      |       |   | 11,612  |   |       |   | 23,020  |   |       |   | 22,071  |  
|Financial Condition             
|                                 | Total assets                        |  |              |        |                |        | $    | 682,692 |      |       | $    | 660,260 |      |       | $    | 495,679 |      |       | $ | 493,852 |   |       | $ | 501,008 |   |       | $ | 372,354 |  
|                                 | Total debt                          |  |              |        |                |        |      | 208,446 |      |       |      | 258,894 |      |       |      | 177,864 |      |       |   | 191,272 |   |       |   | 206,242 |   |       |   | 116,083 |  
|                                 | Shareholders equity                |  |              |        |                |        |      | 260,493 |      |       |      | 197,902 |      |       |      | 167,182 |      |       |   | 154,226 |   |       |   | 150,763 |   |       |   | 124,475 |  
|                                 | Total capitalization                |  |              |        |                |        |      | 468,939 |      |       |      | 456,796 |      |       |      | 345,046 |      |       |   | 345,498 |   |       |   | 357,005 |   |       |   | 240,558 |  
|Performance Statistics          
|                                 | Percent of sales:                   |  |              |        |                |        |      |         |      |       |      |         |      |       |      |         |      |       |   |         |   |       |   |         |   |       |   |         |  
|                                 |                                     |  | Gross profit |        |                |        |      |         |      | 33.0  | %    |         |      | 33.0  | %    |         |      | 34.5  | % |         |   | 34.0  | % |         |   | 36.4  | % |         |   | 36.0  | %
|                                 |                                     |  | EBIT (2,3)   |        |                |        |      |         |      | 7.8   |      |         |      | 10.2  |      |         |      | 10.7  |   |         |   | 8.3   |   |         |   | 13.8  |   |         |   | 12.8  |  
|                                 | Debt as a % of total capitalization |  |              |        |                |        |      | 44.5    |      |       |      | 56.7    |      |       |      | 51.5    |      |       |   | 55.4    |   |       |   | 57.8    |   |       |   | 48.3    |  
|                                 | EBIT return on average net assets   |  |              |        |                |        |      | 8.9     |      |       |      | 12.4    |      |       |      | 12.6    |      |       |   | 9.3     |   |       |   | 16.7    |   |       |   | 21.7    |  
|                                 | Net income return on avg. equity    |  |              |        |                |        |      | 6.7     |      |       |      | 11.2    |      |       |      | 11.2    |      |       |   | 7.8     |   |       |   | 22.7    |   |       |   | 26.7    |  
|Per Share Data                  
|                                 | Net income per share, diluted (2,3) |  |              | (12.9) | %              |        | $    | 1.15    |      |       | $    | 1.63    |      |       | $    | 1.53    |      |       | $ | 1.06    |   |       | $ | 2.43    |   |       | $ | 2.29    |  
|                                 | Dividends declared                  |  |              | 2.5    |                |        |      | 0.22    |      |       |      | 0.22    |      |       |      | 0.22    |      |       |   | 0.22    |   |       |   | 0.215   |   |       |   | 0.194   |  
|                                 | Market price of common stock:       |  |              |        |                |        |      |         |      |       |      |         |      |       |      |         |      |       |   |         |   |       |   |         |   |       |   |         |  
|                                 |                                     |  | High         |        |                |        |      |         |      | 29.28 |      |         | $    | 29.25 |      |         | $    | 24.50 |   |         | $ | 25.88 |   |         | $ | 40.50 |   |         | $ | 36.75 |  
|                                 |                                     |  | Low          |        |                |        |      |         |      | 18.91 |      |         |      | 21.56 |      |         |      | 15.19 |   |         |   | 15.69 |   |         |   | 23.00 |   |         |   | 20.00 |  
|                                 |                                     |  | Close        |        |                | (10.3) | %    |         |      | 18.91 |      |         |      | 28.38 |      |         |      | 23.88 |   |         |   | 23.50 |   |         |   | 23.75 |   |         |   | 32.63 |  
|                                 | P/E ratio at August 31, diluted     |  |              |        |                |        |      | 16.4    |      |       |      | 17.4    |      |       |      | 15.6    |      |       |   | 22.2    |   |       |   | 9.8     |   |       |   | 14.2    |  
|Other Data                      
|                                 | Cash flow from operations           |  |              |        |                |        | $    | 44,540  |      |       | $    | 30,984  |      |       | $    | 36,040  |      |       | $ | 39,463  |   |       | $ | 48,574  |   |       | $ | 35,246  |  
|                                 | Free cash flow (5)                  |  |              |        |                |        |      | 29,428  |      |       |      | 10,784  |      |       |      | 16,198  |      |       |   | 27,851  |   |       |   | 25,554  |   |       |   | 13,175  |  
|                                 | Enterprise value (6)                |  |              | 0.3    | %              |        |      | 479,483 |      |       |      | 591,650 |      |       |      | 439,493 |      |       |   | 448,386 |   |       |   | 468,015 |   |       |   | 472,990 |  
|                                 | Shares outstanding at year end      |  |              |        |                |        |      | 14,333  |      |       |      | 11,726  |      |       |      | 10,956  |      |       |   | 10,941  |   |       |   | 11,022  |   |       |   | 10,938  |  
|                                 | Average diluted shares (7)          |  |              |        |                |        |      | 14,688  |      |       |      | 13,465  |      |       |      | 13,416  |      |       |   | 13,535  |   |       |   | 13,906  |   |       |   | 13,625  |  
|                                 | Number of shareholders (8)          |  |              |        |                |        |      | 2,809   |      |       |      | 2,885   |      |       |      | 2,932   |      |       |   | 3,256   |   |       |   | 3,326   |   |       |   | 2,723   |  
|                                 | Number of employees                 |  |              |        |                |        |      | 3,921   |      |       |      | 4,334   |      |       |      | 3,284   |      |       |   | 3,244   |   |       |   | 3,071   |   |       |   | 2,947   |  
|                                
|Notes to Selected Financial Data |                                     |  |              |        |                |        |      |         |      |       |      |         |      |       |      |         |      |       |   |         |   |       |   |         |   |       |   |        



|(1) |  | Fiscal 2001 reflected the acquisition of Romaco on August 31, 2001. The August 31, 2001 consolidated balance sheet data included Romaco, but the fiscal 2001 consolidated
income statement data did not include Romaco. Fiscal 1998 reflected the acquisitions of Flow Control Equipment, Inc. and Technoglass S.p.A. Fiscal 1997 reflected the
acquisitions of Process Supply Inc., Spectrum Products, Inc., Greerco, and Industrie Tycon, S.p.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | Fiscal 2001 included charges of $2,492,000 related to our global reorganization program, including inventory write-downs of $1,000,000 that are included in gross profit.
Fiscal 2000 included charges of $409,000 relating to the closure of our Fairfield facility, a gain of $918,000 related to the sale of our Fairfield facility and a charge of
$500,000 related to Universal Glasteel Equipment, Inc. Fiscal 1999 included charges of $4,769,000 primarily for the closure of our Fairfield, California manufacturing facility
and one-time severance and early retirement costs of $1,600,000. These special items decreased fiscal 2001 net income by $1,670,000 ($0.12 per diluted share), increased fiscal
2000 net income by $6,000 ($0.00 per diluted share) and decreased fiscal 1999 net income by $4,204,000 ($0.31 per diluted share). See Note 5 of Notes to Consolidated Financial
Statements.

19



---



##### Table of Contents



|(3) |  | In July 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standard (SFAS) No. 142, Goodwill and Other Intangible Assets. SFAS No.
142 established accounting and reporting standards for intangible assets and goodwill. It required that goodwill and certain intangible assets no longer be amortized to
earnings, but instead be reviewed periodically for impairment. We adopted this pronouncement as of the beginning of fiscal 2002. Had the new pronouncement been adopted at the
beginning of fiscal 1997 (i) goodwill amortization in the following amounts would not have been recorded in the periods indicated: fiscal 2001, $5,420,000; fiscal 2000,
$5,541,000; fiscal 1999, $5,439,000; fiscal 1998, $4,798,000; and fiscal 1997, $3,177,000; and (ii) net income per diluted share in the periods indicated would have been as
follows: fiscal 2001, $1.88; fiscal 2000, $1.80; fiscal 1999, $1.32; fiscal 1998, $2.65; and fiscal 1997, $2.44.
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(4) |  | EBITDA represents the sum of income before interest, income taxes, depreciation and amortization. EBITDA is not a measure of performance calculated in accordance with
accounting principles generally accepted in the United States and should not be considered as an alternative to net income as a measure of operating results.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|   
|(5) |  | Free Cash Flow represents net cash and cash equivalents provided by operating activities less capital expenditures. Free Cash Flow is not a measure of performance calculated
in accordance with accounting principles generally accepted in the United States, and should not be considered as an alternative to cash flow as a measure of our liquidity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
|   
|(6) |  | Market capitalization of shares outstanding at year end plus total debt.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   
|(7) |  | Fiscal 2002 and fiscal 2001 reflected an additional 2,190,000 shares, fiscal 2000 reflected an additional 2,297,000 shares and fiscal 1999, fiscal 1998 and fiscal 1997
reflected an additional 2,385,000 shares related to the convertible note issuance.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
|   
|(8) |  | As of September 1, 2002 we had 503 shareholders of record. Based on requests from brokers and other nominees, we estimate there were an additional 2,306 shareholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

20



---



##### Table of Contents






ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

Overview

We are a leading designer, manufacturer and marketer of highly engineered,
application-critical equipment and systems for the pharmaceutical, energy and
industrial markets worldwide. Our principal brand names  Pfaudler®, Moyno®,
Chemineer®, Laetus®, FrymaKoruma®, Siebler®, Hapa® and Hercules®  hold the
number one or two market share position in the niche markets they serve. We
operate in three market focused business segments: pharmaceutical, energy and
industrial.

During the past five years, our strategy has been to increase our focus on
high-growth markets, such as pharmaceutical and energy, and to broaden our
international presence. In furtherance of this strategy, on August 31, 2001, we
acquired Romaco, a European-based manufacturer of processing, dosing, filling,
printing and security equipment for the pharmaceutical and healthcare
industries. Our acquisition of Romaco, which had sales of approximately $142
million in our fiscal 2001, expands the breadth of our pharmaceutical
capabilities and positions us as a leading supplier of primary and secondary
processing equipment to the growing pharmaceutical market. With the addition of
Romaco, our international sales increased to approximately 60% of fiscal 2002
sales from 45% of our fiscal 2001 sales.

The total purchase price of Romaco was $130.1 million. At closing in fiscal
2001, we paid consideration of $95.2 million as follows: $38.7 million in cash,
$2.2 million in a five-year subordinated note, the assumption of net debt of
$38.9 million and 600,000 of our common shares valued at $15.4 million. In the
second quarter of fiscal 2002, we made an additional payment based on Romacos
sales and operating performance for calendar year 2001 of $32.1 million, half
of which was in cash and half of which was in a five-year subordinated note. We
also incurred acquisition costs of $2.8 million in fiscal 2002. We completed
the Romaco acquisition as of the end of fiscal 2001, and, therefore, the
acquisition had no impact on our results of operations in fiscal 2001.

Pro forma result references throughout this discussion give effect to the
Romaco acquisition as if it were made at the beginning of fiscal 2001.

We recorded special items in fiscal 2001 and 2000 that impacted the
comparability of certain information. We did not incur any special charges in
fiscal 2002. The special items that were recorded in fiscal 2001 and 2000 were
as follows:

|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  |        |      |  
|----------------------------------- |  | ------------- | ---- | ---------- |  | ------------------------------------- | ------ | --------- |  | ----- | ---- | ------ |  | ----- | ---- | - |  | - | ------ | --- |  | ------- | ------ | - |  | ------ | ---- | -
|                                    |  | Special Items
|                                    |  |              
|                                    |  | EBIT Impact   |      |            |  |                                       |        |           |  |      
|                                    |  |               |      |            |  |                                       |        |           |  |      
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  | Net   
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  | Income
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  | Per   
|                                    |  | Pharma-       |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        | Net |  | Diluted
|                                    |  | ceutical      |      | Industrial |  | Energy                                |        | Corporate |  | Total |      | Income |  | Share
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |      
|                                    |  |               |      |            |  | (In thousands, except per share data) |        |           |  |       |      |        |  |      
|2001                                |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  |        |      |  
|Global
reorganization
costs         |  | $             | (244 | )          |  | $                                     | (2,148 | )         |  | $     | 0    |        |  | $     | (100 | ) |  | $ | (2,492 | )   |  | $       | (1,670 | ) |  | $      | (.12 | )
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  |        |      |  
|2000                                |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  |        |      |  
|Plant closure
costs                 |  | $             | 0    |            |  | $                                     | 0      |           |  | $     | (409 | )      |  | $     | 0    |   |  | $ | (409   | )   |  | $       | (266   | ) |  | $      | (.02 | )
|Gain on sale of
building            |  |               | 0    |            |  |                                       | 0      |           |  |       | 918  |        |  |       | 0    |   |  |   | 918    |     |  |         | 597    |   |  |        | .04  |  
|UGE long-term
receivable
write-down |  |               | (500 | )          |  |                                       | 0      |           |  |       | 0    |        |  |       | 0    |   |  |   | (500   | )   |  |         | (325   | ) |  |        | (.02 | )
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  |        |      |  
|                                    |  | $             | (500 | )          |  | $                                     | 0      |           |  | $     | 509  |        |  | $     | 0    |   |  | $ | 9      |     |  | $       | 6      |   |  | $      | .00  |  
|                                    |  |               |      |            |  |                                       |        |           |  |       |      |        |  |       |      |   |  |   |        |     |  |         |        |   |  |        |      |  

21



---



##### Table of Contents



In the third quarter of fiscal 2001, we announced a global reorganization
program to consolidate operations in England, Mexico and the Asia-Pacific
regions to strengthen our market presence and achieve more effective channels to
market. In addition, we discontinued certain product offerings in our Chemineer
and Moyno businesses to improve our long-term competitive position through a
more cost-effective product focus. We incurred a one-time charge of $2.3
million, $1.3 million of which related to severance and other costs associated
with the regional consolidations and the balance of which related to inventory
write-downs from discontinued product offerings. There were additional costs in
the third and fourth quarters of fiscal 2001 totalling $0.2 million that we
expensed as incurred primarily for equipment relocation, marketing and employee
training. As of August 31, 2001, we had paid all costs related to the global
reorganization program, without any changes in estimates.

In the fourth quarter of fiscal 2000, we recorded a charge of $0.5 million to
reduce a long-term receivable related to UGE, which is 50% owned by us and 50%
owned by Universal Process Equipment, Inc. The charge was due to weakness in
the used glass-lined reactor and storage vessel markets served by UGE.

In fiscal 1999, due to the downturn in the energy business segment at that
time, we analyzed our capacity requirements for our energy products. As a
result, we recorded a charge of $4.2 million for the closure and relocation of
our Fairfield, California manufacturing operation. We incurred additional
expenses related to the Fairfield plant closure of $0.4 million in fiscal 2000.
These costs were for employee transfers, equipment relocation and training of
new employees at the Texas facility. We sold the Fairfield facility in July
2000, resulting in a pretax gain of $0.9 million.

Results of Operations

The following tables present components of our consolidated income statement
and segment information.

|              |  |      |       |      |  |      |       |   |  |  |       |  
|------------- |  | ---- | ----- | ---- |  | ---- | ----- | - |  |  | ----- | -
|Consolidated  |  | 2002 |       | 2001 |  | 2000
|              |  |      |       |      |  |     
|Sales         |  |      | 100.0 | %    |  |      | 100.0 | % |  |  | 100.0 | %
|Cost of sales |  |      | 67.0  |      |  |      | 67.0  |   |  |  | 65.5  |  
|              |  |      |       |      |  |      |       |   |  |  |       |  
|Gross profit  |  |      | 33.0  |      |  |      | 33.0  |   |  |  | 34.5  |  
|SG&A expenses |  |      | 24.8  |      |  |      | 20.6  |   |  |  | 21.8  |  
|Amortization  |  |      | 0.4   |      |  |      | 1.9   |   |  |  | 2.0   |  
|Other         |  |      | 0.0   |      |  |      | 0.3   |   |  |  | 0.0   |  
|              |  |      |       |      |  |      |       |   |  |  |       |  
|EBIT          |  |      | 7.8   | %    |  |      | 10.2  | % |  |  | 10.7  | %
|              |  |      |       |      |  |      |       |   |  |  |       |  

|                   |                                 |      |         |      |  |      |         |   |  |   |         |  
|------------------ | ------------------------------- | ---- | ------- | ---- |  | ---- | ------- | - |  | - | ------- | -
|By Segment         |                                 | 2002 |         | 2001 |  | 2000
|                   |                                 |      |         |      |  |     
|Pharmaceutical:    | (In thousands, except percents)
|Sales              |                                 | $    | 319,412 |      |  | $    | 171,403 |   |  | $ | 181,891 |  
|Adjusted EBITA (1) |                                 |      | 28,327  |      |  |      | 19,555  |   |  |   | 26,876  |  
|Adjusted EBITA %   |                                 |      | 8.9     | %    |  |      | 11.4    | % |  |   | 14.8    | %
|EBIT               |                                 |      | 27,895  |      |  |      | 17,349  |   |  |   | 24,448  |  
|EBIT %             |                                 |      | 8.7     | %    |  |      | 10.1    | % |  |   | 13.4    | %
|                  
|Energy:            |                                 |      |         |      |  |      |         |   |  |   |         |  
|Sales              |                                 | $    | 91,381  |      |  | $    | 113,906 |   |  | $ | 88,145  |  
|Adjusted EBITA (1) |                                 |      | 19,104  |      |  |      | 28,228  |   |  |   | 17,726  |  
|Adjusted EBITA %   |                                 |      | 20.9    | %    |  |      | 24.8    | % |  |   | 20.1    | %
|EBIT               |                                 |      | 18,773  |      |  |      | 26,078  |   |  |   | 16,130  |  
|EBIT %             |                                 |      | 20.5    | %    |  |      | 22.9    | % |  |   | 18.3    | %
|                  
|Industrial:        |                                 |      |         |      |  |      |         |   |  |   |         |  
|Sales              |                                 | $    | 115,580 |      |  | $    | 140,593 |   |  | $ | 136,678 |  
|Adjusted EBITA (1) |                                 |      | 5,731   |      |  |      | 13,887  |   |  |   | 15,287  |  
|Adjusted EBITA %   |                                 |      | 5.0     | %    |  |      | 9.9     | % |  |   | 11.2    | %
|EBIT               |                                 |      | 5,279   |      |  |      | 8,445   |   |  |   | 12,007  |  
|EBIT %             |                                 |      | 4.6     | %    |  |      | 6.0     | % |  |   | 8.8     | %

22



---



##### Table of Contents



|                   |  |   |         |   |  |   |         |   |  |   |         |  
|------------------ |  | - | ------- | - |  | - | ------- | - |  | - | ------- | -
|Total:             |  |   |         |   |  |   |         |   |  |   |         |  
|Sales              |  | $ | 526,373 |   |  | $ | 425,902 |   |  | $ | 406,714 |  
|Adjusted EBITA (1) |  |   | 42,962  |   |  |   | 53,915  |   |  |   | 51,640  |  
|Adjusted EBITA %   |  |   | 8.2     | % |  |   | 12.7    | % |  |   | 12.7    | %
|EBIT               |  |   | 40,947  |   |  |   | 43,236  |   |  |   | 43,572  |  
|EBIT %             |  |   | 7.8     | % |  |   | 10.2    | % |  |   | 10.7    | %



|(1) |  | Adjusted EBITA represents EBIT before amortization and special items, which are described in the
Special Items table in the Overview section of this Managements Discussion and Analysis. Adjusted
EBITA is not a measure of performance calculated in accordance with accounting principles generally
accepted in the United States and should not be considered an alternative to net income as a measure
of operating results.
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fiscal Year Ended August 31, 2002 Compared with Fiscal Year Ended August 31,
2001

Sales for fiscal 2002 were $526.4 million compared with $425.9 million in the
same period of the prior year. On a pro forma basis, taking into account the
Romaco acquisition, sales decreased $41.7 million, or 7.3%

The pharmaceutical segment had sales of $319.4 million in fiscal 2002 compared
with $171.4 million in the same period of fiscal 2001. On a pro forma basis,
the pharmaceutical segment sales increased $5.8 million, or 1.8%. Overall, this
sales increase was due to the strengthening of the euro against the dollar.
Romacos sales increased by $27.4 million compared with their pro forma fiscal
2001 sales due to the strength of the pharmaceutical and healthcare markets.
However, offsetting this was decreased Reactor Systems sales of $21.6 million.
The decline in Reactor Systems sales was due to the impact of the weak
specialty chemical market and slow industrial economy in the U.S.

The energy segment had sales of $91.4 million in fiscal 2002 compared with
$113.9 million in the same period of fiscal 2001, a decrease of $22.5 million,
or 19.8%. Lower crude oil and natural gas prices caused a reduction in
exploration and production activities in fiscal 2002 compared with fiscal 2001.

The industrial segment had sales of $115.6 million in fiscal 2002 compared with
$140.6 million in fiscal 2001, a decrease of $25.0 million, or 17.8%. This
segment was also negatively impacted by the slow industrial economy in the U.S.

EBIT in fiscal 2002 was $40.9 million compared with $43.2 million in fiscal
2001. In the first quarter of fiscal 2002, we adopted Statement of Financial
Accounting Standard (SFAS) No. 142, Goodwill and Other Intangible Assets,
which required that goodwill no longer be amortized. The adoption of SFAS
No.142 resulted in a $5.4 million reduction in amortization in fiscal 2002.
Adjusted EBITA (EBIT before amortization and special items, which are described
in the Special Items table in the Overview section of this Managements
Discussion and Analysis) was $43.0 million in fiscal 2002 compared with $53.9
million in fiscal 2001, a decrease of $10.9 million, or 20.2%.

The pharmaceutical segment had an Adjusted EBITA of $28.3 million in fiscal
2002 compared with $19.6 million in fiscal 2001. On a pro forma basis, the
pharmaceutical segment Adjusted EBITA in fiscal 2002 increased by $.1 million
over the prior year period.

The energy segment had an Adjusted EBITA of $19.1 million in fiscal 2002
compared with $28.2 million in fiscal 2001, a decrease of $9.1 million, or
32.3%. The decline in energy segment sales reduced Adjusted EBITA by $8.5
million. The remaining decrease was due to increased research and development
costs and a change in sales mix from higher-margin exploration products to
lower-margin wellhead products.

The industrial segment had an Adjusted EBITA of $5.7 million in fiscal 2002
compared with $13.9 million in fiscal 2001, a reduction of $8.2 million, while
sales decreased by $25.0 million. The reduction was due to lower overall sales
volumes and reduced selling prices resulting from the weak markets into which
this segment sells. Adjusted EBITA was also negatively impacted by the mix of
products sold as the volume of high-margin industrial pump aftermarket products
declined significantly.

23



---



##### Table of Contents



Interest expense increased from $12.3 million in fiscal 2001 to $17.6 million
in fiscal 2002. This was due to higher average debt levels resulting from the
acquisition of Romaco. Our effective interest rate was 7.0% in fiscal 2002 and
6.9% in fiscal 2001.

Our effective tax rate was 33.5% in fiscal 2002 compared with 33.1% in fiscal
2001. Net deferred income tax assets of $5.4 million at August 31, 2002
primarily related to U.S. operations.

Net income and net income per diluted share in fiscal 2002 were $14.5 million
and $1.15 compared with $19.6 million and $1.63 in fiscal 2001. The decrease
was due to the weak market conditions and resulting lower sales volumes in the
energy and industrial segments in fiscal 2002. Interest costs were also higher
due to debt incurred for the Romaco acquisition; however, overall the Romaco
acquisition was accretive.

Fiscal Year Ended August 31, 2001 Compared with Fiscal Year Ended August 31, 2000

Sales of $425.9 million in fiscal 2001 were $19.2 million higher than fiscal
2000, a 4.7% increase.

The pharmaceutical segment had sales of $171.4 million in fiscal 2001 compared
with $181.9 million in fiscal 2000. The weakening of the euro and, to a lesser
extent, the British pound had a negative translation effect on sales for the
year of $12.0 million. Excluding this translation effect, sales were 0.8%
higher than the prior year.

The energy segment sales were $113.9 million in fiscal 2001 compared with $88.1
million in fiscal 2000. This increase in fiscal 2001 sales was $25.8 million,
or 29.3%. High natural gas and crude oil prices spurred an increase in
exploration and production activities.

The industrial segment had sales of $140.6 million in fiscal 2001 compared with
$136.7 million in fiscal 2000. The weakening of the British pound had a negative
translation effect on fiscal 2001 sales of $1.0 million. Excluding this
translation effect, sales were 3.6% higher than the prior year. The increase in
fiscal 2001 sales was attributable to an increase in demand for our
corrosion-resistant products in the semiconductor market.

EBIT in fiscal 2001 was $43.2 million compared with $43.6 million in fiscal
2000, a decrease of $0.4 million, or 0.9%. The Adjusted EBITA in fiscal 2001
was $53.9 million compared with $51.6 million in the prior year, an increase of
$2.3 million, or 4.5%.

In the pharmaceutical segment, Adjusted EBITA was $19.6 million in fiscal 2001
and $26.9 million in fiscal 2000, a decrease of $7.3 million, or 27.1%. The
weakening European currencies against the U.S. dollar decreased Adjusted EBITA
by $1.0 million in fiscal 2001. The remaining decline was attributable to lower
sales in Reactor Systems, which was due to the aforementioned low profitability
and capital spending in the chemical process industry and the weak euro
creating competitive pressures for our U.K. operations.

In the energy segment, Adjusted EBITA was $28.2 million in fiscal 2001 compared
with $17.7 million in fiscal 2000, an increase of $10.5 million, or 59.3%. The
increase in Adjusted EBITA was due to the sales volume increase and the cost
reductions from closing the Fairfield facility.

In the industrial segment, Adjusted EBITA was $13.9 million in fiscal 2001 and
$15.3 million in fiscal 2000, a decrease of $1.4 million, or 9.2%. The decline
was due to selling price pressures in our Chemineer business and a higher mix
of low-margin sales to municipalities by our Moyno business.

Interest expense decreased to $12.3 million in fiscal 2001 from $13.5 million
in fiscal 2000. The decrease was due to lower average debt levels in fiscal
2001 and slightly lower interest rates during fiscal 2001. Our effective
interest rate was 6.9% in fiscal 2001 and 7.2% in fiscal 2000.

The effective tax rate was 33.1% in fiscal 2001 and 35.0% in fiscal 2000. The
fiscal 2001 tax rate was lower since we generated a tax benefit from our
foreign sales corporation. Net deferred income tax assets of $8.9 million at
August 31, 2001 primarily related to U.S. operations.

24



---



##### Table of Contents



Net income and net income per diluted share in fiscal 2001 were $19.6 million
and $1.63 compared with $18.1 million and $1.53 in fiscal 2000. The increase
was primarily from the sales increase in the energy segment. Excluding the
effects of the special items described in the Special Items table in the
Overview section of this Managements Discussion and Analysis, fiscal 2001
net income and net income per diluted share would have been higher by $1.7
million and $0.12, respectively.

Liquidity and Capital Resources

Operating Activities

In fiscal 2002, our cash flow from operations was $44.5 million compared with
$31.0 million in fiscal 2001. The improved cash flow from operations was due to
our actions to conserve cash in reaction to the expected weaker economic
environment in fiscal 2002. Because of these actions, inventories were reduced
by $22.3 million, excluding the effects of changes in exchange rates. The
decrease in accrued expenses primarily related to lower variable pay accruals,
income tax accruals and customer advance payments.

We expect our fiscal 2003 operating cash flow to be adequate to fund the fiscal
year 2003 operating needs, scheduled debt services, shareholder dividend
requirements and planned capital expenditures of approximately $15.0 million.
Our planned capital expenditures are related to additional production capacity,
cost reductions and replacement items.

Investing Activities

Our capital expenditures were $15.1 million in fiscal 2002, down from $20.2
million in fiscal 2001. We also generated cash of $4.9 million through
sale-leaseback arrangements. During fiscal 2002, we paid $18.8 million in
earnout payments and acquisition costs related to the Romaco acquisition, and
we paid $1.9 million for refinancing fees in connection with the amended credit
agreement discussed below.

Financing Activities

We entered into a Second Amended and Restated Credit Agreement (Agreement) on
January 9, 2002. This agreement provided for borrowings on a revolving credit
basis up to a maximum of $180.0 million.

In June of 2002, we received net proceeds of approximately $53.2 million from a
secondary stock offering. The proceeds were used to pay down outstanding
borrowings under the Agreement. The Agreement states that the banks commitment
under the Agreement is also reduced by the amount of the gross proceeds from a
stock offering. Therefore, subsequent to the stock offering, the banks
commitment under the Agreement was reduced to $126.1 million. All outstanding
amounts under the Agreement are due and payable on January 9, 2005. Interest is
variable based upon formulas tied to LIBOR or prime, at our option, and is
payable at least quarterly. Under the Agreement and other lines of credit, we
have $119.0 million of unused borrowing capacity. However, due to our financial
covenants, at August 31, 2002, we could only incur additional indebtedness of
$15.0 million. Subsequent to August 31, 2002, the Agreement was amended which
eased the thresholds for our interest coverage and leverage ratios. With the
amended financial covenants, we could incur additional indebtedness of
approximately $45.0 million.

We have $59.7 million of convertible subordinated notes that are due on
September 1, 2003 (fiscal year 2004). We are pursuing various options regarding
the payment of these notes. If necessary, we can use our capacity under the
Agreement to repay these notes, because utilizing borrowings under the
Agreement to retire these notes would not create additional debt and therefore
not impact our position with regard to debt covenants.

25



---



##### Table of Contents



Critical Accounting Policies and Estimates

This Managements Discussion and Analysis is based on our consolidated
financial statements and the related notes. The more critical accounting
policies used in the preparation of our consolidated financial statements are
discussed below.

Revenue Recognition

We recognize revenue at the time of title passage to our customer. We recognize
revenue for certain longer-term contracts based on the percentage of completion
method. The percentage of completion method requires estimates of total
expected contract revenue and costs. We follow this method since we can make
reasonably dependable estimates of the revenue and cost applicable to various
stages of the contract. Revisions in profit estimates are reflected in the
period in which the facts that gave rise to the revision become known.

Use of Estimates

The preparation of financial statements in conformity with accounting
principles generally accepted in the U.S. requires us to make estimates and
assumptions that affect the amounts reported in the consolidated financial
statements and the related notes. Significant estimates made by us include the
allowance for doubtful accounts, inventory valuation, deferred tax asset
valuation allowance, warranty accruals, litigation, product liability and
environmental accruals and retirement benefit obligations.

Our estimate for uncollectible accounts receivable is based upon an analysis of
our prior collection experience, specific customer creditworthiness and current
economic trends within the industries we serve. In circumstances where we are
aware of a specific customers inability to meet its financial obligation to us
(e.g., bankruptcy filings or substantial downgrading of credit ratings), we
record a specific reserve to reduce the receivable to the amount we reasonably
believe will be collected. For all other customers, we recognize reserves for
bad debts based on the length of time that the receivables are past due.
Inventory valuation reserves are determined based on our assessment of the
market conditions for our products. We have recorded valuation allowances to
reflect the estimated amount of deferred tax assets that may not be realized
based upon our analysis of estimated future taxable income and establishment of
tax strategies. Future taxable income, the results of tax strategies and
changes in tax laws could impact these estimates.

Warranty obligations are contingent upon product failure rates, material
required for the repairs and service delivery costs. We estimate the warranty
accrual based on specific product failures that are known to us plus an
additional amount based on the historical relationship of warranty claims to
sales. We record litigation, product liability and environmental reserves based
upon a case-by-case analysis of the facts, circumstances and estimated costs.
Retirement benefit obligations are affected by a number of estimates made by us
in consultation with independent actuaries, including the discount rate,
long-term rate of return on plan assets and assumed increases for wage rate and
health care costs.

These estimates form the basis for making judgments about the carrying value of
our assets and liabilities and are based on the best available information at
the time we prepare our financial statements. These estimates are subject to
change as conditions within and beyond our control change, including but not
limited to economic conditions, the availability of additional information and
actual experience rates different from those used in our estimates.
Accordingly, actual results may differ from these estimates.

Goodwill

As of September 1, 2001, we adopted two new accounting standards issued by the
Financial Accounting Standards Board. SFAS No. 141, Business Combinations,
eliminated the pooling method of accounting for all business combinations
initiated after June 30, 2001 and addressed the initial recognition and
measurement of goodwill and intangible assets acquired in a business
combination. Accordingly, we applied the provisions of SFAS No. 141 to all
business combinations initiated after June 30, 2001. We also adopted SFAS No.
142, Goodwill and Other Intangible Assets, effective September 1, 2001.
Goodwill amortization ceased upon adoption of the standard, and the required
impairment tests were performed. Results of these impairment tests have not
generated any impairment loss to date.

26



---



##### Table of Contents



Goodwill will be tested on an annual basis, or more frequently as impairment
indicators arise. Impairment tests, which involve the use of estimates related
to the fair market values of the business operations with which goodwill is
associated, are performed at the end of our first quarter. Losses, if any,
resulting from impairment tests will be reflected in operating income in our
income statement.

Foreign Currency Accounting

Gains and losses resulting from the settlement of a transaction in a currency
different from that used to record the transaction are charged or credited to
net income when incurred. Adjustments resulting from the translation of
non-U.S. financial statements into U.S. dollars are recognized in accumulated
other comprehensive income or loss for all non-U.S. units.

We use permanently invested intercompany loans as a source of capital to reduce
the exposure to foreign currency fluctuations in our foreign subsidiaries.
These loans are treated as analogous to equity for accounting purposes.
Therefore, we record foreign exchange gains or losses on these intercompany
loans in accumulated other comprehensive income or loss.

27



---



##### Table of Contents






ITEM 7A. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK

Qualitative and Quantitative Disclosures About Market Risk

We maintain operations in the U.S. and over 20 foreign countries. We have
market risk exposure to foreign exchange rates in the normal course of our
business operations. Our significant non-U.S. operations have their local
currencies as their functional currency and primarily buy and sell using that
same currency. We manage our exposure to net assets and cash flows in
currencies other than U.S. dollars by minimizing our non-U.S. dollar net asset
positions. We also enter into hedging transactions, primarily currency swaps,
under established policies and guidelines that enable us to mitigate the
potential adverse impact of foreign exchange rate risk. We do not engage in
trading or other speculative activities with these transactions as established
policies require that these hedging transactions relate to specific currency
exposures.

Our main foreign exchange rate exposures relate to assets, liabilities and cash
flows denominated in British pounds, euros and Canadian dollars and the general
economic exposure that fluctuations in these currencies could have on the U.S.
dollar value of future non-U.S. cash flows. To illustrate the potential impact
of changes in foreign currency exchange rates on us as of August 31, 2002, the
net unhedged exposures in each currency were remeasured assuming a 10% decrease
in foreign exchange rates compared with the U.S. dollar. Using this method, our
EBIT and cash flow from operations for fiscal 2002 would have decreased by $2.6
million and $1.6 million, respectively. This calculation assumed that each
exchange rate would change in the same direction relative to the U.S. dollar.
In addition to the direct effects of changes in exchange rates, these changes
may also affect the volume of sales or the foreign currency sales prices as
competitors products become more or less attractive. Our sensitivity analysis
of the effects of changes in foreign currency exchange rates does not include
any effects of potential changes in sales levels or local currency prices.

We also have market risk exposure to interest rates. At August 31, 2002, we had
$208.5 million in interest-bearing debt obligations subject to market risk
exposure due to changes in interest rates. To manage our exposure to changes in
interest rates, we attempt to maintain a balance between fixed and variable
rate debt. We expect this balance in the debt profile to moderate our financing
cost over time. We are limited in our ability to refinance our fixed rate debt.
However, we have the ability to change the characteristics of our fixed rate
debt to variable rate debt through interest rate swaps to achieve our objective
of balance. At August 31, 2002, we had entered into an interest rate swap
agreement that effectively modifies a portion of our fixed rate debt to
floating rate debt. This agreement involves the receipt of fixed rate amounts
in exchange for floating rate interest payments over the life of the agreement
without an exchange of underlying principal amounts. The mark-to-market values
of both the fair value hedging instrument and the underlying debt obligation
were equal and recorded as offsetting gains and losses in current period
earnings. The fair value hedge qualifies for treatment under the short-cut
method of measuring effectiveness. As a result, there was no impact on earnings
due to hedge ineffectiveness. The interest rate swap agreement totals $30.0
million, expires in 2008 and allows us to receive an effective interest rate of
6.76% and pay an interest rate based on LIBOR.

At August 31, 2002, $155.0 million of our outstanding debt was at fixed rates
with a weighted average interest rate of 7.0% and $53.4 million was at variable
rates with a weighted average interest rate of 5.8%. The estimated fair value
of our debt at August 31, 2002 was approximately $205.5 million. The following
table presents the aggregate maturities and related weighted average interest
rates of our debt obligations at August 31, 2002 by maturity dates (in
thousands, except percents):
28Table of Contents

|           |  |             |         |               |  |                 |      |                 |  |        |        |      |  |        |      |      |  |   |        |  |  |  |      |   |  |   |        |  |  |  |      |  
|---------- |  | ----------- | ------- | ------------- |  | --------------- | ---- | --------------- |  | ------ | ------ | ---- |  | ------ | ---- | ---- |  | - | ------ |  |  |  | ---- | - |  | - | ------ |  |  |  | ---- | -
|           |  | U.S. Dollar |         | U.S. Dollar   |  | Non U.S. Dollar |      | Non U.S. Dollar
|           |  | Fixed Rate  |         | Variable Rate |  | Fixed Rate      |      | Variable Rate  
|Maturity   |  |             |         |               |  |                 |      |                
|Date       |  | Amount      |         | Rate          |  | Amount          |      | Rate            |  | Amount |        | Rate |  | Amount |      | Rate
|           |  |             |         |               |  |                 |      |                 |  |        |        |      |  |        |      |     
|2003       |  |             |         |               |  |                 |      |                 |  | $      | 700    |      |  |        | 4.75 | %    |  | $ | 1,025  |  |  |  | 4.56 | % |  | $ | 2,801  |  |  |  | 5.26 | %
|2004       |  | $           | 59,691  |               |  |                 | 6.50 | %               |  |        | 700    |      |  |        | 4.75 |      |  |   | 1,038  |  |  |  | 4.48 |   |  |   | 3,709  |  |  |  | 5.48 |  
|2005       |  |             |         |               |  |                 |      |                 |  |        | 700    |      |  |        | 4.75 |      |  |   | 771    |  |  |  | 4.09 |   |  |   | 3,011  |  |  |  | 4.56 |  
|2006       |  |             |         |               |  |                 |      |                 |  |        | 700    |      |  |        | 4.75 |      |  |   | 3,038  |  |  |  | 8.71 |   |  |   | 3,715  |  |  |  | 4.40 |  
|2007       |  |             |         |               |  |                 |      |                 |  |        |        |      |  |        |      |      |  |   | 18,506 |  |  |  | 9.79 |   |  |   | 1,015  |  |  |  | 3.72 |  
|Thereafter |  |             | 70,000  |               |  |                 | 6.78 |                 |  |        | 30,000 |      |  |        | 4.26 |      |  |   | 942    |  |  |  | 3.75 |   |  |   | 6,384  |  |  |  | 3.72 |  
|           |  |             |         |               |  |                 |      |                 |  |        |        |      |  |        |      |      |  |   |        |  |  |  |      |   |  |   |        |  |  |  |      |  
|Total      |  | $           | 129,691 |               |  |                 | 6.66 | %               |  | $      | 32,800 |      |  |        | 4.30 | %    |  | $ | 25,320 |  |  |  | 8.83 | % |  | $ | 20,635 |  |  |  | 4.49 | %
|           |  |             |         |               |  |                 |      |                 |  |        |        |      |  |        |      |      |  |   |        |  |  |  |      |   |  |   |        |  |  |  |      |  
|Fair value |  | $           | 126,709 |               |  |                 |      |                 |  | $      | 32,800 |      |  |        |      |      |  | $ | 25,320 |  |  |  |      |   |  | $ | 20,635 |  |  |  |      |  
|           |  |             |         |               |  |                 |      |                 |  |        |        |      |  |        |      |      |  |   |        |  |  |  |      |   |  |   |        |  |  |  |      |  

In the normal course of business, we issue letters of credit to secure
outstanding debt and certain payments to vendors. At August 31, 2002, we have
outstanding letters of credit of $20.0 million that are all due within one
year.

In addition to long-term debt obligations, we have commitments under
non-cancellable operating leases with the following maturities:

|           |  |                |        | 
|---------- |  | -------------- | ------ | 
|           |  | (In thousands)
|2003       |  | $              | 2,411  | 
|2004       |  |                | 1,998  | 
|2005       |  |                | 1,797  | 
|2006       |  |                | 1,848  | 
|2007       |  |                | 1,768  | 
|Thereafter |  |                | 2,174  | 
|           |  |                |        | 
|           |  | $              | 11,996 | 
|           |  |                |        | 

We have no capital lease obligations or unconditional purchase obligations.

29



---



##### Table of Contents






ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

CONSOLIDATED BALANCE SHEET
Robbins & Myers, Inc. and Subsidiaries
(In thousands, except share data)

|                                               |                                         |                                                       |         |         |            |         |         |         |         |         |  
|---------------------------------------------- | --------------------------------------- | ----------------------------------------------------- | ------- | ------- | ---------- | ------- | ------- | ------- | ------- | ------- | -
|                                               |                                         |                                                       |         |         | August 31,
|                                               |                                         |                                                       |         |         |           
|                                               |                                         |                                                       |         |         | 2002       |         | 2001   
|                                               |                                         |                                                       |         |         |            |         |        
|ASSETS                                         |                                         |                                                       |         |         |            |         |         |        
|Current Assets:                                |                                         |                                                       |         |         |            |         |         |        
|                                               | Cash and cash equivalents               |                                                       | $       | 10,534  |            |         | $       | 16,122  |        
|                                               | Accounts receivable                     |                                                       |         | 113,711 |            |         |         | 105,294 |        
|                                               | Inventories                             |                                                       |         | 92,446  |            |         |         | 116,977 |        
|                                               | Other current assets                    |                                                       |         | 12,318  |            |         |         | 13,084  |        
|                                               | Deferred taxes                          |                                                       |         | 14,071  |            |         |         | 16,336  |        
|                                               |                                         |                                                       |         |         |            |         |         |        
|                                               |                                         | Total Current Assets                                  |         |         | 243,080    |         |         |         | 267,813 |        
|Goodwill                                       |                                         |                                                       | 271,948 |         |            |         | 220,648 |        
|Other Intangible Assets                        |                                         |                                                       | 17,604  |         |            |         | 14,799  |        
|Other Assets                                   |                                         |                                                       | 6,201   |         |            |         | 7,603   |        
|Property, Plant and Equipment                  |                                         |                                                       | 143,859 |         |            |         | 149,397 |        
|                                               |                                         |                                                       |         |         |            |         |         |        
|                                               |                                         | $                                                     | 682,692 |         |            | $       | 660,260 |        
|                                               |                                         |                                                       |         |         |            |         |         |        
|LIABILITIES AND SHAREHOLDERS EQUITY           |                                         |                                                       |         |         |            |         |         |        
|Current Liabilities:                           |                                         |                                                       |         |         |            |         |         |        
|                                               | Accounts payable                        |                                                       | $       | 41,964  |            |         | $       | 43,018  |        
|                                               | Accrued expenses                        |                                                       |         | 83,871  |            |         |         | 88,560  |        
|                                               | Current portion of long-term debt       |                                                       |         | 4,526   |            |         |         | 17,669  |        
|                                               |                                         |                                                       |         |         |            |         |         |        
|                                               |                                         | Total Current Liabilities                             |         |         | 130,361    |         |         |         | 149,247 |        
|Long-Term Debt  Less Current Portion          |                                         |                                                       | 203,920 |         |            |         | 241,225 |        
|Deferred Taxes                                 |                                         |                                                       | 8,708   |         |            |         | 7,414   |        
|Other Long-Term Liabilities                    |                                         |                                                       | 70,863  |         |            |         | 56,420  |        
|Minority Interest                              |                                         |                                                       | 8,347   |         |            |         | 8,052   |        
|                                              
|Shareholders Equity:                          |                                         |                                                       |         |         |            |         |         |        
|                                               | Common stock-without par value:         |                                                       |         |         |            |         |         |         |        
|                                               |                                         | Authorized shares-40,000,000                         
|                                               |                                         | Issued shares-14,334,927 in 2002 (11,825,950 in 2001) |         |         | 103,952    |         |         |         | 48,483  |        
|                                               |                                         | Treasury shares-1,429 in 2002 (100,275 in 2001)       |         |         | (29        | )       |         |         | (2,150  | )      
|                                               | Retained earnings                       |                                                       |         | 176,627 |            |         |         | 164,864 |        
|                                               | Accumulated other comprehensive (loss): |                                                       |         |         |            |         |         |         |        
|                                               |                                         | Foreign currency translation                          |         |         | (9,401     | )       |         |         | (10,902 | )      
|                                               |                                         | Minimum pension liability                             |         |         | (10,656    | )       |         |         | (2,393  | )      
|                                               |                                         |                                                       |         |         |            |         |         |        
|                                               |                                         |                                                       | Total   |         |            | (20,057 | )       |         |         | (13,295 | )
|                                               |                                         |                                                       |         |         |            |         |         |        
|                                               |                                         |                                                       | 260,493 |         |            |         | 197,902 |        
|                                               |                                         |                                                       |         |         |            |         |         |        
|                                               |                                         | $                                                     | 682,692 |         |            | $       | 660,260 |        
|                                               |                                         |                                                       |         |         |            |         |         |        
|See Notes to Consolidated Financial Statements |                                         |                                                       |         |         |            |         |         |        

30



---



##### Table of Contents



CONSOLIDATED SHAREHOLDERS EQUITY STATEMENT
Robbins & Myers, Inc. and Subsidiaries
(In thousands, except share and per share data)

|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |        |  
|---------------------------------------------- | -------------------------------------------- | - | ------- | ------ | -------- | - | -------- | ------ | ------------- | - | ------- | ------ | - | - | ----------- | ------ | - | - | ------- | ------ | -
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   | Accumulated |        |   |   |        
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   | Other       |        |   |   |        
|                                               |                                              |   | Common  |        | Treasury |   | Retained |        | Comprehensive |   |         |        |  
|                                               |                                              |   | Shares  |        | Shares   |   | Earnings |        | (Loss)        |   | Total  
|                                               |                                              |   |         |        |          |   |          |        |               |   |        
|Balance at September 1, 1999                   |                                              | $ | 33,968  |        |          | $ | (6,500   | )      |               | $ | 132,015 |        |   | $ | (5,257      | )      |   | $ | 154,226 |       
|                                               | Net income                                   |   |         |        |          |   |          |        |               |   |         | 18,056 |   |   |             |        |   |   |         | 18,056 |  
|                                               | Change in foreign currency translation       |   |         |        |          |   |          |        |               |   |         |        |   |   |             | (5,199 | ) |   |         | (5,199 | )
|                                               | Change in minimum pension liability          |   |         |        |          |   |          |        |               |   |         |        |   |   |             | 2,180  |   |   |         | 2,180  |  
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|                                               | Comprehensive income                         |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 15,037 |  
|                                               | Cash dividends declared, $0.22 per share     |   |         |        |          |   |          |        |               |   |         | (2,407 | ) |   |             |        |   |   |         | (2,407 | )
|                                               | Stock options exercised, 21,500 shares       |   |         | (199   | )        |   |          | 463    |               |   |         |        |   |   |             |        |   |   |         | 264    |  
|                                               | Proceeds from share sales, 70,832 shares     |   |         | (271   | )        |   |          | 1,582  |               |   |         |        |   |   |             |        |   |   |         | 1,311  |  
|                                               | Stock repurchase program, 77,085 shares      |   |         |        |          |   |          | (1,337 | )             |   |         |        |   |   |             |        |   |   |         | (1,337 | )
|                                               | Tax benefit of stock options exercised       |   |         | 88     |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 88     |  
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|Balance at August 31, 2000                     |                                              |   | 33,586  |        |          |   | (5,792   | )      |               |   | 147,664 |        |   |   | (8,276      | )      |   |   | 167,182 |       
|                                               | Net income                                   |   |         |        |          |   |          |        |               |   |         | 19,631 |   |   |             |        |   |   |         | 19,631 |  
|                                               | Change in foreign currency translation       |   |         |        |          |   |          |        |               |   |         |        |   |   |             | (2,757 | ) |   |         | (2,757 | )
|                                               | Change in minimum pension liability          |   |         |        |          |   |          |        |               |   |         |        |   |   |             | (2,262 | ) |   |         | (2,262 | )
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|                                               | Comprehensive income                         |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 14,612 |  
|                                               | Cash dividends declared, $0.22 per share     |   |         |        |          |   |          |        |               |   |         | (2,431 | ) |   |             |        |   |   |         | (2,431 | )
|                                               | Stock options exercised, 130,266 shares      |   |         | (1,473 | )        |   |          | 2,788  |               |   |         |        |   |   |             |        |   |   |         | 1,315  |  
|                                               | Proceeds from share sales, 38,958 shares     |   |         | 121    |          |   |          | 854    |               |   |         |        |   |   |             |        |   |   |         | 975    |  
|                                               | Stock issued for acquisition, 600,000 shares |   |         | 15,354 |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 15,354 |  
|                                               | Performance stock award expense              |   |         | 126    |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 126    |  
|                                               | Tax benefit of stock options exercised       |   |         | 769    |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 769    |  
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|Balance at August 31, 2001                     |                                              |   | 48,483  |        |          |   | (2,150   | )      |               |   | 164,864 |        |   |   | (13,295     | )      |   |   | 197,902 |       
|                                               | Net income                                   |   |         |        |          |   |          |        |               |   |         | 14,503 |   |   |             |        |   |   |         | 14,503 |  
|                                               | Change in foreign currency translation       |   |         |        |          |   |          |        |               |   |         |        |   |   |             | 1,501  |   |   |         | 1,501  |  
|                                               | Change in minimum pension liability          |   |         |        |          |   |          |        |               |   |         |        |   |   |             | (8,263 | ) |   |         | (8,263 | )
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|                                               | Comprehensive income                         |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 7,741  |  
|                                               | Cash dividends declared, $0.22 per share     |   |         |        |          |   |          |        |               |   |         | (2,740 | ) |   |             |        |   |   |         | (2,740 | )
|                                               | Stock options exercised, 167,500 shares      |   |         | 604    |          |   |          | 1,921  |               |   |         |        |   |   |             |        |   |   |         | 2,525  |  
|                                               | Proceeds from share sales, 2,440,323
shares  |   |         | 54,267 |          |   |          | 200    |               |   |         |        |   |   |             |        |   |   |         | 54,467 |  
|                                               | Performance stock award expense              |   |         | (126   | )        |   |          |        |               |   |         |        |   |   |             |        |   |   |         | (126   | )
|                                               | Tax benefit of stock options exercised       |   |         | 724    |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         | 724    |  
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|Balance at August 31, 2002                     |                                              | $ | 103,952 |        |          | $ | (29      | )      |               | $ | 176,627 |        |   | $ | (20,057     | )      |   | $ | 260,493 |       
|                                               |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       
|See Notes to Consolidated Financial Statements |                                              |   |         |        |          |   |          |        |               |   |         |        |   |   |             |        |   |   |         |       

31



---



##### Table of Contents



CONSOLIDATED INCOME STATEMENT
Robbins & Myers, Inc. and Subsidiaries
(In thousands, except per share data)

|                                                 |         |   |         |      |      |   |                        |      |  |   |         |      | 
|------------------------------------------------ | ------- | - | ------- | ---- | ---- | - | ---------------------- | ---- |  | - | ------- | ---- | 
|                                                 |         |   |         |      |      |   | Years ended August 31, |      |  |   |        
|                                                 |         |   | 2002    |      | 2001 |   | 2000                  
|                                                 |         |   |         |      |      |   |                       
|Sales                                            |         | $ | 526,373 |      |      | $ | 425,902                |      |  | $ | 406,714 |     
|Cost of sales                                    |         |   | 352,609 |      |      |   | 285,168                |      |  |   | 266,480 |     
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|Gross profit                                     |         |   | 173,764 |      |      |   | 140,734                |      |  |   | 140,234 |     
|Selling, general and administrative expenses     |         |   | 130,802 |      |      |   | 87,844                 |      |  |   | 88,594  |     
|Amortization                                     |         |   | 2,015   |      |      |   | 8,187                  |      |  |   | 8,077   |     
|Other                                            |         |   | 0       |      |      |   | 1,467                  |      |  |   | (9      | )   
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|Income before interest and income taxes          |         |   | 40,947  |      |      |   | 43,236                 |      |  |   | 43,572  |     
|Interest expense                                 |         |   | 17,565  |      |      |   | 12,312                 |      |  |   | 13,531  |     
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|Income before income taxes and minority interest |         |   | 23,382  |      |      |   | 30,924                 |      |  |   | 30,041  |     
|Income tax expense                               |         |   | 7,831   |      |      |   | 10,229                 |      |  |   | 10,513  |     
|Minority interest                                |         |   | 1,048   |      |      |   | 1,064                  |      |  |   | 1,472   |     
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|Net income                                       |         | $ | 14,503  |      |      | $ | 19,631                 |      |  | $ | 18,056  |     
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|Net income per share:                            |         |   |         |      |      |   |                        |      |  |   |         |     
|                                                 | Basic   |   | $       | 1.17 |      |   | $                      | 1.78 |  |   | $       | 1.65 | 
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|                                                 | Diluted |   | $       | 1.15 |      |   | $                      | 1.63 |  |   | $       | 1.53 | 
|                                                 |         |   |         |      |      |   |                        |      |  |   |         |     
|See Notes to Consolidated Financial Statements   |         |   |         |      |      |   |                        |      |  |   |         |     

32



---



##### Table of Contents



CONSOLIDATED CASH FLOW STATEMENT
Robbins & Myers, Inc. and Subsidiaries
(In thousands)

|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |         |         |  
|-------------------- | ------------------------------------------------------------------------------------------------------ | ------------------------------------------------ | - | ---------------------- | ------- | ---- | - | ------- | ------ | - | - | ------- | ------- | -
|                     |                                                                                                        |                                                  |   | Years Ended August 31,
|                     |                                                                                                        |                                                  |   |                       
|                     |                                                                                                        |                                                  |   | 2002                   |         | 2001 |   | 2000   
|                     |                                                                                                        |                                                  |   |                        |         |      |   |        
|OPERATING ACTIVITIES |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     | Net income                                                                                             |                                                  | $ | 14,503                 |         |      | $ | 19,631  |        |   | $ | 18,056  |        
|                     | Adjustments to reconcile net income to net cash
and cash equivalents provided by operating activities: |                                                  |   |                        |         |      |   |         |        |   |   |         |        
|                     |                                                                                                        | Depreciation                                     |   |                        | 20,028  |      |   |         | 16,161 |   |   |         | 16,293  |  
|                     |                                                                                                        | Amortization                                     |   |                        | 2,015   |      |   |         | 8,187  |   |   |         | 8,077   |  
|                     |                                                                                                        | Deferred taxes                                   |   |                        | 9,369   |      |   |         | 3,306  |   |   |         | (3,434  | )
|                     |                                                                                                        | Asset impairment charges                         |   |                        | 0       |      |   |         | 1,000  |   |   |         | 0       |  
|                     |                                                                                                        | Performance stock awards                         |   |                        | (126    | )    |   |         | 126    |   |   |         | 0       |  
|                     | Changes in operating assets and liabilities  excluding
the effects of acquisitions:                   |                                                  |   |                        |         |      |   |         |        |   |   |         |        
|                     |                                                                                                        | Accounts receivable                              |   |                        | (3,107  | )    |   |         | (2,390 | ) |   |         | (10,212 | )
|                     |                                                                                                        | Inventories                                      |   |                        | 22,269  |      |   |         | (6,408 | ) |   |         | (9,054  | )
|                     |                                                                                                        | Other current assets                             |   |                        | 1,398   |      |   |         | (220   | ) |   |         | 5,675   |  
|                     |                                                                                                        | Other assets                                     |   |                        | (455    | )    |   |         | (207   | ) |   |         | 4,895   |  
|                     |                                                                                                        | Accounts payable                                 |   |                        | (2,897  | )    |   |         | (3,143 | ) |   |         | 7,500   |  
|                     |                                                                                                        | Accrued expenses and other liabilities           |   |                        | (18,457 | )    |   |         | (5,059 | ) |   |         | (1,756  | )
|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     | Net cash and cash equivalents provided by operating activities                                         |                                                  |   | 44,540                 |         |      |   | 30,984  |        |   |   | 36,040  |        
|                    
|INVESTING ACTIVITIES |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     | Capital expenditures, net of nominal disposals                                                         |                                                  |   | (15,112                | )       |      |   | (20,200 | )      |   |   | (19,842 | )      
|                     | Proceeds from sale-leaseback arrangements                                                              |                                                  |   | 4,905                  |         |      |   | 0       |        |   |   | 0       |        
|                     | Amended credit agreement fees                                                                          |                                                  |   | (1,911                 | )       |      |   | 0       |        |   |   | 0       |        
|                     | Purchase of Romaco, net of cash acquired                                                               |                                                  |   | (18,823                | )       |      |   | (38,703 | )      |   |   | 0       |        
|                     | Purchase of Rodec and ABI                                                                              |                                                  |   | 0                      |         |      |   | (6,008  | )      |   |   | 0       |        
|                     | Purchase of Chemineer de Mexico                                                                        |                                                  |   | 0                      |         |      |   | (523    | )      |   |   | (261    | )      
|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     | Net cash and cash equivalents used by investing activities                                             |                                                  |   | (30,941                | )       |      |   | (65,434 | )      |   |   | (20,103 | )      
|                    
|FINANCING ACTIVITIES |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     | Proceeds from debt borrowings                                                                          |                                                  |   | 29,836                 |         |      |   | 69,828  |        |   |   | 12,731  |        
|                     | Payments of long-term debt                                                                             |                                                  |   | (103,275               | )       |      |   | (30,359 | )      |   |   | (18,347 | )      
|                     | Proceeds from sale of common stock                                                                     |                                                  |   | 56,992                 |         |      |   | 2,290   |        |   |   | 1,075   |        
|                     | Purchase of common stock and convertible subordinated notes                                            |                                                  |   | 0                      |         |      |   | 0       |        |   |   | (6,646  | )      
|                     | Dividends paid                                                                                         |                                                  |   | (2,740                 | )       |      |   | (2,431  | )      |   |   | (2,407  | )      
|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     | Net cash and cash equivalents (used) provided by financing activities                                  |                                                  |   | (19,187                | )       |      |   | 39,328  |        |   |   | (13,594 | )      
|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     |                                                                                                        | (Decrease) increase in cash and cash equivalents |   |                        | (5,588  | )    |   |         | 4,878  |   |   |         | 2,343   |  
|                     |                                                                                                        | Cash and cash equivalents at beginning of year   |   |                        | 16,122  |      |   |         | 11,244 |   |   |         | 8,901   |  
|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        
|                     |                                                                                                        | Cash and cash equivalents at end of year         |   | $                      | 10,534  |      |   | $       | 16,122 |   |   | $       | 11,244  |  
|                     |                                                                                                        |                                                  |   |                        |         |      |   |         |        |   |   |        

See Notes to Consolidated Financial Statements

33



---



##### Table of Contents






NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Robbins & Myers, Inc. and Subsidiaries

NOTE 1  SUMMARY OF ACCOUNTING POLICIES

Consolidation

The consolidated financial statements include accounts of Robbins & Myers, Inc.
(we, our) and its subsidiaries. All significant intercompany accounts and
transactions have been eliminated upon consolidation. All of our operations are
conducted in producing and selling original and used equipment and aftermarket
parts in the pharmaceutical and healthcare, general industrial and oil and gas
exploration and recovery industries.

Use of Estimates

The preparation of financial statements in conformity with accounting
principles generally accepted in the United States requires us to make
estimates and assumptions that affect the amounts reported in the consolidated
financial statements and accompanying notes. Actual results could differ from
those estimates.

Accounts Receivable

Accounts receivable relate primarily to customers located in North America and
Western Europe and are concentrated in the pharmaceutical, specialty chemical
and oil and gas markets. To reduce credit risk, we perform credit
investigations prior to accepting an order and, when necessary, require letters
of credit to insure payment.

Our estimate for uncollectible accounts receivable is based upon an
analysis of our prior collection experience, specific customer creditworthiness
and current economic trends within the industries we serve. In circumstances
where we are aware of a specific customers inability to meet its financial
obligation to us (e.g., bankruptcy filings or substantial downgrading of credit
ratings), we record a specific reserve to reduce the receivable to the amount
we reasonably believe will be collected. For all other customers, we recognize
reserves for bad debts based on the length of time that the receivables are
past due.

Inventories

Inventories are stated at the lower of cost or market determined by the
last-in, first-out (LIFO) method in the U.S. and the first-in, first-out
(FIFO) method outside the U.S. Inventory valuation reserves are determined
based on our assessment of the market conditions for our products.

Goodwill and Other Intangible Assets

Goodwill is the excess of the purchase price paid over the value of net assets
of businesses acquired. Goodwill is not amortized, but is tested for impairment
on an annual basis, or more frequently as impairment indicators arise.
Impairment tests, which involve the use of estimates related to the fair market
values of the business operations with which goodwill is associated, are
performed at the end of our first quarter. Losses, if any, resulting from
impairment tests will be reflected in operating income in our income statement.

Amortization of other intangible assets is calculated on the
straight-line basis using the following
lives:

|                       |  |                |  | 
|---------------------- |  | -------------- |  | 
|Patents and trademarks |  | 14 to 17 years
|Non-compete agreements |  | 3 to 5 years  
|Financing costs        |  | 5 years       

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation expense is
recorded over the estimated useful life of the asset on the straight-line
method using the following lives:

|                        |  |               |  | 
|----------------------- |  | ------------- |  | 
|Land improvements       |  | 20 years     
|Buildings               |  | 45 years     
|Machinery and equipment |  | 3 to 15 years

Our normal policy is to expense repairs and improvements made to capital
assets as incurred. In limited circumstances, betterments are capitalized and
amortized over the estimated life of the new asset

34



---



##### Table of Contents



and any remaining value of
the old asset is written off. Repairs to machinery and equipment must result in
an addition to the useful life of the asset before the costs are capitalized.

Foreign Currency Accounting

Gains and losses resulting from the settlement of a transaction in a currency
different from that used to record the transaction are charged or credited to
net income when incurred. Adjustments resulting from the translation of
non-U.S. financial statements into U.S. dollars are recognized in accumulated
other comprehensive income or loss for all non-U.S. units.

Product Warranties

Warranty obligations are contingent upon product failure rates, material
required for the repairs and service delivery costs. We estimate the warranty
accrual based on specific product failures that are known to us plus an
additional amount based on the historical relationship of warranty claims to
sales.

Revenue Recognition

We recognize revenue at the time of title passage to our customer. We recognize
revenue for certain longer-term contracts based on the percentage of completion
method. The percentage of completion method requires estimates of total
expected contract revenue and costs. We follow this method since we can make
reasonably dependable estimates of the revenue and cost applicable to various
stages of the contract. Revisions in profit estimates are reflected in the
period in which the facts that gave rise to the revision become known.

Income Taxes

Income taxes are provided for all items included in the Consolidated Income
Statement regardless of the period when such items are reported for income tax
purposes. Deferred income taxes reflect the net effects of temporary
differences between the carrying amounts of assets and liabilities for
financial reporting purposes and the amounts used for income tax purposes. We
have recorded valuation allowances to reflect the estimated amount of deferred
tax assets that may not be realized based upon our analysis of estimated future
taxable income and establishment of tax strategies. Future taxable income, the
results of tax strategies and changes in tax laws could impact these estimates.

Our policy is to provide U.S. income taxes on non-U.S. income when
remitted to the U.S. We do not provide U.S. income taxes on the remaining
undistributed non-U.S. income, which aggregated $44,000,000 at August 31, 2002,
as it is our intention to maintain our investments in these operations.

Consolidated Cash Flow Statement

Cash and cash equivalents consist of cash balances and temporary investments
having an original maturity of 90 days or less.

Fair Value of Financial Instruments

The following methods and assumptions were used by us in estimating the fair
value of financial instruments:



| |                                                                                                                            
| | ---------------------------------------------------------------------------------------------------------------------------
| | Cash and cash equivalents  The amounts reported approximate market value.                                                 
|
| | Long-term debt  The market value of our debt is $205,464,000 at August
31, 2002 and $257,203,000 at August 31, 2001.      
| | These amounts are based on the terms, interest rates and maturities currently
available to us for similar debt instruments.
|
| | Foreign exchange contracts  The amounts reported are estimated using
quoted market prices for
similar instruments.        

Common Stock Plans

Common stock plans involving the issuance of stock options are accounted for as
noncompensatory plans. Common stock plans involving the issuance of a variable
number of shares based on performance are accounted for as compensatory plans.

Derivatives and Hedging Activities

We account for derivative instruments in accordance with Statement of Financial
Accounting Standards (SFAS) No. 133, Accounting for Derivatives and Hedging
Activities, as amended. This standard requires the recognition of all
derivatives on the balance sheet at fair value and recognition of the resulting
gains or losses as adjustments to earnings or other comprehensive income. We
formally document all relationships between hedging instruments and hedged
items, as well as our risk

35



---



##### Table of Contents



management objective and strategy for undertaking
various hedge transactions. Our hedging activities are transacted only with a
highly-rated institution, reducing the exposure to credit risk in the event of
nonperformance. We use derivatives for fair value hedging purposes. For
derivative instruments that hedge the exposure to changes in the fair value of
certain fixed rate debt, designated as fair value hedges, the effective portion
of the net gain or loss on the derivative instrument, as well as the offsetting
gain or loss on the fixed rate debt attributable to the hedged risk, are
recorded in current period earnings. We use swap agreements to convert a
portion of fixed rate debt to a floating rate basis, thus hedging for changes
in the fair value of the fixed rate debt being hedged. We have determined that
this interest rate swap, designated as a fair value hedge, qualifies for
treatment under the short-cut method of measuring effectiveness. Under the
provisions of SFAS No. 133, this hedge is determined to be perfectly effective
and there is no requirement to periodically evaluate effectiveness.

Reclassifications

Certain prior year amounts are reclassified to conform with the current year
presentation.

NOTE 2  BUSINESS ACQUISITIONS

On December 12, 2000, we acquired certain assets of Campbell Industries Ltd.
(DBA Rodec Tubing Rotors) (Rodec) for $2,802,000. Rodec is a Canadian company
that designs, manufactures, and markets oil and gas production equipment
including artificial lift accessories and down-hole tools with annual sales of
$3,000,000.

On June 12, 2001, we acquired certain assets of Alberta Basic Industries
(ABI) for $3,206,000. ABI is also a Canadian manufacturer of down-hole tools
for oil and gas production equipment with annual sales of approximately
$3,000,000.

On August 31, 2001, we purchased the stock of Romaco NV, a Netherland
Antilles corporation (Romaco). Romaco is a leading supplier of processing and
packaging equipment for the pharmaceutical, healthcare and cosmetics industries
with pro forma fiscal year 2001 sales of $142,217,000. The total purchase price
of Romaco was $130,111,000. At closing in fiscal 2001, we paid consideration of
$95,238,000 as follows: $38,703,000 in cash, $2,235,000 in a five-year
subordinated note, the assumption of net debt of $38,946,000 and 600,000 of our
common shares valued at $15,354,000. In fiscal 2002, we made an additional
payment of $32,100,000 based on Romacos sales and operating performance for
calendar year 2001, half of which was in cash and half of which was in a
five-year subordinated note, and we incurred acquisition costs of $2,773,000.
We completed the Romaco acquisition at the end of fiscal 2001, and, therefore,
the acquisition had no impact on our results of operations in fiscal 2001.

The following table summarizes the fair values of the assets acquired and
liabilities assumed of Romaco at the date of acquisition.

|                              |                           |   |                 |         | 
|----------------------------- | ------------------------- | - | --------------- | ------- | 
|                              |                           |   | August 31, 2001
|                              |                           |   |                
|                              |                           |   | (In thousands) 
|Current assets                |                           | $ | 82,212          |        
|Property, plant and equipment |                           |   | 29,772          |        
|Goodwill                      |                           |   | 75,835          |        
|Other assets                  |                           |   | 1,246           |        
|                              |                           |   |                 |        
|                              | Total assets acquired     |   |                 | 189,065 | 
|Current liabilities           |                           |   | 68,488          |        
|Long-term debt                |                           |   | 24,089          |        
|Other liabilities             |                           |   | 3,342           |        
|                              |                           |   |                 |        
|                              | Total liabilities assumed |   |                 | 95,919  | 
|                              |                           |   |                 |        
|                              | Net assets acquired       |   | $               | 93,146  | 
|                              |                           |   |                 |        

Since the Romaco acquisition occurred on August 31, 2001, the results of
their operations were not included in our fiscal 2001 Consolidated Income
Statement. Following are our unaudited pro forma consolidated results of
operations assuming the acquisition of Romaco had occurred at the beginning of
fiscal 2000. In preparing the pro forma data, adjustments were made to the
historical financial information. These were primarily interest costs related
to financing the transaction, adjustments to the corporate costs and income
taxes. There was no amortization of the Romaco goodwill included in the pro
forma amounts.

36



---



##### Table of Contents



|                             |  |                       |         |      |  |   |         | 
|---------------------------- |  | --------------------- | ------- | ---- |  | - | ------- | 
|                             |  | 2001                  |         | 2000
|                             |  |                       |         |     
|                             |  | (In thousands, except
|                             |  | per share data)      
|                             |  |                      
|Sales                        |  | $                     | 568,119 |      |  | $ | 541,239 | 
|Net income                   |  |                       | 22,693  |      |  |   | 20,358  | 
|Basic net income per share   |  |                       | 1.95    |      |  |   | 1.76    | 
|Diluted net income per share |  |                       | 1.78    |      |  |   | 1.62    | 

On June 30, 1999, we purchased 51% of Chemineer de Mexico, S.A. de C.V.
(Chemineer de Mexico), a Mexican corporation and its licensee in Mexico for
$1,600,000. On December 31, 1999, we purchased an additional 16.3% of Chemineer
de Mexico for $261,000. The remaining 32.7% of Chemineer de Mexico was
purchased in April 2001 for $523,000.

NOTE 3  NEW ACCOUNTING PRONOUNCEMENT

As of September 1, 2001, we adopted SFAS No. 142, Goodwill and Other
Intangible Assets, which addresses the financial accounting and reporting
standards for the acquisition of intangible assets outside of a business
combination and for goodwill and other intangible assets subsequent to their
acquisition. This accounting standard required that goodwill be separately
disclosed from other intangible assets in the consolidated balance sheet, and
no longer be amortized, but tested for impairment on a periodic basis. The
provisions of this accounting standard also require the completion of a
transitional impairment test within six months of adoption. There were no
indicators of impairment identified by us as a result of the transitional
impairment test that was performed. As required by SFAS No. 142, a review was
performed at year end with no indicators of impairment identified.

In accordance with SFAS No. 142, we discontinued the amortization of
goodwill effective September 1, 2001. A reconciliation of previously reported
net income and net income per share to the amounts adjusted for the exclusion
of goodwill amortization, net of the related income tax effect follows:

|                                  |                                   |   |                       |      |      |   |        |      | 
|--------------------------------- | --------------------------------- | - | --------------------- | ---- | ---- | - | ------ | ---- | 
|                                  |                                   |   | 2001                  |      | 2000
|                                  |                                   |   |                       |      |     
|                                  |                                   |   | (In thousands, except
|                                  |                                   |   | per share data)      
|Reported net income               |                                   | $ | 19,631                |      |      | $ | 18,056 |     
|Goodwill amortization, net of tax |                                   |   | 3,404                 |      |      |   | 3,602  |     
|                                  |                                   |   |                       |      |      |   |        |     
|Adjusted net income               |                                   | $ | 23,035                |      |      | $ | 21,658 |     
|                                  |                                   |   |                       |      |      |   |        |     
|Basic net income per share:       |                                   |   |                       |      |      |   |        |     
|                                  | Reported net income               |   | $                     | 1.78 |      |   | $      | 1.65 | 
|                                  | Goodwill amortization, net of tax |   |                       | 0.31 |      |   |        | 0.33 | 
|                                  |                                   |   |                       |      |      |   |        |     
|                                  | Adjusted net income               |   | $                     | 2.09 |      |   | $      | 1.98 | 
|                                  |                                   |   |                       |      |      |   |        |     
|Diluted net income per share:     |                                   |   |                       |      |      |   |        |     
|                                  | Reported net income               |   | $                     | 1.63 |      |   | $      | 1.53 | 
|                                  | Goodwill amortization, net of tax |   |                       | 0.25 |      |   |        | 0.27 | 
|                                  |                                   |   |                       |      |      |   |        |     
|                                  | Adjusted net income               |   | $                     | 1.88 |      |   | $      | 1.80 | 
|                                  |                                   |   |                       |      |      |   |        |     

37



---



##### Table of Contents



NOTE 4  BALANCE SHEET INFORMATION

Accounts receivable

|                                 |  |                |       |      |  |   |       | 
|-------------------------------- |  | -------------- | ----- | ---- |  | - | ----- | 
|                                 |  | 2002           |       | 2001
|                                 |  |                |       |     
|                                 |  | (In thousands)
|Allowances for doubtful accounts |  | $              | 2,717 |      |  | $ | 3,332 | 
|                                 |  |                |       |      |  |   |       | 

Inventories

|                                |                   |                |        |        |      |   |         |        | 
|------------------------------- | ----------------- | -------------- | ------ | ------ | ---- | - | ------- | ------ | 
|                                |                   |                | 2002   |        | 2001
|                                |                   |                |        |        |     
|FIFO:                           |                   | (In thousands)
|                                | Finished products |                | $      | 30,928 |      |   | $       | 37,191 | 
|                                | Work in process   |                |        | 23,981 |      |   |         | 38,913 | 
|                                | Raw materials     |                |        | 43,682 |      |   |         | 45,968 | 
|                                |                   |                |        |        |      |   |         |       
|                                |                   |                | 98,591 |        |      |   | 122,072 |       
|LIFO reserve, U. S. inventories |                   |                | (6,145 | )      |      |   | (5,095  | )     
|                                |                   |                |        |        |      |   |         |       
|                                |                   | $              | 92,446 |        |      | $ | 116,977 |       
|                                |                   |                |        |        |      |   |         |       
|Non-U.S. inventories at FIFO    |                   | $              | 63,085 |        |      | $ | 78,462  |       
|                                |                   |                |        |        |      |   |         |       

Property, plant and equipment

|                              |  |                |         |      |  |   |         | 
|----------------------------- |  | -------------- | ------- | ---- |  | - | ------- | 
|                              |  | 2002           |         | 2001
|                              |  |                |         |     
|                              |  | (In thousands)
|Land and improvements         |  | $              | 10,236  |      |  | $ | 7,945   | 
|Buildings                     |  |                | 77,494  |      |  |   | 70,591  | 
|Machinery and equipment       |  |                | 174,196 |      |  |   | 174,397 | 
|                              |  |                |         |      |  |   |         | 
|                              |  |                | 261,926 |      |  |   | 252,933 | 
|Less accumulated depreciation |  |                | 118,067 |      |  |   | 103,536 | 
|                              |  |                |         |      |  |   |         | 
|                              |  | $              | 143,859 |      |  | $ | 149,397 | 
|                              |  |                |         |      |  |   |         | 

Accrued expenses

|                                   |  |                |        |      |  |   |        | 
|---------------------------------- |  | -------------- | ------ | ---- |  | - | ------ | 
|                                   |  | 2002           |        | 2001
|                                   |  |                |        |     
|                                   |  | (In thousands)
|Salaries, wages and payroll taxes  |  | $              | 13,266 |      |  | $ | 16,281 | 
|Customer advances                  |  |                | 19,831 |      |  |   | 19,749 | 
|Pension benefits                   |  |                | 5,216  |      |  |   | 5,179  | 
|U.S. other postretirement benefits |  |                | 2,000  |      |  |   | 2,000  | 
|Warranty costs                     |  |                | 9,405  |      |  |   | 10,176 | 
|Accrued interest                   |  |                | 4,068  |      |  |   | 4,292  | 
|Income taxes                       |  |                | 2,647  |      |  |   | 5,855  | 
|Commissions                        |  |                | 3,131  |      |  |   | 2,494  | 
|Other                              |  |                | 24,307 |      |  |   | 22,534 | 
|                                   |  |                |        |      |  |   |        | 
|                                   |  | $              | 83,871 |      |  | $ | 88,560 | 
|                                   |  |                |        |      |  |   |        | 

Other long-term liabilities

|                                   |  |                |        |      |  |   |        | 
|---------------------------------- |  | -------------- | ------ | ---- |  | - | ------ | 
|                                   |  | 2002           |        | 2001
|                                   |  |                |        |     
|                                   |  | (In thousands)
|German pension liability           |  | $              | 28,555 |      |  | $ | 24,867 | 
|U.S. other postretirement benefits |  |                | 12,414 |      |  |   | 12,108 | 
|U.S. pension liability             |  |                | 15,139 |      |  |   | 3,512  | 
|Italy long-term tax liability      |  |                | 1,269  |      |  |   | 2,694  | 
|Casualty insurance reserves        |  |                | 467    |      |  |   | 653    | 
|Deferred research grants           |  |                | 781    |      |  |   | 1,245  | 
|Other                              |  |                | 12,238 |      |  |   | 11,341 | 
|                                   |  |                |        |      |  |   |        | 
|                                   |  | $              | 70,863 |      |  | $ | 56,420 | 
|                                   |  |                |        |      |  |   |        | 

38



---



##### Table of Contents



NOTE 5  INCOME STATEMENT INFORMATION

Other

|                                    |  |      |   |      |  |                |       |   |  |   |      |  
|----------------------------------- |  | ---- | - | ---- |  | -------------- | ----- | - |  | - | ---- | -
|                                    |  | 2002 |   | 2001 |  | 2000          
|                                    |  |      |   |      |  |               
|                                    |  |      |   |      |  | (in thousands) |       |   |  |  
|Plant closure costs                 |  | $    | 0 |      |  | $              | (25   | ) |  | $ | 409  |  
|Global reorganization costs         |  |      | 0 |      |  |                | 1,492 |   |  |   | 0    |  
|Gain on sale of building            |  |      | 0 |      |  |                | 0     |   |  |   | (918 | )
|UGE long-term receivable write-down |  |      | 0 |      |  |                | 0     |   |  |   | 500  |  
|                                    |  |      |   |      |  |                |       |   |  |   |      |  
|                                    |  | $    | 0 |      |  | $              | 1,467 |   |  | $ | (9   | )
|                                    |  |      |   |      |  |                |       |   |  |   |      |  

In the third quarter of fiscal 2001, we announced that we would
consolidate operations in England, Mexico and the Asia-Pacific regions in order
to strengthen our market presence and achieve more effective channels to
market. In addition, we discontinued selective product offerings in the
Chemineer and Moyno businesses in order to improve long-term competitive
positioning through a more cost-effective product focus. We incurred a one-time
charge of $2,300,000 with approximately $1,300,000 related to severance and
other costs associated with the regional consolidations, and the balance
related to inventory write-downs from discontinued product offerings. There were
additional costs in the third and fourth quarter of fiscal 2001 of $192,000
that were expensed as incurred primarily for equipment relocation, marketing
and employee training. All costs related to the Global Reorganization Program
were paid as of August 31, 2001 with no changes in estimates made.

In the fourth quarter of fiscal 2000, we recorded a charge of $500,000 to
reduce a long-term receivable related to Universal Glasteel Equipment (UGE),
which is 50% owned by us and 50% owned by Universal Process Equipment, Inc.
(UPE). The charge is due to weakness in the used glass-lined reactor and
storage vessel markets served by UGE.

In fiscal 1999, due to the downturn in our energy segment at that time, we
analyzed our capacity requirements for our energy products. As a result, we
recorded a charge of $4,200,000 for the closure and relocation of our
Fairfield, California, manufacturing operations. We incurred additional
expenses related to the Fairfield plant closure of $409,000 in fiscal 2000.
These costs were for employee transfers, equipment relocation and training of
new employees at the Texas facility. The Fairfield facility was sold in July
2000 resulting in a pretax gain of $918,000.

Minimum lease payments

Future minimum payments, by year and in the aggregate, under non-cancellable
operating leases with initial or remaining terms of one year or more consisted
of the following at August 31, 2002:

|           |  |                |        | 
|---------- |  | -------------- | ------ | 
|           |  | (In thousands)
|           |  |               
|2003       |  | $              | 2,411  | 
|2004       |  |                | 1,998  | 
|2005       |  |                | 1,797  | 
|2006       |  |                | 1,848  | 
|2007       |  |                | 1,768  | 
|Thereafter |  |                | 2,174  | 
|           |  |                |        | 
|           |  | $              | 11,996 | 
|           |  |                |        | 

The sale-leaseback arrangements that we entered into in fiscal 2002 were
for equipment. There was no gain or loss recorded as a result of the
sale-leaseback transactions, and the leases were recorded as operating leases.

Rental expense for all operating leases in 2002, 2001 and 2000 was
approximately $2,990,000, $2,925,000 and $2,914,000, respectively.

NOTE 6  CASH FLOW STATEMENT INFORMATION

In fiscal 2002, we recorded the following non-cash investing and financing
transactions: $16,050,000 of debt issued in connection with the acquisition of
Romaco; $3,724,000 increase in deferred tax assets,

39



---



##### Table of Contents



$11,987,000 increase in
long-term liabilities and $8,263,000 increase in the minimum pension liability
related to our pension plans; and $724,000 increase in common stock and
decrease in income tax payable related to the tax benefits of stock options
exercised.

In fiscal 2001, we recorded the following non-cash investing and financing
transactions: $15,354,000 of stock issued and $41,181,000 of debt assumed in
connection with the acquisition of Romaco and $769,000 increase in common stock
and decrease in income tax payable related to the tax benefits of stock options
exercised.

In fiscal 2000, we recorded the following non-cash investing and financing
transactions: $500,000 increase in other intangibles and common stock;
$6,500,000 increase in deferred tax assets, $1,500,000 increase in accrued
liabilities and $5,000,000 increase in other long term liabilities related to a
tax election made in Italy to allow for the tax deductibility of goodwill; and
$88,000 increase in common stock and decrease in income tax payable related to
the tax benefits of stock options exercised.

Supplemental cash flow information consisted of the following:

|                            |  |      |        |      |  |                |        |  |  |   |        | 
|--------------------------- |  | ---- | ------ | ---- |  | -------------- | ------ |  |  | - | ------ | 
|                            |  | 2002 |        | 2001 |  | 2000          
|                            |  |      |        |      |  |               
|                            |  |      |        |      |  | (in thousands) |        |  |  |  
|Interest paid               |  | $    | 17,789 |      |  | $              | 12,428 |  |  | $ | 13,738 | 
|Taxes paid  net of refunds |  |      | 1,670  |      |  |                | 15,733 |  |  |   | 8,456  | 

NOTE 7 GOODWILL AND OTHER INTANGIBLE ASSETS

Changes in the carrying amount of goodwill for fiscal 2002, by operating
segment, are as follows:

|                                           |  |                |         |         |  |                |        |       |  |   |        |  |  |   |         | 
|------------------------------------------ |  | -------------- | ------- | ------- |  | -------------- | ------ | ----- |  | - | ------ |  |  | - | ------- | 
|                                           |  | Pharmaceutical |         | Energy  |  | Industrial     |        |       |  |  
|                                           |  | Segment        |         | Segment |  | Segment        |        | Total
|                                           |  |                |         |         |  |                |        |      
|                                           |  |                |         |         |  | (In thousands) |        |       |  |  
|Balance as of September 1, 2001            |  | $              | 110,159 |         |  | $              | 68,026 |       |  | $ | 42,463 |  |  | $ | 220,648 | 
|Goodwill acquired during the period        |  |                | 34,873  |         |  |                | 0      |       |  |   | 0      |  |  |   | 34,873  | 
|Non-cash opening balance sheet
adjustments |  |                | 7,980   |         |  |                | 0      |       |  |   | 0      |  |  |   | 7,980   | 
|Translation adjustments and other          |  |                | 8,126   |         |  |                | 72     |       |  |   | 249    |  |  |   | 8,447   | 
|                                           |  |                |         |         |  |                |        |       |  |   |        |  |  |   |         | 
|Balance as of August 31, 2002              |  | $              | 161,138 |         |  | $              | 68,098 |       |  | $ | 42,712 |  |  | $ | 271,948 | 
|                                           |  |                |         |         |  |                |        |       |  |   |        |  |  |   |         | 

During fiscal year 2002, we recorded the earnout consideration payment to
the former owner of Romaco. The earnout consideration was $32,100,000 and was
paid half in cash and half in a 10.00% five-year subordinated note. The amount
of the earnout consideration was recorded as an increase to goodwill. The
portion of the earnout consideration that was paid with the 10.00% subordinated
note is a non-cash transaction and is therefore not reflected on our
Consolidated Statement of Cash Flows. The non-cash opening balance sheet
adjustments were the result of finalizing the opening balance sheet of Romaco.

As required by SFAS No. 142, intangible assets that do not meet the
criteria for recognition apart from goodwill must be reclassified. As a result
of our analysis, $3,100,000 of acquisition costs were transferred to goodwill
as of September 1, 2001.

40



---



##### Table of Contents



Information regarding our other intangible assets is as follows:

|                       |  |          |        |              |  |     |        |        |  |                |        |             |  |   |        |  |  |   |        |  |  |   |        | 
|---------------------- |  | -------- | ------ | ------------ |  | --- | ------ | ------ |  | -------------- | ------ | ----------- |  | - | ------ |  |  | - | ------ |  |  | - | ------ | 
|                       |  | 2002     |        | 2001        
|                       |  |          |        |             
|                       |  | Carrying |        | Accumulated  |  |     |        |        |  | Carrying       |        | Accumulated |  |   |        | 
|                       |  | Amount   |        | Amortization |  | Net |        | Amount |  | Amortization   |        | Net        
|                       |  |          |        |              |  |     |        |        |  |                |        |            
|                       |  |          |        |              |  |     |        |        |  | (In thousands) |        |             |  |   |        |  |  |  
|Patents and
Trademarks |  | $        | 7,260  |              |  | $   | 1,103  |        |  | $              | 6,157  |             |  | $ | 6,662  |  |  | $ | 708    |  |  | $ | 5,954  | 
|Non-compete
Agreements |  |          | 10,752 |              |  |     | 7,823  |        |  |                | 2,929  |             |  |   | 10,655 |  |  |   | 7,016  |  |  |   | 3,639  | 
|Financing
Costs        |  |          | 6,668  |              |  |     | 3,363  |        |  |                | 3,305  |             |  |   | 4,740  |  |  |   | 2,697  |  |  |   | 2,043  | 
|Pension
Intangible     |  |          | 4,564  |              |  |     | 0      |        |  |                | 4,564  |             |  |   | 2,592  |  |  |   | 0      |  |  |   | 2,592  | 
|Other                  |  |          | 2,038  |              |  |     | 1,389  |        |  |                | 649    |             |  |   | 1,705  |  |  |   | 1,134  |  |  |   | 571    | 
|                       |  |          |        |              |  |     |        |        |  |                |        |             |  |   |        |  |  |   |        |  |  |   |        | 
|Total                  |  | $        | 31,282 |              |  | $   | 13,678 |        |  | $              | 17,604 |             |  | $ | 26,354 |  |  | $ | 11,555 |  |  | $ | 14,799 | 
|                       |  |          |        |              |  |     |        |        |  |                |        |             |  |   |        |  |  |   |        |  |  |   |        | 

We estimate that amortization expense will be approximately $2,000,000 for
each of the next five years.

NOTE 8  LONG-TERM DEBT

|                                     |                       |   |                |         |      |   |         |         | 
|------------------------------------ | --------------------- | - | -------------- | ------- | ---- | - | ------- | ------- | 
|                                     |                       |   | 2002           |         | 2001
|                                     |                       |   |                |         |     
|                                     |                       |   | (In thousands)
|Senior debt:                         |                       |   |                |         |      |   |         |        
|                                     | Revolving credit loan |   | $              | 10,444  |      |   | $       | 53,589  | 
|                                     | Senior notes          |   |                | 100,000 |      |   |         | 100,000 | 
|                                     | Other                 |   |                | 18,024  |      |   |         | 43,379  | 
|6.50% Convertible subordinated notes |                       |   | 59,691         |         |      |   | 59,691  |        
|10.00% subordinated notes            |                       |   | 20,287         |         |      |   | 2,235   |        
|                                     |                       |   |                |         |      |   |         |        
|Total debt                           |                       |   | 208,446        |         |      |   | 258,894 |        
|Less current portion                 |                       |   | 4,526          |         |      |   | 17,669  |        
|                                     |                       |   |                |         |      |   |         |        
|                                     |                       | $ | 203,920        |         |      | $ | 241,225 |        
|                                     |                       |   |                |         |      |   |         |        

Our Bank Credit Agreement (Agreement) provides that we may borrow on a
revolving credit basis up to a maximum of $126,123,000. All outstanding amounts
under the Agreement are due and payable on January 9, 2005. Interest is
variable based upon formulas tied to LIBOR or prime, at our option, and is
payable at least quarterly. At August 31, 2002, the weighted average interest
rate for all amounts outstanding was 3.72%. Indebtedness under the Agreement is
unsecured, except for guarantees by our U.S. subsidiaries, the pledge of the
stock of our U.S. subsidiaries and the pledge of the stock of certain non-U.S.
subsidiaries. Under this Agreement and other lines of credit, we have
$119,000,000 of unused borrowing capacity. However, due to our financial
covenants, at August 31, 2002 we could only incur additional indebtedness of
$15,000,000. Subsequent at August 31, 2002, the Agreement was amended which
eased the thresholds for our interest coverage and leverage ratios. With the
amended financial covenants, we could incur additional indebtedness of
approximately $45,000,000.

We have $100,000,000 of Senior Notes (Senior Notes) issued in two
series. Series A in the principal amount of $70,000,000 has an interest rate of
6.76% and is due May 1, 2008, and Series B in the principal amount of
$30,000,000 has an interest rate of 6.84% and is due May 1, 2010. Interest is
payable semi-annually on May 1 and November 1.

The above agreements have certain restrictive covenants including
limitations on cash dividends, treasury stock purchases and capital
expenditures and thresholds for interest coverage and leverage ratios. The
amount of cash dividends and treasury stock purchases, other than in relation
to stock option exercises, we may incur in each fiscal year is restricted to
the greater of $3,500,000 or 50% of our
41Table of Contents

consolidated net income for the
immediately preceding fiscal year, plus a portion of any unused amounts from
the preceding fiscal year.

We have $20,287,000 of 10.00% Subordinated Notes (Subordinated Notes)
with the former owner of Romaco. The Subordinated Notes are due in 2006 and
2007 and interest is payable quarterly.

We have $59,691,000 of 6.50% Convertible Subordinated Notes (Convertible
Subordinated Notes). The Convertible Subordinated Notes are due on September
1, 2003, and bear interest at 6.50%, payable semi-annually on March 1 and
September 1 and are convertible into common stock at a rate of $27.25 per
share. Holders may convert at any time until maturity and we may call for
redemption at any time until maturity at par. The Convertible Subordinated
Notes and the Subordinated Notes are subordinated to all of our other
indebtedness.

Our other debt primarily consists of unsecured non-U.S. bank lines of
credit with interest rates ranging from 4.00% to 8.00%.

We have entered into an interest rate swap agreement. The interest rate
swap agreement utilized by us effectively modifies our exposure to interest
rate risk by converting our fixed rate debt to floating rate debt. This
agreement involves the receipt of fixed rate amounts in exchange for floating
rate interest payments over the life of the agreement without an exchange of
underlying principal amounts. The mark-to-market values of both the fair value
hedging instrument and the underlying debt obligation were equal and recorded
as offsetting gains and losses in current period earnings. The fair value hedge
qualifies for treatment under the short-cut method of measuring effectiveness.
As a result, there is no impact on earnings due to hedge ineffectiveness. The
interest rate swap agreement totals $30,000,000, expires in 2008 and allows us
to receive an interest rate of 6.76% and pay an interest rate based on LIBOR.

Aggregate principal payments of long-term debt, for the five years
subsequent to August 31, 2002, are as follows:

|                    |  |                |         | 
|------------------- |  | -------------- | ------- | 
|                    |  | (In thousands)
|                    |  |               
|2003                |  | $              | 4,526   | 
|2004                |  |                | 65,138  | 
|2005                |  |                | 4,482   | 
|2006                |  |                | 7,453   | 
|2007                |  |                | 19,521  | 
|2008 and thereafter |  |                | 107,326 | 
|                    |  |                |         | 
|Total               |  | $              | 208,446 | 
|                    |  |                |         | 

NOTE 9  RETIREMENT BENEFITS

We sponsor two defined contribution plans covering most U.S. salaried employees
and certain U.S. hourly employees. Contributions are made to the plans based on
a percentage of eligible amounts contributed by participating employees. We
also sponsor several defined benefit plans covering all U.S. employees and
certain non-U.S. employees. Benefits are based on years of service and
employees compensation or stated amounts for each year of service. Our funding
policy is consistent with the funding requirements of applicable regulations.
At August 31, 2002 and 2001, pension investments included 311,700 shares of our
common stock.

In addition to pension benefits, we provide health care and life insurance
benefits for certain of our retired U.S. employees. Our policy is to fund the
cost of these benefits as claims are paid.

Retirement and other post-retirement plan costs are as follows:
42Table of Contents

|                                        |  |      |                  |      |  |                |        |   |  |   |        |  
|--------------------------------------- |  | ---- | ---------------- | ---- |  | -------------- | ------ | - |  | - | ------ | -
|                                        |  |      | Pension Benefits |      | 
|                                        |  |      |                  |      | 
|                                        |  |      |                  |      |  |               
|                                        |  | 2002 |                  | 2001 |  | 2000          
|                                        |  |      |                  |      |  |               
|                                        |  |      |                  |      |  | (In thousands) |        |   |  |  
|Service cost                            |  | $    | 4,031            |      |  | $              | 3,602  |   |  | $ | 3,547  |  
|Interest cost                           |  |      | 7,870            |      |  |                | 7,278  |   |  |   | 7,165  |  
|Expected return on plan assets          |  |      | (6,752           | )    |  |                | (7,049 | ) |  |   | (6,388 | )
|Amortization of prior service cost      |  |      | 746              |      |  |                | 593    |   |  |   | 557    |  
|Amortization of transition obligation   |  |      | (212             | )    |  |                | (202   | ) |  |   | (118   | )
|Recognized net actuarial losses (gains) |  |      | 67               |      |  |                | (148   | ) |  |   | (126   | )
|                                        |  |      |                  |      |  |                |        |   |  |   |        |  
|Net periodic benefit cost               |  | $    | 5,750            |      |  | $              | 4,074  |   |  | $ | 4,637  |  
|                                        |  |      |                  |      |  |                |        |   |  |   |        |  
|Defined contribution cost               |  | $    | 1,077            |      |  | $              | 1,064  |   |  | $ | 950    |  
|                                        |  |      |                  |      |  |                |        |   |  |   |        |  

|                          |  |      |                |      |  |                |       |  |  |   |       | 
|------------------------- |  | ---- | -------------- | ---- |  | -------------- | ----- |  |  | - | ----- | 
|                          |  |      | Other Benefits |      | 
|                          |  |      |                |      | 
|                          |  |      |                |      |  |               
|                          |  | 2002 |                | 2001 |  | 2000          
|                          |  |      |                |      |  |               
|                          |  |      |                |      |  | (In thousands) |       |  |  |  
|Service cost              |  | $    | 297            |      |  | $              | 275   |  |  | $ | 220   | 
|Interest cost             |  |      | 1,694          |      |  |                | 1,650 |  |  |   | 1,533 | 
|Net amortization          |  |      | 609            |      |  |                | 521   |  |  |   | 330   | 
|                          |  |      |                |      |  |                |       |  |  |   |       | 
|Net periodic benefit cost |  | $    | 2,600          |      |  | $              | 2,446 |  |  | $ | 2,083 | 
|                          |  |      |                |      |  |                |       |  |  |   |       | 

43



---



##### Table of Contents



The funded status and amounts recorded in the balance sheet are as follows:

|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|-------------------------------------------------------------- |  | ---------------- | ------- | -------------- |  | ---- | ------- | ---- |  | - | ------- | - |  | - | ------- | -
|                                                               |  | Pension Benefits |         | Other Benefits
|                                                               |  |                  |         |               
|                                                               |  | 2002             |         | 2001           |  | 2002 |         | 2001
|                                                               |  |                  |         |                |  |      |         |     
|                                                               |  | (In thousands)  
|Change in benefit obligation:                                  |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Beginning of year                                              |  | $                | 116,862 |                |  | $    | 112,560 |      |  | $ | 23,955  |   |  | $ | 21,123  |  
|Service cost                                                   |  |                  | 4,031   |                |  |      | 3,602   |      |  |   | 297     |   |  |   | 275     |  
|Interest cost                                                  |  |                  | 7,870   |                |  |      | 7,278   |      |  |   | 1,694   |   |  |   | 1,650   |  
|Plan amendments                                                |  |                  | 2,128   |                |  |      | 439     |      |  |   | 0       |   |  |   | 0       |  
|Currency exchange rate impact                                  |  |                  | 3,110   |                |  |      | 719     |      |  |   | 0       |   |  |   | 0       |  
|Actuarial losses                                               |  |                  | 2,122   |                |  |      | 607     |      |  |   | 3,493   |   |  |   | 3,555   |  
|Curtailment                                                    |  |                  | 0       |                |  |      | 0       |      |  |   | (1,438  | ) |  |   | 0       |  
|Benefit payments                                               |  |                  | (8,056  | )              |  |      | (8,343  | )    |  |   | (2,658  | ) |  |   | (2,648  | )
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|End of year                                                    |  | $                | 128,067 |                |  | $    | 116,862 |      |  | $ | 25,343  |   |  | $ | 23,955  |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Change in plan assets:                                         |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Beginning of year                                              |  | $                | 79,588  |                |  | $    | 85,822  |      |  | $ | 0       |   |  | $ | 0       |  
|Actual return                                                  |  |                  | (6,276  | )              |  |      | (5,007  | )    |  |   | 0       |   |  |   | 0       |  
|Company contributions                                          |  |                  | 6,642   |                |  |      | 7,116   |      |  |   | 2,658   |   |  |   | 2,648   |  
|Benefit payments                                               |  |                  | (8,056  | )              |  |      | (8,343  | )    |  |   | (2,658  | ) |  |   | (2,648  | )
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|End of year                                                    |  | $                | 71,898  |                |  | $    | 79,588  |      |  | $ | 0       |   |  | $ | 0       |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Funded status                                                  |  | $                | (56,169 | )              |  | $    | (37,274 | )    |  | $ | (25,343 | ) |  | $ | (23,955 | )
|Unrecognized net actuarial losses                              |  |                  | 24,081  |                |  |      | 8,051   |      |  |   | 8,545   |   |  |   | 7,307   |  
|Unrecognized transition obligation                             |  |                  | (656    | )              |  |      | (817    | )    |  |   | 0       |   |  |   | 0       |  
|Unamortized prior service cost                                 |  |                  | 3,946   |                |  |      | 2,564   |      |  |   | 2,384   |   |  |   | 2,540   |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Amount recognized                                              |  | $                | (28,798 | )              |  | $    | (27,476 | )    |  | $ | (14,414 | ) |  | $ | (14,108 | )
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Recorded as follows:                                           |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Accrued expenses                                               |  | $                | (5,216  | )              |  | $    | (5,179  | )    |  | $ | (2,000  | ) |  | $ | (2,000  | )
|Other long-term liabilities                                    |  |                  | (43,694 | )              |  |      | (28,379 | )    |  |   | (12,414 | ) |  |   | (12,108 | )
|Intangible assets                                              |  |                  | 4,564   |                |  |      | 2,592   |      |  |   | 0       |   |  |   | 0       |  
|Accumulated other comprehensive loss                           |  |                  | 15,548  |                |  |      | 3,490   |      |  |   | 0       |   |  |   | 0       |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|                                                               |  | $                | (28,798 | )              |  | $    | (27,476 | )    |  | $ | (14,414 | ) |  | $ | (14,108 | )
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  
|Deferred tax liability on accumulated other
comprehensive loss |  | $                | (4,892  | )              |  | $    | (1,097  | )    |  | $ | 0       |   |  | $ | 0       |  
|                                                               |  |                  |         |                |  |      |         |      |  |   |         |   |  |   |         |  

Pension plans with accumulated (ABO) and projected (PBO) benefit
obligations in excess of plan assets:

|                               |  |                |         |      |  |   |         | 
|------------------------------ |  | -------------- | ------- | ---- |  | - | ------- | 
|                               |  | 2002           |         | 2001
|                               |  |                |         |     
|                               |  | (In thousands)
|Accumulated benefit obligation |  | $              | 123,275 |      |  | $ | 99,051  | 
|Projected benefit obligation   |  |                | 128,067 |      |  |   | 102,844 | 
|Plan assets                    |  |                | 71,898  |      |  |   | 64,975  | 

In 2002 and 2001, $30,287,000 and $26,352,000, respectively, of the
unfunded ABO and $31,837,000 and $27,670,000, respectively, of the unfunded PBO
related to our pension plan for our German operation. Funding of pension
obligations is not required in Germany.

44



---



##### Table of Contents



Actuarial weighted average assumptions used to determine plan costs and
liabilities are as follows:

|                                |  |                  |      |                |  |      |      |      |  |         |           |   |     |  |      |  
|------------------------------- |  | ---------------- | ---- | -------------- |  | ---- | ---- | ---- |  | ------- | --------- | - | --- |  | ---- | -
|                                |  | Pension Benefits |      | Other Benefits
|                                |  |                  |      |               
|                                |  | 2002             |      | 2001           |  | 2002 |      | 2001
|                                |  |                  |      |                |  |      |      |     
|Weighted average assumptions:   |  |                  |      |                |  |      |      |      |  |         |           |   |     |  |      |  
|Discount rate                   |  |                  | 7.00 | %              |  |      | 7.00 | %    |  |         | 7.00      | % |     |  | 7.00 | %
|Expected return on plan assets  |  |                  | 9.00 |                |  |      | 9.00 |      |  |         | N/A       |   |     |  | N/A  |  
|Rate of compensation increase   |  |                  | 5.50 |                |  |      | 5.50 |      |  |         | N/A       |   |     |  | N/A  |  
|Health care cost increase       |  |                  | N/A  |                |  |      | N/A  |      |  |         | 10.0%-5.0 | % |     |  | 6.00 | %
|Health care cost grading period |  |                  | N/A  |                |  |      | N/A  |      |  | 5 years |           |   | N/A | 

The assumed health care trend rate has a significant effect on the
amounts reported for health care benefits. A one percentage point change in
assumed health care rate would have the following effects:

|                                  |  |                |     |          |  |   |      |  
|--------------------------------- |  | -------------- | --- | -------- |  | - | ---- | -
|                                  |  | Increase       |     | Decrease
|                                  |  |                |     |         
|                                  |  | (In thousands)
|Service and interest cost         |  | $              | 86  |          |  | $ | (82  | )
|Postretirement benefit obligation |  |                | 987 |          |  |   | (941 | )

NOTE 10  INCOME TAXES

Deferred income taxes reflect the net effects of temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes
and the amounts used for income tax purposes.

Deferred tax assets and liabilities

|             |                                                 |  |                |       |      |  |        |       | 
|------------ | ----------------------------------------------- |  | -------------- | ----- | ---- |  | ------ | ----- | 
|             |                                                 |  | 2002           |       | 2001
|             |                                                 |  |                |       |     
|             |                                                 |  | (In thousands)
|Assets:      |                                                 |  |                |       |      |  |        |      
|             | Postretirement benefit obligations              |  | $              | 5,027 |      |  | $      | 5,474 | 
|             | Net operating loss carryforward                 |  |                | 551   |      |  |        | 5,914 | 
|             | U.S. credit carryforward                        |  |                | 2,236 |      |  |        | 1,385 | 
|             | Other liabilities                               |  |                | 2,260 |      |  |        | 1,218 | 
|             | Inventory allowances                            |  |                | 3,332 |      |  |        | 2,598 | 
|             | Warranty reserve                                |  |                | 2,294 |      |  |        | 2,838 | 
|             | Insurance reserve                               |  |                | 842   |      |  |        | 973   | 
|             | Pension benefits                                |  |                | 6,275 |      |  |        | 2,000 | 
|             | Other items                                     |  |                | 527   |      |  |        | 1,166 | 
|             |                                                 |  |                |       |      |  |        |      
|             |                                                 |  | 23,344         |       |      |  | 23,566 |      
|             | Less valuation allowance                        |  |                | 1,271 |      |  |        | 893   | 
|             |                                                 |  |                |       |      |  |        |      
|             |                                                 |  | 22,073         |       |      |  | 22,673 |      
|             |                                                 |  |                |       |      |  |        |      
|Liabilities: |                                                 |  |                |       |      |  |        |      
|             | Tax depreciation in excess of book depreciation |  |                | 6,438 |      |  |        | 7,062 | 
|             | Goodwill and purchased asset basis differences  |  |                | 9,745 |      |  |        | 5,982 | 
|             | Other items                                     |  |                | 527   |      |  |        | 707   | 
|             |                                                 |  |                |       |      |  |        |      
|             |                                                 |  | 16,710         |       |      |  | 13,751 |      
|             |                                                 |  |                |       |      |  |        |      
|             | Net deferred tax asset                          |  | $              | 5,363 |      |  | $      | 8,922 | 
|             |                                                 |  |                |       |      |  |        |      

The valuation allowance was related to the credit carryforwards that
begin to expire in fiscal 2003.

45



---



##### Table of Contents



Expense

|                                          |              |   |                |        |      |   |        |       |  |   |        |        |  
|----------------------------------------- | ------------ | - | -------------- | ------ | ---- | - | ------ | ----- |  | - | ------ | ------ | -
|                                          |              |   | 2002           |        | 2001 |   | 2000  
|                                          |              |   |                |        |      |   |       
|                                          |              |   | (In thousands)
|Current:                                  |              |   |                |        |      |   |        |       |  |   |        |       
|                                          | U.S. federal |   | $              | (6,751 | )    |   | $      | 2,727 |  |   | $      | 4,002  |  
|                                          | Non-U.S.     |   |                | 5,877  |      |   |        | 3,925 |  |   |        | 9,570  |  
|                                          | U.S. state   |   |                | (664   | )    |   |        | 271   |  |   |        | 375    |  
|                                          |              |   |                |        |      |   |        |       |  |   |        |       
|                                          |              |   | (1,538         | )      |      |   | 6,923  |       |  |   | 13,947 |       
|                                          |              |   |                |        |      |   |        |       |  |   |        |       
|Deferred:                                 |              |   |                |        |      |   |        |       |  |   |        |       
|                                          | U.S. federal |   |                | 6,863  |      |   |        | 2,961 |  |   |        | 1,028  |  
|                                          | Non-U.S.     |   |                | 1,820  |      |   |        | 49    |  |   |        | (4,558 | )
|                                          | U.S. state   |   |                | 686    |      |   |        | 296   |  |   |        | 96     |  
|                                          |              |   |                |        |      |   |        |       |  |   |        |       
|                                          |              |   | 9,369          |        |      |   | 3,306  |       |  |   | (3,434 | )     
|                                          |              |   |                |        |      |   |        |       |  |   |        |       
|                                          |              | $ | 7,831          |        |      | $ | 10,229 |       |  | $ | 10,513 |       
|                                          |              |   |                |        |      |   |        |       |  |   |        |       
|Tax expense included in minority interest |              | $ | 395            |        |      | $ | 599    |       |  | $ | 838    |       
|                                          |              |   |                |        |      |   |        |       |  |   |        |       
|Non U.S. pretax income                    |              | $ | 23,521         |        |      | $ | 11,270 |       |  | $ | 14,946 |       
|                                          |              |   |                |        |      |   |        |       |  |   |        |       

A summary of the differences between the effective income tax rate
attributable to operations and the statutory rate is as follows:

|                                                         |  |      |      |      |  |      |      |   |  |  |      |  
|-------------------------------------------------------- |  | ---- | ---- | ---- |  | ---- | ---- | - |  |  | ---- | -
|                                                         |  | 2002 |      | 2001 |  | 2000
|                                                         |  |      |      |      |  |     
|U.S. statutory rate                                      |  |      | 35.0 | %    |  |      | 35.0 | % |  |  | 35.0 | %
|U.S. state income taxes, net of U.S. federal tax benefit |  |      | 0.0  |      |  |      | 1.2  |   |  |  | 1.9  |  
|Foreign Sales Corporation/ETI                            |  |      | (1.5 | )    |  |      | (4.2 | ) |  |  | (1.5 | )
|Non U.S. taxes                                           |  |      | (0.8 | )    |  |      | (0.1 | ) |  |  | .5   |  
|Other items  net                                        |  |      | 0.8  |      |  |      | 1.2  |   |  |  | (.9  | )
|                                                         |  |      |      |      |  |      |      |   |  |  |      |  
|                                                         |  |      | 33.5 | %    |  |      | 33.1 | % |  |  | 35.0 | %
|                                                         |  |      |      |      |  |      |      |   |  |  |      |  

NOTE 11  COMMON STOCK

We sponsor a long-term incentive stock plan to provide for the granting of stock
based compensation to officers and other key employees. In addition, we sponsor
stock option and stock compensation plans for non-employee directors. Under the
plans, the stock option price per share may not be less than the fair market
value per share as of the date of grant. For officers and other key employees,
outstanding grants become exercisable over a three year period, while options
for non-employee directors are immediately exercisable. Proceeds from the sale
of stock issued under option arrangements are credited to common stock. We make
no charges or credits against earnings with respect to these options.

Summaries of amounts issued under the stock option plans are presented
in the following tables.

46



---



##### Table of Contents



Stock option activity

|                                       |           |  |           |          |                 |   |           |       | 
|-------------------------------------- | --------- |  | --------- | -------- | --------------- | - | --------- | ----- | 
|                                       |           |  |           |          |                 |   | Weighted-
|                                       |           |  | Stock     |          | Average Option 
|                                       |           |  | Options   |          | Price Per Share
|                                       |           |  |           |          |                
|Outstanding at September 1, 1999       |           |  | 904,267   |          |                 | $ | 21.11     |      
|                                       | Granted   |  |           | 192,800  |                 |   |           | 21.04 | 
|                                       | Exercised |  |           | (21,500  | )               |   |           | 12.24 | 
|                                       | Canceled  |  |           | (61,667  | )               |   |           | 25.76 | 
|                                       |           |  |           |          |                 |   |           |      
|Outstanding at August 31, 2000         |           |  | 1,013,900 |          |                 |   | 19.22     |      
|                                       | Granted   |  |           | 147,000  |                 |   |           | 27.68 | 
|                                       | Exercised |  |           | (130,266 | )               |   |           | 10.10 | 
|                                       | Canceled  |  |           | (10,500  | )               |   |           | 26.30 | 
|                                       |           |  |           |          |                 |   |           |      
|Outstanding at August 31, 2001         |           |  | 1,020,134 |          |                 |   | 23.12     |      
|                                       | Granted   |  |           | 222,500  |                 |   |           | 25.12 | 
|                                       | Exercised |  |           | (167,500 | )               |   |           | 15.07 | 
|                                       | Canceled  |  |           | (333     | )               |   |           | 20.88 | 
|                                       |           |  |           |          |                 |   |           |      
|Outstanding at August 31, 2002         |           |  | 1,074,801 |          |                 |   | 24.78     |      
|                                       |           |  |           |          |                 |   |           |      
|Exercisable
stock options at year-end  |           |  |           |          |                 |   |           |      
|2000                                   |           |  |           |          |                 |   | 669,933   |      
|2001                                   |           |  |           |          |                 |   | 730,081   |      
|2002                                   |           |  |           |          |                 |   | 860,363   |      
|Shares
available for grant at year-end |           |  |           |          |                 |   |           |      
|2000                                   |           |  |           |          |                 |   | 357,200   |      
|2001                                   |           |  |           |          |                 |   | 210,200   |      
|2002                                   |           |  |           |          |                 |   | 537,700   |      

Components of outstanding stock options at August 31, 2002

| |  |          |               |             |  |               |           |                |  |           |      |  |  |   |       | 
| |  | -------- | ------------- | ----------- |  | ------------- | --------- | -------------- |  | --------- | ---- |  |  | - | ----- | 
| |  |          |               |             |  |               |           |                |  | Weighted- |      |  |  |  
| |  | Range of |               |             |  |               |           | Average        |  | Weighted-
| |  | Exercise |               | Number      |  | Contract Life |           | Average       
| |  | Price    |               | Outstanding |  | in Years      |           | Exercise Price
| |  |          |               |             |  |               |           |               
| |  | $        | 7.75 - 17.50  |             |  |               | 101,500   |                |  |           | 4.20 |  |  | $ | 11.52 | 
| |  |          | 20.88 - 39.50 |             |  |               | 973,301   |                |  |           | 9.45 |  |  |   | 26.02 | 
| |  |          |               |             |  |               |           |                |  |           |      |  |  |   |       | 
| |  | $        | 7.75 - 39.50  |             |  |               | 1,074,801 |                |  |           | 8.96 |  |  | $ | 24.78 | 
| |  |          |               |             |  |               |           |                |  |           |      |  |  |   |       | 

Components of exercisable stock options at August 31, 2002

| |  |          |               |             |  |                |         |           |  |   |       | 
| |  | -------- | ------------- | ----------- |  | -------------- | ------- | --------- |  | - | ----- | 
| |  | Range of |               |             |  |                |         | Weighted-
| |  | Exercise |               | Number      |  | Average       
| |  | Price    |               | Exercisable |  | Exercise Price
| |  |          |               |             |  |               
| |  | $        | 7.75 - 17.50  |             |  |                | 101,500 |           |  | $ | 11.52 | 
| |  |          | 20.88 - 39.50 |             |  |                | 758,863 |           |  |   | 26.43 | 
| |  |          |               |             |  |                |         |           |  |   |       | 
| |  | $        | 7.75 - 39.50  |             |  |                | 860,363 |           |  | $ | 24.67 | 
| |  |          |               |             |  |                |         |           |  |   |       | 

We also sponsor a long-term incentive stock plan. Under this plan,
selected participants receive performance units which convert into a variable
number of restricted shares based on a three year measurement of how favorably
the total return on our shares compares to the total shareholder return of the
Russell 2000 Company Group (Group). The restricted shares earned range from
75% to 200% of the performance units awarded. The 75% threshold is earned when
our return is at the 50th percentile of total shareholder return of the Group
and 200% is earned when our return is at the 80th percentile or greater. No
restricted shares are earned if our return is less than the median return of the
Group. Restricted shares earned under the program are issued to the participants
at the end of the three year measurement period and are subject to forfeit if
the participant leaves our employment within the

47



---



##### Table of Contents



following two years. For the
three year performance period ended August 31, 2002, no amounts were earned.

For purposes of pro forma disclosure as required by SFAS No. 123,
Accounting for Stock Based Compensation, the estimated fair value of options
are amortized to expense over the options vesting period. Our pro forma
information is as follows:

|                                |         |   |                                       |      |      |   |        |      |  |   |        |      | 
|------------------------------- | ------- | - | ------------------------------------- | ---- | ---- | - | ------ | ---- |  | - | ------ | ---- | 
|                                |         |   | 2002                                  |      | 2001 |   | 2000  
|                                |         |   |                                       |      |      |   |       
|                                |         |   | (In thousands, except per share data)
|Pro forma net income            |         | $ | 13,349                                |      |      | $ | 19,084 |      |  | $ | 17,194 |     
|Pro forma net income per share: |         |   |                                       |      |      |   |        |      |  |   |        |     
|                                | Basic   |   |                                       | 1.08 |      |   |        | 1.73 |  |   |        | 1.57 | 
|                                | Diluted |   |                                       | 1.07 |      |   |        | 1.59 |  |   |        | 1.46 | 

Pro forma information regarding net income and net income per share is
required by SFAS No. 123, and has been determined as if we had accounted for
stock options granted subsequent to August 31, 1995 under the fair value method
of that Statement. The fair value for these options was estimated at the date of
grant using a Black-Scholes model with the following weighted-average
assumptions:

|                                    |  |          |       |          |  |          |       |   |  |   |       |  
|----------------------------------- |  | -------- | ----- | -------- |  | -------- | ----- | - |  | - | ----- | -
|                                    |  | 2002     |       | 2001     |  | 2000    
|                                    |  |          |       |          |  |         
|Expected volatility of common stock |  |          | 33.50 | %        |  |          | 33.20 | % |  |   | 34.70 | %
|Risk free interest rate             |  |          | 4.55  |          |  |          | 4.72  |   |  |   | 6.00  |  
|Dividend yield                      |  |          | .75   |          |  |          | .75   |   |  |   | .75   |  
|Expected life of option             |  | 6.90 yrs |       | 6.90 yrs |  | 6.90 yrs
|Fair value at grant date            |  | $        | 15.80 |          |  | $        | 11.49 |   |  | $ | 10.49 |  

Option valuation models, such as the Black-Scholes model, were
developed for use in estimating the fair value of traded options which have no
vesting restrictions and are freely transferable. In addition, option valuation
models require the input of highly subjective assumptions including the expected
stock price volatility. Because our options have characteristics significantly
different from those of traded options, and because changes in the subjective
input assumptions can materially affect the fair value estimate, in our opinion,
existing models do not provide a reliable single measure of the fair value of
our stock options.

48



---



##### Table of Contents



NOTE 12  NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income
per share:

|                      |                                       |                                        |   |                                       |        |      |   |        |        |  |   |        |        | 
|--------------------- | ------------------------------------- | -------------------------------------- | - | ------------------------------------- | ------ | ---- | - | ------ | ------ |  | - | ------ | ------ | 
|                      |                                       |                                        |   | 2002                                  |        | 2001 |   | 2000  
|                      |                                       |                                        |   |                                       |        |      |   |       
|                      |                                       |                                        |   | (In thousands, except per share data)
|Numerator:            |                                       |                                        |   |                                       |        |      |   |        |        |  |   |       
|                      | Basic:                                |                                        |   |                                       |        |      |   |        |        |  |   |        |       
|                      |                                       | Net Income                             |   | $                                     | 14,503 |      |   | $      | 19,631 |  |   | $      | 18,056 | 
|                      | Effect of dilutive securities:        |                                        |   |                                       |        |      |   |        |        |  |   |        |       
|                      |                                       | Convertible debt interest              |   |                                       | 2,328  |      |   |        | 2,328  |  |   |        | 2,438  | 
|                      |                                       |                                        |   |                                       |        |      |   |        |        |  |   |        |        | 
|                      | Income attributable to diluted shares |                                        | $ | 16,831                                |        |      | $ | 21,959 |        |  | $ | 20,494 |       
|                      |                                       |                                        |   |                                       |        |      |   |        |        |  |   |        |        | 
|Denominator:          |                                       |                                        |   |                                       |        |      |   |        |        |  |   |       
|                      | Basic:                                |                                        |   |                                       |        |      |   |        |        |  |   |        |       
|                      |                                       | Weighted average shares                |   |                                       | 12,379 |      |   |        | 11,050 |  |   |        | 10,946 | 
|                      | Effect of dilutive securities:        |                                        |   |                                       |        |      |   |        |        |  |   |        |       
|                      |                                       | Convertible debt                       |   |                                       | 2,190  |      |   |        | 2,190  |  |   |        | 2,297  | 
|                      |                                       | Dilutive options and
restricted shares |   |                                       | 119    |      |   |        | 225    |  |   |        | 173    | 
|                      |                                       |                                        |   |                                       |        |      |   |        |        |  |   |        |        | 
|                      | Diluted                               |                                        |   | 14,688                                |        |      |   | 13,465 |        |  |   | 13,416 |       
|                      |                                       |                                        |   |                                       |        |      |   |        |        |  |   |        |        | 
|Net income per share: |                                       |                                        |   |                                       |        |      |   |        |        |  |   |       
|                      | Basic:                                |                                        | $ | 1.17                                  |        |      | $ | 1.78   |        |  | $ | 1.65   |       
|                      | Diluted:                              |                                        | $ | 1.15                                  |        |      | $ | 1.63   |        |  | $ | 1.53   |       

NOTE 13  BUSINESS SEGMENTS AND GEOGRAPHIC INFORMATION

As a result of the Romaco acquisition on August 31, 2001, during the first
quarter of fiscal 2002 we reorganized resulting in our operations being
aggregated into three reportable business segments: pharmaceutical, energy and
industrial. The amounts presented for fiscal 2001 and 2000 have been restated to
reflect this reorganization. Our pharmaceutical segment includes our Reactor
Systems and Romaco businesses and is focused on the pharmaceutical and
healthcare industries. Our Reactor Systems business designs, manufactures and
markets primary processing equipment including glass-lined reactors and storage
vessels. Our Romaco business designs, manufactures and markets secondary
processing, dosing, filling, printing and security equipment. Our energy segment
designs, manufactures and markets equipment and systems used in oil and gas
exploration and recovery. Our equipment and systems include hydraulic drilling
power sections, down-hole pumps and a broad line of ancillary equipment, such as
rod guides, rod and tubing rotators, wellhead systems, pipeline closure products
and valves. Our industrial segment is comprised of our Moyno, Chemineer and
Edlon businesses, which design, manufacture and market products that are used in
specialty chemical, wastewater treatment and a variety of other industrial
applications. The primary products are progressing cavity pump products, mixing
and turbine agitation equipment, and fluoropolymer-lined products and
accessories.

We evaluate performance and allocate resources based on Income before
Interest and Taxes (EBIT). Identifiable assets by business segment include all
assets directly identified with those operations. Corporate assets consist
mostly of cash and intangible assets. The accounting policies of the reportable
segments are the same as those described in the summary of significant
accounting policies except that we account for U.S. inventory on a FIFO basis at
the segment level compared to a LIFO basis at the consolidated level.

49



---



##### Table of Contents



The following tables provide information about our reportable business
segments.

|                               |                            |  |                |         |      |  |      |         |      |  |   |         |    
|------------------------------ | -------------------------- |  | -------------- | ------- | ---- |  | ---- | ------- | ---- |  | - | ------- | ---
|                               |                            |  | 2002           |         | 2001 |  | 2000
|                               |                            |  |                |         |      |  |     
|                               |                            |  | (In thousands)
|Unaffiliated Customer Sales:   |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Pharmaceutical (1)         |  | $              | 319,412 |      |  | $    | 171,403 |      |  | $ | 181,891 |    
|                               | Energy (2)                 |  |                | 91,381  |      |  |      | 113,906 |      |  |   | 88,145  |    
|                               | Industrial                 |  |                | 115,580 |      |  |      | 140,593 |      |  |   | 136,678 |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Total                      |  | $              | 526,373 |      |  | $    | 425,902 |      |  | $ | 406,714 |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|Intersegment Sales:            |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Pharmaceutical (1)         |  | $              | 934     |      |  | $    | 883     |      |  | $ | 1,954   |    
|                               | Energy (2)                 |  |                | 0       |      |  |      | 0       |      |  |   | 0       |    
|                               | Industrial                 |  |                | 0       |      |  |      | 0       |      |  |   | 0       |    
|                               | Corporate and Eliminations |  |                | (934    | )    |  |      | (883    | )    |  |   | (1,954  | )  
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Total                      |  | $              | 0       |      |  | $    | 0       |      |  | $ | 0       |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|Depreciation and Amortization: |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Pharmaceutical (1)         |  | $              | 10,194  |      |  | $    | 7,563   |      |  | $ | 7,969   |    
|                               | Energy (2)                 |  |                | 5,534   |      |  |      | 7,260   |      |  |   | 7,005   |    
|                               | Industrial                 |  |                | 5,366   |      |  |      | 8,641   |      |  |   | 8,512   |    
|                               | Corporate and Eliminations |  |                | 949     |      |  |      | 884     |      |  |   | 884     |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Total                      |  | $              | 22,043  |      |  | $    | 24,348  |      |  | $ | 24,370  |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|EBIT:                          |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Pharmaceutical (1)         |  | $              | 27,895  |      |  | $    | 17,349  | (3)  |  | $ | 24,448  | (3)
|                               | Energy (2)                 |  |                | 18,773  |      |  |      | 26,078  |      |  |   | 16,130  | (5)
|                               | Industrial                 |  |                | 5,279   |      |  |      | 8,445   | (4)  |  |   | 12,007  |    
|                               | Corporate and Eliminations |  |                | (11,000 | )    |  |      | (8,636  | )(6) |  |   | (9,013  | )  
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Total                      |  | $              | 40,947  |      |  | $    | 43,236  |      |  | $ | 43,572  |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|Identifiable Assets:           |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Pharmaceutical (1)         |  | $              | 408,086 |      |  | $    | 352,167 |      |  | $ | 202,666 |    
|                               | Energy (2)                 |  |                | 131,374 |      |  |      | 142,674 |      |  |   | 135,278 |    
|                               | Industrial                 |  |                | 114,926 |      |  |      | 135,886 |      |  |   | 135,287 |    
|                               | Corporate and Eliminations |  |                | 28,306  |      |  |      | 29,533  |      |  |   | 22,448  |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Total                      |  | $              | 682,692 |      |  | $    | 660,260 |      |  | $ | 495,679 |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|Capital Expenditures:          |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Pharmaceutical (1)         |  | $              | 8,761   |      |  | $    | 7,652   |      |  | $ | 7,860   |    
|                               | Energy (2)                 |  |                | 682     |      |  |      | 5,805   |      |  |   | 4,660   |    
|                               | Industrial                 |  |                | 5,505   |      |  |      | 6,674   |      |  |   | 7,242   |    
|                               | Corporate and Eliminations |  |                | 164     |      |  |      | 69      |      |  |   | 80      |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        
|                               | Total                      |  | $              | 15,112  |      |  | $    | 20,200  |      |  | $ | 19,842  |    
|                               |                            |  |                |         |      |  |      |         |      |  |   |        

50



---



##### Table of Contents



Information about our operations in different geographical regions is
presented below. Our primary operations are in the U.S. and Europe. Sales are
attributed to countries based on the location of the customer.

|                         |                     |   |                |         |      |   |         |         |  |   |         |         | 
|------------------------ | ------------------- | - | -------------- | ------- | ---- | - | ------- | ------- |  | - | ------- | ------- | 
|                         |                     |   | 2002           |         | 2001 |   | 2000   
|                         |                     |   |                |         |      |   |        
|                         |                     |   | (In thousands)
|Sales (1) and (2):       |                     |   |                |         |      |   |         |         |  |   |         |        
|                         | United States       |   | $              | 209,713 |      |   | $       | 234,007 |  |   | $       | 211,329 | 
|                         | Europe              |   |                | 219,949 |      |   |         | 93,358  |  |   |         | 101,548 | 
|                         | Other North America |   |                | 42,834  |      |   |         | 49,714  |  |   |         | 48,916  | 
|                         | South America       |   |                | 20,230  |      |   |         | 11,699  |  |   |         | 13,508  | 
|                         | Asia                |   |                | 33,647  |      |   |         | 37,124  |  |   |         | 31,413  | 
|                         |                     |   |                |         |      |   |         |         |  |   |         |        
|                         |                     | $ | 526,373        |         |      | $ | 425,902 |         |  | $ | 406,714 |        
|                         |                     |   |                |         |      |   |         |         |  |   |         |        
|Identifiable Assets (1): |                     |   |                |         |      |   |         |         |  |   |         |        
|                         | United States       |   | $              | 299,943 |      |   | $       | 326,334 |  |   | $       | 310,798 | 
|                         | Europe              |   |                | 292,987 |      |   |         | 233,191 |  |   |         | 106,060 | 
|                         | Other North America |   |                | 33,340  |      |   |         | 38,418  |  |   |         | 31,983  | 
|                         | South America       |   |                | 4,338   |      |   |         | 6,861   |  |   |         | 4,077   | 
|                         | Asia                |   |                | 24,058  |      |   |         | 25,923  |  |   |         | 20,313  | 
|                         | Corporate           |   |                | 28,026  |      |   |         | 29,533  |  |   |         | 22,448  | 
|                         |                     |   |                |         |      |   |         |         |  |   |         |        
|                         |                     | $ | 682,692        |         |      | $ | 660,260 |         |  | $ | 495,679 |        
|                         |                     |   |                |         |      |   |         |         |  |   |         |        

|(1) |  | Includes the balance sheet of Romaco on the acquisition date of
August 31, 2001 and their operations in fiscal 2002.                                                              
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | Includes the operations of acquisitions from the respective dates of their
acquisition: Rodec  December 12, 2000 and ABI  June 12, 2001.                                        
|   
|(3) |  | Fiscal 2001 included one-time costs of $244,000 related to our Global
Reorganization Program. Fiscal 2000 included a $500,000 charge related to
Universal Glasteel Equipment, Inc.
|   
|(4) |  | Fiscal 2001 included one-time costs of $2,148,000 related to our Global
Reorganization Program.                                                                                   
|   
|(5) |  | Fiscal 2000 included charges of $409,000 for the closure of the Fairfield,
California manufacturing facility, and a $918,000 gain on the sale of the
Fairfield facility.          
|   
|(6) |  | Fiscal 2001 included one-time costs of $100,000 for our Global Reorganization Program.                                                                                            

51



---



##### Table of Contents



NOTE 14  QUARTERLY DATA (UNAUDITED)

|                                                 |         |   |                                       |        |     |   |         |        |     |   |         |        |  |   |         |        |  |   |         |        | 
|------------------------------------------------ | ------- | - | ------------------------------------- | ------ | --- | - | ------- | ------ | --- | - | ------- | ------ |  | - | ------- | ------ |  | - | ------- | ------ | 
|                                                 |         |   | 2002 Quarters                         |        |     |   |        
|                                                 |         |   |                                       |        |     |   |        
|                                                 |         |   | 1st                                   |        | 2nd |   | 3rd     |        | 4th |   | Total  
|                                                 |         |   |                                       |        |     |   |         |        |     |   |        
|                                                 |         |   | (In thousands, except per share data)
|Sales                                            |         | $ | 139,387                               |        |     | $ | 130,002 |        |     | $ | 124,812 |        |  | $ | 132,172 |        |  | $ | 526,373 |       
|Gross profit                                     |         |   | 46,944                                |        |     |   | 43,522  |        |     |   | 41,393  |        |  |   | 41,905  |        |  |   | 173,764 |       
|EBIT                                             |         |   | 12,625                                |        |     |   | 11,227  |        |     |   | 9,365   |        |  |   | 7,730   |        |  |   | 40,947  |       
|Income before income taxes and
minority interest |         |   | 8,572                                 |        |     |   | 6,661   |        |     |   | 4,456   |        |  |   | 3,693   |        |  |   | 23,382  |       
|Net income                                       |         |   | 5,441                                 |        |     |   | 4,170   |        |     |   | 2,696   |        |  |   | 2,196   |        |  |   | 14,503  |       
|Net income per share:                            |         |   |                                       |        |     |   |         |        |     |   |         |        |  |   |         |        |  |   |         |       
|                                                 | Basic   |   | $                                     | 0.46   |     |   | $       | 0.35   |     |   | $       | 0.23   |  |   | $       | 0.16   |  |   | $       | 1.17   | 
|                                                 | Diluted |   |                                       | 0.43   |     |   |         | 0.34   |     |   |         | 0.23   |  |   |         | 0.16   |  |   |         | 1.15   | 
|Weighted average common shares:                  |         |   |                                       |        |     |   |         |        |     |   |         |        |  |   |         |        |  |   |         |       
|                                                 | Basic   |   |                                       | 11,773 |     |   |         | 11,832 |     |   |         | 11,894 |  |   |         | 14,020 |  |   |         | 12,379 | 
|                                                 | Diluted |   |                                       | 14,120 |     |   |         | 14,115 |     |   |         | 14,203 |  |   |         | 16,275 |  |   |         | 14,688 | 

|                                                 |         |   |                                       |        |     |   |         |        |        |   |         |        |  |   |         |        |  |   |         |        | 
|------------------------------------------------ | ------- | - | ------------------------------------- | ------ | --- | - | ------- | ------ | ------ | - | ------- | ------ |  | - | ------- | ------ |  | - | ------- | ------ | 
|                                                 |         |   | 2001 Quarters                         |        |     |   |        
|                                                 |         |   |                                       |        |     |   |        
|                                                 |         |   | 1st                                   |        | 2nd |   | 3rd(1)  |        | 4th(1) |   | Total  
|                                                 |         |   |                                       |        |     |   |         |        |        |   |        
|                                                 |         |   | (In thousands, except per share data)
|Sales                                            |         | $ | 96,027                                |        |     | $ | 104,244 |        |        | $ | 113,177 |        |  | $ | 112,454 |        |  | $ | 425,902 |       
|Gross profit                                     |         |   | 33,190                                |        |     |   | 34,938  |        |        |   | 36,373  |        |  |   | 36,233  |        |  |   | 140,734 |       
|EBIT                                             |         |   | 10,229                                |        |     |   | 10,504  |        |        |   | 9,854   |        |  |   | 12,649  |        |  |   | 43,236  |       
|Income before income taxes and
minority interest |         |   | 7,325                                 |        |     |   | 7,445   |        |        |   | 6,685   |        |  |   | 9,469   |        |  |   | 30,924  |       
|Net income                                       |         |   | 4,584                                 |        |     |   | 4,639   |        |        |   | 4,101   |        |  |   | 6,307   |        |  |   | 19,631  |       
|Net income per share:                            |         |   |                                       |        |     |   |         |        |        |   |         |        |  |   |         |        |  |   |         |       
|                                                 | Basic   |   | $                                     | 0.42   |     |   | $       | 0.42   |        |   | $       | 0.37   |  |   | $       | 0.57   |  |   | $       | 1.78   | 
|                                                 | Diluted |   |                                       | 0.39   |     |   |         | 0.39   |        |   |         | 0.35   |  |   |         | 0.51   |  |   |         | 1.63   | 
|Weighted average common shares:                  |         |   |                                       |        |     |   |         |        |        |   |         |        |  |   |         |        |  |   |         |       
|                                                 | Basic   |   |                                       | 10,973 |     |   |         | 11,014 |        |   |         | 11,090 |  |   |         | 11,116 |  |   |         | 11,050 | 
|                                                 | Diluted |   |                                       | 13,372 |     |   |         | 13,411 |        |   |         | 13,475 |  |   |         | 13,524 |  |   |         | 13,465 | 



|(1) |  | The third and fourth quarters of fiscal 2001 included one-time costs of
$2,341,000 and $151,000, respectively, for our Global Reorganization
Program.
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------

52



---



##### Table of Contents






ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

None.

53



---



##### Table of Contents



PART III




ITEM 10. DIRECTORS AND EXECUTIVE
OFFICERS OF THE REGISTRANT

The information required by this Item 10 is incorporated herein by
reference to the Proxy Statement for our Annual Meeting of Shareholders on
December 11, 2002, except for certain information concerning our executive
officers which is set forth in Part I of this Report.




ITEM 11. EXECUTIVE COMPENSATION

The information required by this Item 11 is incorporated herein by
reference to the Proxy Statement for our Annual Meeting of Shareholders on
December 11, 2002.




ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS

The information required by this Item 12 is incorporated herein by
reference to the Proxy Statement for our Annual Meeting of Shareholders on
December 11, 2002.




ITEM 13. CERTAIN RELATIONSHIPS AND
RELATED TRANSACTIONS

The information required by this Item 13 is incorporated herein by
reference to the Proxy Statement for our Annual Meeting of Shareholders on
December 11, 2002.

54



---



##### Table of Contents






PART IV




ITEM 14. CONTROLS AND PROCEDURES



|(a) |  | Based on a recent evaluation, which was performed within 90 days of the
filing of this Annual Report on Form 10-K, our Chief Executive Officer and
Chief Financial Officer have concluded that our disclosure controls and
procedures (as defined in Securities Exchange Act Rules 13a-14 and 15d-14)
are effective in timely alerting them to material information relating to
us (including our consolidated subsidiaries) required to be included in
periodic reports filed under the Securities Exchange Act.
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(b) |  | There have been no significant changes in our internal controls or in
other factors that could significantly affect these controls subsequent to
August 31, 2002.                                                                                                                                                                                                                                                                                                                                                

55



---



##### Table of Contents






ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

|                                                                                                                                  |   |     |  |                                   |  |                             
|--------------------------------------------------------------------------------------------------------------------------------- | - | --- |  | --------------------------------- |  | ----------------------------
|(a)                                                                                                                               |   | (1) |  |                                   |  | FINANCIAL STATEMENTS        
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|The following consolidated financial statements of Robbins &
Myers, Inc. and
its               subsidiaries are at Item 8 hereof. |   |     |  |                                   | 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|Consolidated Balance Sheet  August 31, 2002 and 2001.                                                                           
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|Consolidated Income Statement -
              Years ended August 31, 2002, 2001, and 2000.                                       
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|Consolidated Shareholders Equity Statement -
              Years ended August 31, 2002, 2001, and 2000.                         
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|Consolidated Cash Flow Statement -
              Years ended August 31, 2002, 2001, and 2000.                                    
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|Notes to Consolidated Financial Statements.                                                                                      
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|(a)                                                                                                                               |   | (2) |  |                                   |  | FINANCIAL STATEMENT SCHEDULE
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                  |   |     |  |                                   |  |                             
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|                                                                                                                                 
|Schedule II                                                                                                                       | - |     |  | Valuation and Qualifying Accounts

All other schedules are omitted because they are not applicable, or not
required, or because the required information is included in the consolidated
financial statements or notes thereto.

|    |  |     |  |  |  |                                                                                                                                                
|--- |  | --- |  |  |  | -----------------------------------------------------------------------------------------------------------------------------------------------
|(a) |  | (3) |  |  |  | EXHIBITS. See
INDEX to EXHIBITS.                                                                                                               
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|(b) |  |     |  |  |  | REPORTS ON FORM 8-K. During the quarter ended August 31,
2002, we filed one report on Form 8-K. A report on Form 8-K was
filed August 19, 2002.

56



---



##### Table of Contents






SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, Robbins & Myers, Inc. has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized, on this
19th day of November, 2002.

|                                                                                                          
|----------------------------------------------------------------------------------------------------------
|ROBBINS & MYERS, INC                                                                                      
|                                                                                                          
|BY  /s/ Gerald L. ConnellyGerald L. Connelly
            President and Chief
            Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this
Report has been signed below by the following persons on behalf of Robbins &
Myers, Inc. and in the capacities and on the date indicated:

|                                                                                                                       |  |                                                                          |  |                                                                                                            
|---------------------------------------------------------------------------------------------------------------------- |  | ------------------------------------------------------------------------ |  | -----------------------------------------------------------------------------------------------------------
|NAME                                                                                                                   |  | TITLE                                                                    |  | DATE                                                                                                       
|                                                                                                                       |  |                                                                          |  |                                                                                                            
|/s/ Gerald L. ConnellyGerald L. Connelly                                                                               |  | Director, President and
Chief Executive Officer                          |  | November 19, 2002                                                                                          
|                                                                                                                      
|/s/ Kevin J. BrownKevin J. Brown                                                                                       |  | Vice President and Chief
Financial Officer
(Principal Financial
Officer) |  | November 19, 2002                                                                                          
|                                                                                                                      
|                                                                                                                       |  |                                                                          |  |                                                                                                            
|                                                                                                                      
|/s/ Thomas J. SchockmanThomas J. Schockman                                                                             |  | Corporate Controller
(Principal Accounting
Officer)                      |  | November 19, 2002                                                                                          
|                                                                                                                      
|                                                                                                                       |  |                                                                          |  |                                                                                                            
|                                                                                                                      
|*Maynard H. Murch, IV
*Robert J. Kegerreis
*Thomas P. Loftis
*William D. Manning
*Jerome F. Tatar
*John N. Taylor, Jr. |  | Chairman Of Board
Director
Director
Director
Director
Director           |  | November 19, 2002
November 19, 2002
November 19, 2002
November 19, 2002
November 19, 2002
November 19, 2002

*The undersigned, by signing his name hereto, executes this Report on Form
10-K for the year ended August 31, 2002 pursuant to powers of attorney executed
by the above-named persons and filed with the Securities and Exchange
Commission.

|                                                                           
|---------------------------------------------------------------------------
|/s/ Gerald L. ConnellyGerald L. Connelly
            Their Attorney-in-fact

57



---



##### Table of Contents






CERTIFICATIONS

I, Gerald L. Connelly, certify that:

| |    |                                                                                                                                                                                                                                                                                                                   | 
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
| | 1. | I have reviewed this annual report on Form 10-K of Robbins & Myers,
Inc. (the Registrant)                                                                                                                                                                                                                      
|
| | 2. | Based on my knowledge, this annual report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstance
under such statements were made, not misleading with respect to the
period covered by this annual report;
|
| | 3. | Based on my knowledge, the financial statements, and other
financial information included in this annual report, fairly present in
all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented
in this annual report;            
|
| | 4. | The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
have:                                                                                            
|

| |    |                                                                                                                                                                                                                                                                                             
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | a) | designed such disclosure controls and procedures to
ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in
which this annual report is being prepared;
|
| | b) | evaluated the effectiveness of the registrants
disclosure controls and procedures as of a date within 90 days
prior to the filing date of this annual report (the Evaluation
Date); and                                                                                                  
|
| | c) | presented in this annual report our conclusions about
the effectiveness of the disclosure controls and procedures
based on our evaluation as of the Evaluation Date;                                                                                                                        
|

| |    |                                                                                                                                                                                                                                                    | 
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
| | 5. | The registrants other certifying officer and I have disclosed,
based on our most recent evaluation, to the registrants auditors and
the audit committee of the registrants board of directors (or persons
performing the equivalent functions):
|

| |    |                                                                                                                                                                                                                                                                                               
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | a) | all significant deficiencies in the design or
operation of internal controls which could adversely affect the
registrants ability to record, process, summarize and report
financial data and have identified for the registrants auditors
any material weaknesses in internal controls; and
|
| | b) | any fraud, whether or not material, that involves
management or other employees who have a significant role in the
registrants internal controls; and                                                                                                                                        

58



---



##### Table of Contents





|6. |  | The registrants other certifying officer and I have indicated in
this annual report whether there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant
deficiencies and material weaknesses.
|-- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|      |  |                   |  | 
|----- |  | ----------------- |  | 
|Date: |  | November 19, 2002
|      |  |                  

| |  |  |  |                                                                               
| |  |  |  | ------------------------------------------------------------------------------
| |  |  |  | /s/ Gerald L. ConnellyGerald L. Connelly
President and Chief Executive Officer

59



---



##### Table of Contents



CERTIFICATIONS

I, Kevin J. Brown, certify that:



| |    |                                                                                                                                                                                                                                                                                                                   | 
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
| | 1. | I have reviewed this annual report on Form 10-K of Robbins & Myers,
Inc. (the Registrant).                                                                                                                                                                                                                     
|
| | 2. | Based on my knowledge, this annual report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstance
under such statements were made, not misleading with respect to the
period covered by this annual report;
|
| | 3. | Based on my knowledge, the financial statements, and other
financial information included in this annual report, fairly present in
all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented
in this annual report;            
|
| | 4. | The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
have:                                                                                            
|

| |    |                                                                                                                                                                                                                                                                                             
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | a) | designed such disclosure controls and procedures to
ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in
which this annual report is being prepared;
|
| | b) | evaluated the effectiveness of the registrants
disclosure controls and procedures as of a date within 90 days
prior to the filing date of this annual report (the Evaluation
Date); and                                                                                                  
|
| | c) | presented in this annual report our conclusions about
the effectiveness of the disclosure controls and procedures based
on our evaluation as of the Evaluation Date;                                                                                                                        
|

| |    |                                                                                                                                                                                                                                                    | 
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
| | 5. | The registrants other certifying officer and I have disclosed,
based on our most recent evaluation, to the registrants auditors and
the audit committee of the registrants board of directors (or persons
performing the equivalent functions):
|

| |    |                                                                                                                                                                                                                                                                                               
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | d) | all significant deficiencies in the design or operation
of internal controls which could adversely affect the
registrants ability to record, process, summarize and report
financial data and have identified for the registrants auditors
any material weaknesses in internal controls; and
|
| | e) | any fraud, whether or not material, that involves
management or other employees who have a significant role in the
registrants internal controls; and                                                                                                                                        

60



---



##### Table of Contents





| | 6. |  | The registrants other certifying officer and I have indicated in
this annual report whether there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant
deficiencies and material weaknesses.
| | -- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|      |  |                   |  |                                                                                     
|----- |  | ----------------- |  | ------------------------------------------------------------------------------------
|Date: |  | November 19, 2002 |  |                                                                                     
|      |  |                   |  |                                                                                     
|     
|      |  |                   |  | /s/ Kevin J. BrownKevin J. Brown
Vice President, Finance and
Chief Financial Officer

61



---



##### Table of Contents






Report of Independent Auditors

Shareholders and Board of Directors
Robbins & Myers, Inc. and Subsidiaries

We have audited the accompanying consolidated balance sheets of Robbins &
Myers, Inc. and Subsidiaries as of August 31, 2002 and 2001, and the related
consolidated statements of income, shareholders equity and cash flows for each
of the three years in the period ended August 31, 2002. Our audits also
included the financial statement schedule listed in the Index at
Item 15(a).
These financial statements and schedule are the responsibility of the Company.
Our responsibility is to express an opinion on these financial statements and
schedule based on our audits.

We conducted our audits in accordance with auditing standards generally
accepted in the United States. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of Robbins & Myers,
Inc. and Subsidiaries at August 31, 2002 and 2001, and the consolidated results
of their operations and their cash flows for each of the three years in the
period ended August 31, 2002, in conformity with accounting principles
generally accepted in the United States.
Also, in our opinion, the related financial statement schedule, when considered
in relation to the basic financial statements taken as a whole, presents fairly
in all material respects the information set forth therein.

|                                |  |                      
|------------------------------- |  | ---------------------
|                                |  | /s/ Ernst & Young LLP
|                               
|Dayton, Ohio
September 30, 2002 |  |                      

62



---



##### Table of Contents






SCHEDULE II  VALUATION AND QUALIFYING ACCOUNTS

|                            |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |        | 
|--------------------------- | --------------------------------------------- | --------------------------------- |  | ---------------- | ---------------- | ------------ | -------------- | ------ | ------ |  |  | ------------ | ----------------- | -------- | --------- | --------- |  |  |  | - | ----- | - |  |  |  |  |  | - | ------ | - |  |  | -- | - |  |  |  |  |  |  |  |  |  | - | ----- |  |  |  | -- | - |  |  |  |  |  | - | ------ | 
|COL. A                      |                                               | COL. B                            |  | COL. C           |                  | COL. D       |                | COL. E
|                            |                                               |                                   |  |                  |                  |              |                |       
|                            |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           | ADDITIONS |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  | 
|                            |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  | 
|DESCRIPTION                 |                                               | Balance at Beginning              |  | Charged to Costs | Charged to Other | Deductions - | Balance at End
|                            |                                               |                                   |  |                  |                  | of Period    |                |        |        |  |  | and Expenses | Accounts-Describe | Describe | of Period
|                            |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |          
|Year Ended August 31, 2002: |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |  
|                           
|                           
|                           
|                           
|                            | Allowances and reserves deducted from assets: |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |       
|                           
|                           
|                           
|                           
|                            |                                               | Uncollectable accounts receivable |  |                  |                  |              |                | $      | 3,332  |  |  |              |                   |          |           |           |  |  |  | $ | 826   |   |  |  |  |  |  | $ | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  | $ | 1,441 |  |  |  | (1 | ) |  |  |  |  |  | $ | 2,717  | 
|                           
|                           
|                           
|                           
|                            |                                               | Inventory obsolescence            |  |                  |                  |              |                |        | 19,065 |  |  |              |                   |          |           |           |  |  |  |   | 2,314 |   |  |  |  |  |  |   | 6,094  |   |  |  | (4 | ) |  |  |  |  |  |  |  |  |  |   | 6,598 |  |  |  | (2 | ) |  |  |  |  |  |   | 20,875 | 
|                           
|                           
|                           
|                           
|                            | Other reserves:                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |       
|                           
|                           
|                           
|                           
|                            |                                               | Warranty claims                   |  |                  |                  |              |                |        | 10,176 |  |  |              |                   |          |           |           |  |  |  |   | 2,219 |   |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 2,990 |  |  |  | (3 | ) |  |  |  |  |  |   | 9,405  | 
|                           
|                           
|                           
|                           
|                            |                                               | Restructuring liabilities         |  |                  |                  |              |                |        | 155    |  |  |              |                   |          |           |           |  |  |  |   | (155  | ) |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 0     |  |  |  |    |   |  |  |  |  |  |   | 0      | 
|                           
|                           
|                           
|                           
|                            |                                               | Current
& L-Tinsurance reserves   |  |                  |                  |              |                |        | 2,484  |  |  |              |                   |          |           |           |  |  |  |   | 2,622 |   |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 2,859 |  |  |  | (7 | ) |  |  |  |  |  |   | 2,247  | 
|                           
|                           
|                           
|                           
|                            |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |  
|                           
|                           
|                           
|                           
|Year
Ended August 31, 2001 
|                           
|                           
|                           
|                           
|                            | Allowances and reserves deducted from assets: |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |       
|                           
|                           
|                           
|                           
|                            |                                               | Uncollectable accounts receivable |  |                  |                  |              |                | $      | 1,726  |  |  |              |                   |          |           |           |  |  |  | $ | 616   |   |  |  |  |  |  | $ | 1,840  |   |  |  | (4 | ) |  |  |  |  |  |  |  |  |  | $ | 850   |  |  |  | (1 | ) |  |  |  |  |  | $ | 3,332  | 
|                           
|                           
|                           
|                           
|                            |                                               | Inventory obsolescence            |  |                  |                  |              |                |        | 9,065  |  |  |              |                   |          |           |           |  |  |  |   | 2,112 |   |  |  |  |  |  |   | 11,229 |   |  |  | (4 | ) |  |  |  |  |  |  |  |  |  |   | 3,341 |  |  |  | (2 | ) |  |  |  |  |  |   | 19,065 | 
|                           
|                           
|                           
|                           
|                            | Other reserves:                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |       
|                           
|                           
|                           
|                           
|                            |                                               | Warranty claims                   |  |                  |                  |              |                |        | 8,332  |  |  |              |                   |          |           |           |  |  |  |   | 1,800 |   |  |  |  |  |  |   | 2,000  |   |  |  | (4 | ) |  |  |  |  |  |  |  |  |  |   | 1,956 |  |  |  | (3 | ) |  |  |  |  |  |   | 10,176 | 
|                           
|                           
|                           
|                           
|                            |                                               | Restructuring liabilities         |  |                  |                  |              |                |        | 836    |  |  |              |                   |          |           |           |  |  |  |   | 0     |   |  |  |  |  |  |   | (550   | ) |  |  | (6 | ) |  |  |  |  |  |  |  |  |  |   | 131   |  |  |  | (5 | ) |  |  |  |  |  |   | 155    | 
|                           
|                           
|                           
|                           
|                            |                                               | Current & L-T insurance reserves  |  |                  |                  |              |                |        | 2,798  |  |  |              |                   |          |           |           |  |  |  |   | 2,543 |   |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 2,857 |  |  |  | (7 | ) |  |  |  |  |  |   | 2,484  | 
|                           
|                           
|                           
|                           
|                            |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |  
|                           
|                           
|                           
|                           
|Year Ended August 31, 2000: |                                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |  
|                           
|                           
|                           
|                           
|                            | Allowances and reserves deducted from assets: |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |       
|                           
|                           
|                           
|                           
|                            |                                               | Uncollectable accounts receivable |  |                  |                  |              |                | $      | 1,688  |  |  |              |                   |          |           |           |  |  |  | $ | 498   |   |  |  |  |  |  | $ | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  | $ | 460   |  |  |  | (1 | ) |  |  |  |  |  | $ | 1,726  | 
|                           
|                           
|                           
|                           
|                            |                                               | Inventory obsolescence            |  |                  |                  |              |                |        | 10,273 |  |  |              |                   |          |           |           |  |  |  |   | 1,304 |   |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 2,512 |  |  |  | (2 | ) |  |  |  |  |  |   | 9,065  | 
|                           
|                           
|                           
|                           
|                            | Other reserves:                               |                                   |  |                  |                  |              |                |        |        |  |  |              |                   |          |           |           |  |  |  |   |       |   |  |  |  |  |  |   |        |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   |       |  |  |  |    |   |  |  |  |  |  |   |       
|                           
|                           
|                           
|                           
|                            |                                               | Warranty claims                   |  |                  |                  |              |                |        | 9,863  |  |  |              |                   |          |           |           |  |  |  |   | 749   |   |  |  |  |  |  |   | (450   | ) |  |  | (8 | ) |  |  |  |  |  |  |  |  |  |   | 1,830 |  |  |  | (3 | ) |  |  |  |  |  |   | 8,332  | 
|                           
|                           
|                           
|                           
|                            |                                               | Restructuring liabilities         |  |                  |                  |              |                |        | 2,273  |  |  |              |                   |          |           |           |  |  |  |   | 0     |   |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 1,437 |  |  |  | (5 | ) |  |  |  |  |  |   | 836    | 
|                           
|                           
|                           
|                           
|                            |                                               | Current & L-T insurance reserves  |  |                  |                  |              |                |        | 2,355  |  |  |              |                   |          |           |           |  |  |  |   | 2,007 |   |  |  |  |  |  |   | 0      |   |  |  |    |   |  |  |  |  |  |  |  |  |  |   | 1,564 |  |  |  | (7 | ) |  |  |  |  |  |   | 2,798  | 



| |  | Note (1) Represents accounts receivable written off against the reserve.   
| |  | ---------------------------------------------------------------------------
|
|
|
|
| |  | Note (2) Inventory items scrapped and written off against the reserve.     
|
|
|
|
| |  | Note (3) Warranty cost incurred applied against the reserve.               
|
|
|
|
| |  | Note (4) Amount due to acquisition of Romaco.                              
|
|
|
|
| |  | Note (5) Spending against restructing reserve.                             
|
|
|
|
| |  | Note (6) Reduction in liability due to lower estimated environmental costs.
|
|
|
|
| |  | Note (7) Spending against casualty reserve.                                
|
|
|
|
| |  | Note (8) Reduction of warranty accrual due to warranty claim settlement.   

63



---



##### Table of Contents






INDEX TO EXHIBITS



|(2) |  | PLAN OF ACQUISITION, REORGANIZATION, ARRANGEMENT, LIQUIDATION OR
SUCCESSION:
|--- |  | ----------------------------------------------------------------------------

|    |  |                                                                                                                                                                                                                                                                                                                                                           |  | 
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | 
|2.1 |  | Stock Purchase Agreement, dated August 10, 2001,
among Robbins & Myers Holdings, Inc. (as Buyer),
Robbins & Myers, Inc. (as sole stockholder of Buyer), and
Brian Fenwick-Smith (as Seller), as amended by
Amendment No. 1 to Stock Purchase Agreement
dated August 28, 2001, was filed as Exhibit 2.1 to our
Report on Form 8-K dated September 17, 2001 |  | 



|(3) |  | ARTICLES OF INCORPORATION AND BY-LAWS:
|--- |  | --------------------------------------

|    |  |                                                                                                                                                        
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------
|3.1 |  | Amended Articles of Incorporation of Robbins
& Myers, Inc. were filed as Exhibit 3.1 to
our Report on Form 10-Q for the
quarter ended February 28, 1998
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|3.2 |  | Code of Regulations of Robbins & Myers, Inc.
was filed as Exhibit 3.2 to our Annual Report on
Form 10-K for the year ended August 31, 2001             



|(4) |  | INSTRUMENTS DEFINING THE RIGHTS OF SECURITY
HOLDERS, INCLUDING INDENTURES:
|--- |  | --------------------------------------------------------------------------

|    |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|4.1 |  | Indenture relating to $65,000,000 Convertible
Subordinated Notes due 2003, with
Star Bank, N.A. , as Trustee, dated September 1, 1996
was filed as Exhibit 4.1 to our Annual Report
on Form 10-K for the year ended August 31, 1996                                                                                                                                                                                                                 
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|4.2 |  | Second Amended and Restated Credit Agreement dated
January 9, 2002 among Robbins & Myers, Inc., the
Lenders name therein, Bank One, N.A. as Administrative
Agent and Issuing Bank, Harris Trust and Savings Bank,
as Co-Syndication Agent, Wachovia Bank, N.A., as
Co-syndication Agent and Bank of Nova Scotia, as
Documentation Agent and Issuing Bank was filed
as Exhibit 4.1 to our Report on Form 10-Q for the
Quarter Ended November 30, 2001

64



---



##### Table of Contents



|    |  |                                                                                                                                                                                                                    
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|   
|   
|   
|4.3 |  | Amended No. 1 to Credit Agreement dated as of
September 27, 2002 to the Second Amended
and Restated Credit Agreement dated January 9, 2002
was filed as Exhibit 4.1 to our Report on Form 8-K
dated October 2, 2002
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|4.4 |  | Pledge and Security Agreement between Robbins & Myers, Inc.
and Bank One, Dayton, N.A., dated November 26, 1996
was filed as Exhibit 4.3 to our Annual Report on
Form 10-K for the year ended August 31, 1996      
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|4.5 |  | Form of $100 million senior note agreement dated May 1, 1998
was filed as Exhibit 4.1 to our Report
on Form 10-Q for the quarter ended May 31, 1998                                                                
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|4.6 |  | Robbins & Myers, Inc. 10.00% Subordinated Note Due 2006 in
the principal amount of Euro 2,452,000, dated
August 31, 2001                                                                                           
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|   
|4.7 |  | Robbins & Myers, Inc. 10.00% Subordinated Notes Due 2007
in the principal amount of Euro 18,190,662, dated
February 28, 2002                                                                                       



|(10) |  | MATERIAL CONTRACTS:
|---- |  | -------------------

|     |  |                                                                                                                                                                                                                                       
|---- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|10.1 |  | Robbins & Myers, Inc. Cash Balance Pension Plan (As
Amended and Restated Effective as of
October 1, 1999) was filed as Exhibit 10.1 to our
Annual Report on Form 10-K for the year ended
August 31, 2001                              
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|10.2 |  | Robbins & Myers, Inc. Employee Savings
Plan as amended through August 31, 2000 was filed
as Exhibit 10.4 to our Annual Report on
Form 10-K for the year ended August 31, 2000                                                         
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|10.3 |  | Robbins & Myers, Inc. Executive Supplemental Retirement
Plan adopted February 2000 and Amendment No. 1
to such Plan adopted August 2000 was filed as Exhibit
10.5 to our Annual Report on Form 10-K for
the year ended August 31, 2000
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|    
|10.4 |  | Robbins & Myers, Inc. Executive Supplemental
Pension Plan adopted July 2000 was filed as Exhibit
10.6 to our Annual Report on Form 10-K for
the year ended August 31, 2000                                                            

65



---



##### Table of Contents



|      |  |                                                                                                                                                                                                         
|----- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.5  |  | Form of Indemnification Agreement between
Robbins & Myers, Inc., and each director was filed
as Exhibit 10.5 to our Annual Report on Form 10-K
for the year ended August 31, 2001                       
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.6  |  | Robbins & Myers, Inc. 1994 Directors Stock
Compensation Plan was filed as Exhibit
10.6 to our Annual Report on Form 10-K for
the year ended August 31, 2001                                             
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.7  |  | Robbins & Myers, Inc. 1994 Long-Term Incentive
Stock Plan as amended was filed as Exhibit 10.11
to our Report on Form 10-K for the
year ended August 31, 1996                                           
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.8  |  | Robbins & Myers, Inc. 1995 Stock Option Plan for
Non-Employee Directors was filed as
Exhibit 10.12 to our Report on
Form 10-K for the year ended August 31, 1996                                        
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.9  |  | Robbins & Myers, Inc. Senior Executive Annual Cash
Bonus Plan was filed as Exhibit 10.13 to our
Report on Form 10-K for the year
ended August 31, 1996                                                  
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.10 |  | Salary Continuation Agreement between Robbins &
Myers, Inc. and Gerald L. Connelly, dated
February 19, 1999 was filed as Exhibit 10.1 to
our Report on Form 10-Q for the
Quarter Ended February 28, 1999
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|     
|10.11 |  | Robbins & Myers, Inc. 1999 Long-Term
Incentive Stock Plan was filed as Exhibit 4.3
to our Registration Statement on
Form S-8 (No. 333-35856)                                                            

66



---



##### Table of Contents





|(21) |  | SUBSIDIARIES OF THE REGISTRANT                
|---- |  | ----------------------------------------------
|    
|     |  | 21.1     Subsidiaries of Robbins & Myers, Inc.
|    
|(23) |  | CONSENTS OF EXPERTS AND COUNSEL               

|                                     
|-------------------------------------
|23.1
    Consent of Ernst & Young LLP



|(24) |  | POWER OF ATTORNEY
|---- |  | -----------------

|     |  |                                                                                                                          
|---- |  | -------------------------------------------------------------------------------------------------------------------------
|24.1 |  | Powers of Attorney of any person who
signed this Report on Form 10-K on
behalf of another pursuant to a
Power of Attorney



|(99) |  | OTHER EXHIBITS
|---- |  | --------------

|     |  |                                                                                                                                                                                   
|---- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|99.1 |  | Section 906 CEO Certification                                                                                                                                                     
|    
|    
|    
|    
|99.2 |  | Section 906 CFO Certification                                                                                                                                                     
|    
|    
|    
|    
|    
|F  |  | Indicates Exhibit is being filed with this Report.                                                                                                                                
|    
|    
|    
|    
|*  |  | Indicates that Exhibit is incorporated by reference in this Report
from a previous filing with the Commission.                                                                    
|    
|    
|    
|    
|R  |  | Instrument with respect to indebtedness that does not exceed 10% of
the Companys total assets which is not being filed, but will be
furnished to the Commission upon its request.

67